date generated: 2023-08-29
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
x | |
---|---|
0610009B22Rik | -2.2697336 |
0610009E02Rik | -0.3519839 |
0610009L18Rik | -0.9139963 |
0610010K14Rik | -0.1751685 |
0610012G03Rik | 0.5678859 |
0610030E20Rik | 1.4359134 |
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 16937 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8287 |
num_profile_genes_not_in_sets | 8650 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: mouse_msigdb_reactome_2022-02-16.gmtGene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 433 |
num_genesets_included | 1171 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Top N= 50 gene sets
## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 8.74e-05 | -0.654 | 9.59e-04 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 5.27e-05 | -0.648 | 6.23e-04 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.86e-20 | -0.575 | 4.36e-18 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 8.89e-08 | -0.555 | 2.57e-06 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.92e-13 | -0.553 | 1.25e-11 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 3.62e-24 | -0.549 | 2.12e-21 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 4.81e-22 | -0.542 | 1.45e-19 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 2.31e-19 | -0.537 | 3.86e-17 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 12 | 1.55e-03 | -0.528 | 1.19e-02 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 4.91e-03 | 0.514 | 3.02e-02 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 3.40e-06 | -0.498 | 5.85e-05 |
COMPLEX I BIOGENESIS | 56 | 1.50e-10 | -0.495 | 8.35e-09 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 4.94e-03 | -0.489 | 3.03e-02 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 7.48e-03 | 0.488 | 4.21e-02 |
CRMPS IN SEMA3A SIGNALING | 16 | 7.19e-04 | 0.488 | 6.33e-03 |
SELENOAMINO ACID METABOLISM | 109 | 2.85e-18 | -0.483 | 3.71e-16 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 9.03e-03 | -0.477 | 4.85e-02 |
PROTEIN METHYLATION | 17 | 7.85e-04 | -0.470 | 6.81e-03 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 8.39e-03 | -0.459 | 4.61e-02 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 1.34e-15 | -0.458 | 1.21e-13 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 5.94e-04 | -0.455 | 5.31e-03 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.38e-02 | 0.450 | 6.84e-02 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 3.79e-03 | 0.447 | 2.49e-02 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 1.43e-03 | 0.447 | 1.12e-02 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 47 | 1.20e-07 | -0.446 | 3.28e-06 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 1.46e-08 | -0.446 | 5.50e-07 |
NONSENSE MEDIATED DECAY NMD | 109 | 9.02e-16 | -0.446 | 9.49e-14 |
TRIGLYCERIDE CATABOLISM | 14 | 4.25e-03 | -0.441 | 2.75e-02 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 161 | 4.97e-22 | -0.441 | 1.45e-19 |
CRISTAE FORMATION | 31 | 2.30e-05 | -0.439 | 3.06e-04 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 2.82e-17 | -0.438 | 3.30e-15 |
NRAGE SIGNALS DEATH THROUGH JNK | 55 | 2.09e-08 | 0.437 | 7.63e-07 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 6.58e-09 | -0.437 | 2.85e-07 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 8.00e-09 | -0.434 | 3.23e-07 |
SIGNALING BY LEPTIN | 10 | 1.78e-02 | 0.433 | 8.24e-02 |
INTERLEUKIN 12 SIGNALING | 37 | 5.34e-06 | -0.432 | 8.61e-05 |
PROCESSING OF SMDT1 | 16 | 2.91e-03 | -0.430 | 2.02e-02 |
GLYCOGEN SYNTHESIS | 14 | 5.60e-03 | -0.428 | 3.33e-02 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 54 | 7.14e-08 | -0.424 | 2.20e-06 |
TRANSLATION | 286 | 7.33e-35 | -0.423 | 8.59e-32 |
MITOCHONDRIAL TRANSLATION | 93 | 1.81e-12 | -0.423 | 1.11e-10 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 1.91e-03 | -0.423 | 1.40e-02 |
METABOLISM OF POLYAMINES | 58 | 3.07e-08 | -0.420 | 1.06e-06 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 8.84e-04 | 0.419 | 7.50e-03 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 2.51e-04 | -0.415 | 2.44e-03 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 2.37e-02 | -0.413 | 1.04e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 2.46e-03 | -0.412 | 1.75e-02 |
ACTIVATION OF SMO | 16 | 4.72e-03 | 0.408 | 2.96e-02 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.88e-20 | -0.408 | 5.63e-18 |
CROSSLINKING OF COLLAGEN FIBRILS | 15 | 6.47e-03 | 0.406 | 3.68e-02 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 8.74e-05 | -0.654000 | 9.59e-04 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 5.27e-05 | -0.648000 | 6.23e-04 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.86e-20 | -0.575000 | 4.36e-18 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 8.89e-08 | -0.555000 | 2.57e-06 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.92e-13 | -0.553000 | 1.25e-11 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 3.62e-24 | -0.549000 | 2.12e-21 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 4.81e-22 | -0.542000 | 1.45e-19 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 2.31e-19 | -0.537000 | 3.86e-17 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 12 | 1.55e-03 | -0.528000 | 1.19e-02 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 4.91e-03 | 0.514000 | 3.02e-02 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 3.40e-06 | -0.498000 | 5.85e-05 |
COMPLEX I BIOGENESIS | 56 | 1.50e-10 | -0.495000 | 8.35e-09 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 4.94e-03 | -0.489000 | 3.03e-02 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 7.48e-03 | 0.488000 | 4.21e-02 |
CRMPS IN SEMA3A SIGNALING | 16 | 7.19e-04 | 0.488000 | 6.33e-03 |
SELENOAMINO ACID METABOLISM | 109 | 2.85e-18 | -0.483000 | 3.71e-16 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 9.03e-03 | -0.477000 | 4.85e-02 |
PROTEIN METHYLATION | 17 | 7.85e-04 | -0.470000 | 6.81e-03 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 8.39e-03 | -0.459000 | 4.61e-02 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 1.34e-15 | -0.458000 | 1.21e-13 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 5.94e-04 | -0.455000 | 5.31e-03 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.38e-02 | 0.450000 | 6.84e-02 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 3.79e-03 | 0.447000 | 2.49e-02 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 1.43e-03 | 0.447000 | 1.12e-02 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 47 | 1.20e-07 | -0.446000 | 3.28e-06 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 1.46e-08 | -0.446000 | 5.50e-07 |
NONSENSE MEDIATED DECAY NMD | 109 | 9.02e-16 | -0.446000 | 9.49e-14 |
TRIGLYCERIDE CATABOLISM | 14 | 4.25e-03 | -0.441000 | 2.75e-02 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 161 | 4.97e-22 | -0.441000 | 1.45e-19 |
CRISTAE FORMATION | 31 | 2.30e-05 | -0.439000 | 3.06e-04 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 2.82e-17 | -0.438000 | 3.30e-15 |
NRAGE SIGNALS DEATH THROUGH JNK | 55 | 2.09e-08 | 0.437000 | 7.63e-07 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 6.58e-09 | -0.437000 | 2.85e-07 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 8.00e-09 | -0.434000 | 3.23e-07 |
SIGNALING BY LEPTIN | 10 | 1.78e-02 | 0.433000 | 8.24e-02 |
INTERLEUKIN 12 SIGNALING | 37 | 5.34e-06 | -0.432000 | 8.61e-05 |
PROCESSING OF SMDT1 | 16 | 2.91e-03 | -0.430000 | 2.02e-02 |
GLYCOGEN SYNTHESIS | 14 | 5.60e-03 | -0.428000 | 3.33e-02 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 54 | 7.14e-08 | -0.424000 | 2.20e-06 |
TRANSLATION | 286 | 7.33e-35 | -0.423000 | 8.59e-32 |
MITOCHONDRIAL TRANSLATION | 93 | 1.81e-12 | -0.423000 | 1.11e-10 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 1.91e-03 | -0.423000 | 1.40e-02 |
METABOLISM OF POLYAMINES | 58 | 3.07e-08 | -0.420000 | 1.06e-06 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 8.84e-04 | 0.419000 | 7.50e-03 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 2.51e-04 | -0.415000 | 2.44e-03 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 2.37e-02 | -0.413000 | 1.04e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 2.46e-03 | -0.412000 | 1.75e-02 |
ACTIVATION OF SMO | 16 | 4.72e-03 | 0.408000 | 2.96e-02 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.88e-20 | -0.408000 | 5.63e-18 |
CROSSLINKING OF COLLAGEN FIBRILS | 15 | 6.47e-03 | 0.406000 | 3.68e-02 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 2.16e-02 | -0.400000 | 9.56e-02 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 2.62e-04 | 0.399000 | 2.54e-03 |
INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 3.41e-04 | 0.398000 | 3.17e-03 |
RORA ACTIVATES GENE EXPRESSION | 18 | 3.48e-03 | 0.398000 | 2.33e-02 |
STABILIZATION OF P53 | 55 | 3.34e-07 | -0.398000 | 7.39e-06 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 6.05e-03 | -0.396000 | 3.52e-02 |
TRANSLESION SYNTHESIS BY POLH | 19 | 2.91e-03 | -0.394000 | 2.02e-02 |
METHYLATION | 11 | 2.51e-02 | -0.390000 | 1.09e-01 |
PYRUVATE METABOLISM | 27 | 4.60e-04 | -0.390000 | 4.21e-03 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 1.00e-06 | -0.388000 | 1.95e-05 |
INTERLEUKIN 37 SIGNALING | 17 | 5.56e-03 | 0.388000 | 3.32e-02 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 1.54e-02 | 0.388000 | 7.40e-02 |
EARLY PHASE OF HIV LIFE CYCLE | 13 | 1.54e-02 | -0.388000 | 7.40e-02 |
NCAM1 INTERACTIONS | 40 | 2.21e-05 | 0.388000 | 3.01e-04 |
TRANSLESION SYNTHESIS BY POLK | 17 | 6.24e-03 | -0.383000 | 3.62e-02 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 1.77e-02 | 0.380000 | 8.24e-02 |
CELLULAR RESPONSE TO STARVATION | 145 | 4.52e-15 | -0.377000 | 3.53e-13 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 65 | 1.64e-07 | -0.376000 | 4.08e-06 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 14 | 1.50e-02 | 0.375000 | 7.33e-02 |
CHOLESTEROL BIOSYNTHESIS | 24 | 1.48e-03 | -0.375000 | 1.15e-02 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 9.76e-04 | 0.374000 | 8.04e-03 |
DEGRADATION OF DVL | 56 | 1.33e-06 | -0.374000 | 2.50e-05 |
IRAK4 DEFICIENCY TLR2 4 | 12 | 2.52e-02 | -0.373000 | 1.09e-01 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 64 | 2.47e-07 | -0.373000 | 5.78e-06 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 2.11e-04 | -0.373000 | 2.08e-03 |
ORC1 REMOVAL FROM CHROMATIN | 68 | 1.24e-07 | -0.371000 | 3.29e-06 |
INTERLEUKIN 12 FAMILY SIGNALING | 44 | 2.37e-05 | -0.368000 | 3.12e-04 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 31 | 3.92e-04 | -0.368000 | 3.62e-03 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 1.70e-04 | -0.367000 | 1.72e-03 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 3.55e-02 | 0.366000 | 1.42e-01 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 10 | 4.57e-02 | 0.365000 | 1.66e-01 |
DEGRADATION OF AXIN | 54 | 3.52e-06 | -0.365000 | 5.97e-05 |
HEDGEHOG LIGAND BIOGENESIS | 62 | 6.85e-07 | -0.365000 | 1.39e-05 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 4.86e-03 | 0.364000 | 3.01e-02 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 1.36e-03 | 0.363000 | 1.07e-02 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 1.53e-07 | -0.363000 | 3.88e-06 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 5.00e-03 | -0.363000 | 3.05e-02 |
ANTIGEN PROCESSING CROSS PRESENTATION | 94 | 1.30e-09 | -0.362000 | 6.63e-08 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 87 | 6.47e-09 | -0.360000 | 2.85e-07 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 70 | 1.94e-07 | -0.360000 | 4.71e-06 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 6.56e-04 | 0.359000 | 5.82e-03 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 5.05e-02 | -0.357000 | 1.77e-01 |
INTERLEUKIN 6 SIGNALING | 10 | 5.11e-02 | 0.356000 | 1.79e-01 |
PENTOSE PHOSPHATE PATHWAY | 13 | 2.62e-02 | -0.356000 | 1.12e-01 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 58 | 2.73e-06 | -0.356000 | 4.78e-05 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 1.02e-06 | -0.356000 | 1.96e-05 |
INFLUENZA INFECTION | 145 | 1.78e-13 | -0.354000 | 1.22e-11 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 5.03e-03 | 0.354000 | 3.05e-02 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 11 | 4.34e-02 | -0.352000 | 1.61e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 62 | 1.69e-06 | 0.352000 | 3.05e-05 |
G1 S DNA DAMAGE CHECKPOINTS | 66 | 8.58e-07 | -0.350000 | 1.70e-05 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 5.91e-08 | -0.349000 | 1.87e-06 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 3.68e-02 | -0.348000 | 1.44e-01 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 4.71e-03 | -0.348000 | 2.96e-02 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 5.76e-02 | -0.347000 | 1.97e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 2.03e-02 | 0.346000 | 9.10e-02 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 3.66e-03 | -0.343000 | 2.42e-02 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 2.66e-05 | -0.340000 | 3.43e-04 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 68 | 1.46e-06 | -0.338000 | 2.71e-05 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 1.10e-02 | -0.337000 | 5.79e-02 |
CELLULAR RESPONSE TO HYPOXIA | 73 | 6.88e-07 | -0.336000 | 1.39e-05 |
PROTEIN UBIQUITINATION | 69 | 1.64e-06 | -0.334000 | 3.01e-05 |
HDMS DEMETHYLATE HISTONES | 27 | 2.69e-03 | 0.334000 | 1.89e-02 |
COLLAGEN CHAIN TRIMERIZATION | 39 | 3.21e-04 | 0.333000 | 3.01e-03 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 60 | 8.49e-06 | -0.332000 | 1.26e-04 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 7.30e-03 | -0.330000 | 4.13e-02 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 1.29e-02 | -0.330000 | 6.49e-02 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 79 | 4.28e-07 | -0.329000 | 9.28e-06 |
PHOSPHORYLATION OF THE APC C | 17 | 1.91e-02 | -0.328000 | 8.74e-02 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 6.45e-03 | -0.328000 | 3.68e-02 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 13 | 4.05e-02 | 0.328000 | 1.55e-01 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 4.11e-02 | 0.327000 | 1.56e-01 |
PRE NOTCH PROCESSING IN GOLGI | 18 | 1.71e-02 | 0.325000 | 8.06e-02 |
CHAPERONE MEDIATED AUTOPHAGY | 20 | 1.22e-02 | -0.324000 | 6.24e-02 |
RHOBTB3 ATPASE CYCLE | 10 | 7.63e-02 | -0.324000 | 2.38e-01 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 4.35e-02 | 0.323000 | 1.61e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 53 | 4.78e-05 | 0.323000 | 5.78e-04 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 1.04e-02 | -0.323000 | 5.51e-02 |
DNA REPLICATION PRE INITIATION | 80 | 6.74e-07 | -0.321000 | 1.39e-05 |
SIGNALING BY ROBO RECEPTORS | 206 | 2.94e-15 | -0.319000 | 2.46e-13 |
RRNA PROCESSING | 194 | 2.55e-14 | -0.317000 | 1.87e-12 |
AMINE LIGAND BINDING RECEPTORS | 29 | 3.17e-03 | 0.317000 | 2.17e-02 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 50 | 1.12e-04 | -0.316000 | 1.17e-03 |
NEPHRIN FAMILY INTERACTIONS | 22 | 1.04e-02 | 0.316000 | 5.50e-02 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 1.48e-02 | -0.315000 | 7.27e-02 |
CELLULAR HEXOSE TRANSPORT | 11 | 7.26e-02 | 0.313000 | 2.30e-01 |
INSULIN RECEPTOR RECYCLING | 20 | 1.69e-02 | -0.309000 | 7.99e-02 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 4.32e-03 | -0.306000 | 2.78e-02 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 7.91e-02 | 0.306000 | 2.43e-01 |
PYROPTOSIS | 21 | 1.54e-02 | -0.305000 | 7.40e-02 |
REPRESSION OF WNT TARGET GENES | 14 | 4.84e-02 | 0.305000 | 1.73e-01 |
REGULATION OF RAS BY GAPS | 67 | 1.70e-05 | -0.304000 | 2.37e-04 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 5.81e-02 | -0.304000 | 1.98e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 1.89e-02 | -0.303000 | 8.66e-02 |
REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 9.79e-02 | 0.302000 | 2.77e-01 |
LONG TERM POTENTIATION | 23 | 1.22e-02 | 0.302000 | 6.24e-02 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 60 | 5.56e-05 | 0.301000 | 6.45e-04 |
REGULATION OF BACH1 ACTIVITY | 11 | 8.45e-02 | -0.300000 | 2.53e-01 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 11 | 8.47e-02 | -0.300000 | 2.53e-01 |
DNA REPLICATION | 122 | 1.12e-08 | -0.300000 | 4.37e-07 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 67 | 2.44e-05 | -0.298000 | 3.17e-04 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 37 | 1.71e-03 | 0.298000 | 1.28e-02 |
NEUREXINS AND NEUROLIGINS | 54 | 1.53e-04 | 0.298000 | 1.55e-03 |
SYNTHESIS OF PE | 13 | 6.36e-02 | 0.297000 | 2.11e-01 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 5.08e-03 | -0.296000 | 3.06e-02 |
COLLAGEN FORMATION | 78 | 7.56e-06 | 0.293000 | 1.15e-04 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 316 | 4.08e-19 | -0.293000 | 5.97e-17 |
INTERLEUKIN 20 FAMILY SIGNALING | 13 | 6.80e-02 | 0.292000 | 2.20e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 4.07e-06 | -0.291000 | 6.80e-05 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 5.13e-02 | 0.291000 | 1.79e-01 |
CDC42 GTPASE CYCLE | 152 | 6.45e-10 | 0.291000 | 3.43e-08 |
RAS PROCESSING | 24 | 1.40e-02 | -0.290000 | 6.90e-02 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 4.79e-03 | 0.288000 | 2.98e-02 |
ABC TRANSPORTER DISORDERS | 69 | 3.51e-05 | -0.288000 | 4.41e-04 |
RHOB GTPASE CYCLE | 67 | 4.79e-05 | 0.287000 | 5.78e-04 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 84 | 5.37e-06 | -0.287000 | 8.61e-05 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 73 | 2.28e-05 | 0.287000 | 3.06e-04 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 1.00e-01 | -0.286000 | 2.80e-01 |
FCERI MEDIATED NF KB ACTIVATION | 77 | 1.74e-05 | -0.283000 | 2.40e-04 |
LGI ADAM INTERACTIONS | 14 | 6.73e-02 | 0.282000 | 2.19e-01 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 85 | 6.85e-06 | -0.282000 | 1.07e-04 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 2.57e-02 | -0.281000 | 1.10e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 1.32e-02 | 0.281000 | 6.59e-02 |
PURINE CATABOLISM | 16 | 5.19e-02 | -0.281000 | 1.80e-01 |
INTERLEUKIN 6 FAMILY SIGNALING | 19 | 3.48e-02 | 0.280000 | 1.40e-01 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 1.37e-02 | -0.279000 | 6.82e-02 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 3.61e-02 | -0.278000 | 1.43e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 4.18e-02 | -0.277000 | 1.57e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 5.53e-04 | 0.277000 | 4.98e-03 |
PKMTS METHYLATE HISTONE LYSINES | 48 | 9.45e-04 | 0.276000 | 7.91e-03 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 4.31e-02 | 0.275000 | 1.61e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 6.52e-02 | -0.275000 | 2.15e-01 |
ENOS ACTIVATION | 11 | 1.15e-01 | -0.275000 | 3.10e-01 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 8.76e-02 | 0.274000 | 2.59e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 3.98e-02 | -0.272000 | 1.53e-01 |
METABOLISM OF COFACTORS | 18 | 4.57e-02 | -0.272000 | 1.66e-01 |
SCAVENGING BY CLASS A RECEPTORS | 13 | 9.16e-02 | -0.270000 | 2.64e-01 |
S PHASE | 154 | 7.33e-09 | -0.270000 | 3.06e-07 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 1.68e-05 | 0.270000 | 2.37e-04 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 1.21e-01 | -0.270000 | 3.21e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 1.53e-02 | -0.270000 | 7.40e-02 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 1.21e-02 | -0.269000 | 6.23e-02 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 8.43e-03 | -0.269000 | 4.61e-02 |
REGULATED NECROSIS | 46 | 1.76e-03 | -0.267000 | 1.31e-02 |
TRP CHANNELS | 18 | 5.25e-02 | 0.264000 | 1.82e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 37 | 5.75e-03 | -0.262000 | 3.39e-02 |
IRON UPTAKE AND TRANSPORT | 52 | 1.07e-03 | -0.262000 | 8.75e-03 |
G ALPHA 12 13 SIGNALLING EVENTS | 74 | 9.76e-05 | 0.262000 | 1.04e-03 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 11 | 1.34e-01 | -0.261000 | 3.42e-01 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 3.87e-02 | 0.261000 | 1.50e-01 |
G PROTEIN ACTIVATION | 22 | 3.54e-02 | -0.259000 | 1.41e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 35 | 8.02e-03 | 0.259000 | 4.47e-02 |
INTEGRIN SIGNALING | 24 | 2.84e-02 | 0.259000 | 1.20e-01 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 1.57e-01 | -0.258000 | 3.79e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 20 | 4.59e-02 | -0.258000 | 1.66e-01 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 1.59e-01 | -0.258000 | 3.81e-01 |
G2 M CHECKPOINTS | 135 | 2.57e-07 | -0.257000 | 5.90e-06 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 4.69e-02 | 0.257000 | 1.68e-01 |
HSF1 ACTIVATION | 25 | 2.65e-02 | -0.256000 | 1.13e-01 |
PROTEIN LOCALIZATION | 156 | 3.75e-08 | -0.255000 | 1.25e-06 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 28 | 1.94e-02 | -0.255000 | 8.82e-02 |
RET SIGNALING | 36 | 8.24e-03 | 0.255000 | 4.57e-02 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 1.29e-02 | 0.254000 | 6.49e-02 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 150 | 8.09e-08 | -0.254000 | 2.43e-06 |
INOSITOL PHOSPHATE METABOLISM | 47 | 2.64e-03 | 0.254000 | 1.86e-02 |
PHASE 2 PLATEAU PHASE | 13 | 1.14e-01 | 0.253000 | 3.08e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 3.16e-02 | -0.253000 | 1.29e-01 |
PI METABOLISM | 79 | 1.05e-04 | 0.252000 | 1.11e-03 |
PEPTIDE HORMONE METABOLISM | 59 | 8.11e-04 | -0.252000 | 6.94e-03 |
LAMININ INTERACTIONS | 28 | 2.14e-02 | 0.251000 | 9.48e-02 |
COLLAGEN DEGRADATION | 51 | 1.93e-03 | 0.251000 | 1.41e-02 |
REGULATION OF BETA CELL DEVELOPMENT | 25 | 3.00e-02 | 0.251000 | 1.24e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 1.70e-01 | 0.251000 | 3.97e-01 |
O LINKED GLYCOSYLATION | 87 | 5.45e-05 | 0.250000 | 6.39e-04 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 9.44e-02 | 0.249000 | 2.70e-01 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 83 | 8.76e-05 | -0.249000 | 9.59e-04 |
MITOPHAGY | 29 | 2.03e-02 | -0.249000 | 9.10e-02 |
VOLTAGE GATED POTASSIUM CHANNELS | 40 | 6.46e-03 | 0.249000 | 3.68e-02 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 9.67e-02 | -0.248000 | 2.76e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 8.32e-03 | 0.247000 | 4.60e-02 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 9.74e-02 | 0.247000 | 2.77e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 94 | 3.56e-05 | 0.247000 | 4.44e-04 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 1.39e-01 | -0.246000 | 3.53e-01 |
RHOBTB2 GTPASE CYCLE | 23 | 4.15e-02 | -0.246000 | 1.57e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 7.13e-02 | 0.246000 | 2.28e-01 |
SEPARATION OF SISTER CHROMATIDS | 165 | 5.40e-08 | -0.246000 | 1.76e-06 |
MET ACTIVATES RAS SIGNALING | 10 | 1.80e-01 | -0.245000 | 4.14e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 1.00e-01 | 0.245000 | 2.80e-01 |
ACTIVATION OF RAC1 | 13 | 1.26e-01 | -0.245000 | 3.28e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 1.82e-01 | 0.244000 | 4.14e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 1.28e-01 | 0.244000 | 3.33e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 86 | 9.60e-05 | 0.243000 | 1.03e-03 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 2.99e-02 | 0.242000 | 1.24e-01 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.39e-02 | -0.240000 | 6.87e-02 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 1.50e-01 | -0.240000 | 3.70e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 7.89e-02 | -0.239000 | 2.43e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 9.80e-02 | 0.239000 | 2.77e-01 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 11 | 1.71e-01 | 0.238000 | 3.99e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 104 | 2.96e-05 | -0.237000 | 3.77e-04 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 1.56e-01 | -0.237000 | 3.77e-01 |
CALNEXIN CALRETICULIN CYCLE | 26 | 3.68e-02 | -0.237000 | 1.44e-01 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 12 | 1.57e-01 | -0.236000 | 3.79e-01 |
FORMATION OF APOPTOSOME | 10 | 1.96e-01 | -0.236000 | 4.32e-01 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 63 | 1.24e-03 | -0.235000 | 1.00e-02 |
PRE NOTCH EXPRESSION AND PROCESSING | 64 | 1.15e-03 | 0.235000 | 9.32e-03 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 1.99e-01 | -0.235000 | 4.35e-01 |
METABOLISM OF STEROID HORMONES | 20 | 7.00e-02 | -0.234000 | 2.25e-01 |
MET ACTIVATES RAP1 AND RAC1 | 11 | 1.80e-01 | -0.234000 | 4.14e-01 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 1.45e-01 | -0.234000 | 3.62e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 4.33e-02 | -0.234000 | 1.61e-01 |
IRE1ALPHA ACTIVATES CHAPERONES | 49 | 4.70e-03 | 0.234000 | 2.96e-02 |
CARNITINE METABOLISM | 14 | 1.30e-01 | 0.233000 | 3.37e-01 |
RAB GERANYLGERANYLATION | 59 | 2.02e-03 | -0.232000 | 1.47e-02 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 141 | 1.93e-06 | -0.232000 | 3.43e-05 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 6.72e-02 | -0.231000 | 2.19e-01 |
LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 2.66e-02 | -0.230000 | 1.13e-01 |
CYTOPROTECTION BY HMOX1 | 120 | 1.40e-05 | -0.230000 | 2.03e-04 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 1.52e-01 | -0.229000 | 3.73e-01 |
ECM PROTEOGLYCANS | 66 | 1.28e-03 | 0.229000 | 1.02e-02 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 13 | 1.52e-01 | 0.229000 | 3.73e-01 |
SHC MEDIATED CASCADE FGFR4 | 11 | 1.88e-01 | -0.229000 | 4.23e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 8.44e-02 | -0.229000 | 2.53e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 2.11e-01 | -0.229000 | 4.51e-01 |
OLFACTORY SIGNALING PATHWAY | 30 | 3.04e-02 | -0.228000 | 1.25e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 3.04e-02 | 0.228000 | 1.25e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 2.56e-02 | 0.228000 | 1.10e-01 |
RAC1 GTPASE CYCLE | 176 | 1.97e-07 | 0.228000 | 4.71e-06 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 1.92e-01 | -0.227000 | 4.26e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 106 | 5.71e-05 | 0.226000 | 6.56e-04 |
CLEC7A DECTIN 1 SIGNALING | 95 | 1.40e-04 | -0.226000 | 1.45e-03 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 31 | 3.01e-02 | -0.225000 | 1.25e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 14 | 1.45e-01 | -0.225000 | 3.62e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 3.97e-02 | -0.225000 | 1.53e-01 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 24 | 5.81e-02 | -0.223000 | 1.98e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 51 | 5.98e-03 | 0.223000 | 3.50e-02 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 4.96e-02 | 0.222000 | 1.75e-01 |
CELL CYCLE CHECKPOINTS | 243 | 2.89e-09 | -0.221000 | 1.35e-07 |
TNFR2 NON CANONICAL NF KB PATHWAY | 83 | 4.98e-04 | -0.221000 | 4.52e-03 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 6.19e-02 | -0.220000 | 2.07e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 40 | 1.67e-02 | 0.219000 | 7.95e-02 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 93 | 2.71e-04 | -0.219000 | 2.60e-03 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 111 | 7.60e-05 | -0.218000 | 8.56e-04 |
ERBB2 ACTIVATES PTK6 SIGNALING | 10 | 2.34e-01 | 0.217000 | 4.80e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 1.78e-02 | -0.217000 | 8.24e-02 |
DEATH RECEPTOR SIGNALLING | 133 | 1.65e-05 | 0.216000 | 2.35e-04 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 6.64e-02 | -0.216000 | 2.17e-01 |
C TYPE LECTIN RECEPTORS CLRS | 113 | 7.22e-05 | -0.216000 | 8.21e-04 |
TIE2 SIGNALING | 17 | 1.23e-01 | -0.216000 | 3.24e-01 |
DAG AND IP3 SIGNALING | 40 | 1.84e-02 | 0.215000 | 8.49e-02 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 23 | 7.40e-02 | -0.215000 | 2.34e-01 |
NETRIN 1 SIGNALING | 48 | 1.01e-02 | 0.215000 | 5.39e-02 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 50 | 8.72e-03 | 0.214000 | 4.72e-02 |
GAP JUNCTION ASSEMBLY | 22 | 8.19e-02 | -0.214000 | 2.50e-01 |
HOST INTERACTIONS OF HIV FACTORS | 124 | 3.90e-05 | -0.214000 | 4.81e-04 |
RHOC GTPASE CYCLE | 73 | 1.63e-03 | 0.213000 | 1.23e-02 |
PROGRAMMED CELL DEATH | 187 | 5.07e-07 | -0.213000 | 1.08e-05 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 1.18e-01 | 0.213000 | 3.15e-01 |
P75NTR REGULATES AXONOGENESIS | 10 | 2.45e-01 | -0.212000 | 4.88e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 6.17e-02 | 0.212000 | 2.07e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 2.04e-01 | 0.212000 | 4.42e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 1.11e-01 | -0.211000 | 3.02e-01 |
SIGNALING BY NOTCH1 | 75 | 1.62e-03 | 0.211000 | 1.23e-02 |
CHROMATIN MODIFYING ENZYMES | 218 | 9.00e-08 | 0.210000 | 2.57e-06 |
GAP JUNCTION DEGRADATION | 11 | 2.30e-01 | -0.209000 | 4.76e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 8.29e-02 | -0.209000 | 2.52e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 11 | 2.30e-01 | 0.209000 | 4.76e-01 |
TCR SIGNALING | 101 | 2.96e-04 | -0.208000 | 2.80e-03 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 1.63e-01 | 0.208000 | 3.83e-01 |
SMOOTH MUSCLE CONTRACTION | 33 | 3.91e-02 | -0.208000 | 1.51e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 1.08e-01 | 0.207000 | 2.96e-01 |
MITOTIC METAPHASE AND ANAPHASE | 206 | 2.97e-07 | -0.207000 | 6.69e-06 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 30 | 4.95e-02 | 0.207000 | 1.75e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 2.14e-01 | -0.207000 | 4.52e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 9.36e-02 | 0.207000 | 2.69e-01 |
GP1B IX V ACTIVATION SIGNALLING | 10 | 2.60e-01 | 0.206000 | 5.02e-01 |
GLYCOGEN METABOLISM | 25 | 7.52e-02 | -0.206000 | 2.35e-01 |
G2 M DNA DAMAGE CHECKPOINT | 65 | 4.23e-03 | -0.205000 | 2.75e-02 |
FC EPSILON RECEPTOR FCERI SIGNALING | 124 | 8.10e-05 | -0.205000 | 9.03e-04 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 2.19e-01 | 0.205000 | 4.58e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 61 | 5.68e-03 | -0.205000 | 3.36e-02 |
APOPTOSIS | 165 | 6.54e-06 | -0.204000 | 1.04e-04 |
ANCHORING FIBRIL FORMATION | 14 | 1.87e-01 | 0.203000 | 4.23e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 9.14e-02 | -0.203000 | 2.64e-01 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 2.44e-01 | 0.203000 | 4.88e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 7.49e-02 | -0.202000 | 2.35e-01 |
MEIOTIC RECOMBINATION | 38 | 3.19e-02 | -0.201000 | 1.30e-01 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 1.12e-01 | -0.200000 | 3.05e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 25 | 8.34e-02 | -0.200000 | 2.52e-01 |
INTRA GOLGI TRAFFIC | 43 | 2.33e-02 | 0.200000 | 1.02e-01 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 12 | 2.31e-01 | -0.200000 | 4.76e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 1.96e-01 | 0.199000 | 4.32e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 1.74e-02 | -0.198000 | 8.20e-02 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 4.54e-02 | -0.198000 | 1.66e-01 |
STIMULI SENSING CHANNELS | 74 | 3.24e-03 | 0.198000 | 2.18e-02 |
EXTRACELLULAR MATRIX ORGANIZATION | 240 | 1.41e-07 | 0.197000 | 3.68e-06 |
PHASE 0 RAPID DEPOLARISATION | 29 | 6.63e-02 | 0.197000 | 2.17e-01 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 25 | 9.02e-02 | -0.196000 | 2.62e-01 |
SIGNALING BY NOTCH4 | 83 | 2.10e-03 | -0.195000 | 1.52e-02 |
DNA DAMAGE BYPASS | 47 | 2.11e-02 | -0.195000 | 9.38e-02 |
ASPARTATE AND ASPARAGINE METABOLISM | 10 | 2.90e-01 | -0.193000 | 5.28e-01 |
LAGGING STRAND SYNTHESIS | 20 | 1.35e-01 | -0.193000 | 3.44e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 2.68e-01 | 0.193000 | 5.11e-01 |
UCH PROTEINASES | 90 | 1.57e-03 | -0.193000 | 1.20e-02 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 5.96e-02 | 0.192000 | 2.02e-01 |
MAPK6 MAPK4 SIGNALING | 84 | 2.32e-03 | -0.192000 | 1.66e-02 |
PLATELET AGGREGATION PLUG FORMATION | 32 | 6.03e-02 | 0.192000 | 2.03e-01 |
PHOSPHOLIPID METABOLISM | 185 | 7.07e-06 | 0.192000 | 1.09e-04 |
GLYCOGEN STORAGE DISEASES | 12 | 2.53e-01 | -0.191000 | 4.94e-01 |
KILLING MECHANISMS | 10 | 2.97e-01 | 0.190000 | 5.36e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 27 | 8.84e-02 | 0.189000 | 2.59e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 38 | 4.37e-02 | -0.189000 | 1.61e-01 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 19 | 1.54e-01 | -0.189000 | 3.76e-01 |
REGULATION OF IFNG SIGNALING | 13 | 2.38e-01 | -0.189000 | 4.84e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 3.63e-02 | 0.189000 | 1.44e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.18e-01 | 0.188000 | 3.16e-01 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 1.19e-02 | 0.188000 | 6.20e-02 |
SIGNALING BY NOTCH2 | 33 | 6.26e-02 | 0.187000 | 2.08e-01 |
TRIGLYCERIDE METABOLISM | 23 | 1.20e-01 | -0.187000 | 3.19e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 2.83e-01 | 0.187000 | 5.24e-01 |
RMTS METHYLATE HISTONE ARGININES | 43 | 3.41e-02 | 0.187000 | 1.38e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 1.97e-01 | 0.187000 | 4.32e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 5.00e-02 | 0.186000 | 1.76e-01 |
METABOLISM OF RNA | 644 | 9.73e-16 | -0.186000 | 9.49e-14 |
MET ACTIVATES PTK2 SIGNALING | 29 | 8.31e-02 | 0.186000 | 2.52e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.23e-01 | 0.186000 | 3.24e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 2.87e-01 | 0.186000 | 5.26e-01 |
RHO GTPASES ACTIVATE KTN1 | 11 | 2.87e-01 | -0.185000 | 5.26e-01 |
MRNA SPLICING | 188 | 1.23e-05 | -0.185000 | 1.80e-04 |
RHOA GTPASE CYCLE | 141 | 1.52e-04 | 0.185000 | 1.55e-03 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 1.35e-01 | -0.184000 | 3.44e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 15 | 2.18e-01 | 0.184000 | 4.57e-01 |
RHOBTB GTPASE CYCLE | 35 | 6.01e-02 | -0.184000 | 2.03e-01 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 2.95e-01 | 0.182000 | 5.33e-01 |
INTERLEUKIN 15 SIGNALING | 12 | 2.75e-01 | 0.182000 | 5.17e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 1.60e-01 | 0.181000 | 3.83e-01 |
DARPP 32 EVENTS | 23 | 1.32e-01 | -0.181000 | 3.39e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 8.10e-02 | 0.181000 | 2.48e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 3.22e-01 | 0.181000 | 5.62e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 2.80e-01 | 0.180000 | 5.21e-01 |
DSCAM INTERACTIONS | 10 | 3.25e-01 | 0.180000 | 5.64e-01 |
SIGNALING BY FGFR2 IN DISEASE | 36 | 6.22e-02 | -0.180000 | 2.08e-01 |
POLYMERASE SWITCHING | 14 | 2.45e-01 | -0.179000 | 4.88e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 10 | 3.27e-01 | -0.179000 | 5.67e-01 |
FATTY ACID METABOLISM | 145 | 2.10e-04 | -0.178000 | 2.08e-03 |
SIGNALING BY NOTCH3 | 48 | 3.27e-02 | 0.178000 | 1.32e-01 |
SIGNALING BY CSF3 G CSF | 29 | 9.80e-02 | -0.178000 | 2.77e-01 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 2.50e-01 | 0.178000 | 4.92e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 2.36e-01 | -0.177000 | 4.83e-01 |
INWARDLY RECTIFYING K CHANNELS | 31 | 8.86e-02 | -0.177000 | 2.59e-01 |
RHO GTPASES ACTIVATE PKNS | 47 | 3.68e-02 | -0.176000 | 1.44e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 1.97e-01 | 0.176000 | 4.32e-01 |
MITOTIC SPINDLE CHECKPOINT | 96 | 2.99e-03 | -0.175000 | 2.06e-02 |
HIV INFECTION | 220 | 7.94e-06 | -0.175000 | 1.19e-04 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 2.04e-02 | 0.175000 | 9.14e-02 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 1.04e-01 | 0.174000 | 2.87e-01 |
FRS MEDIATED FGFR4 SIGNALING | 13 | 2.76e-01 | -0.174000 | 5.18e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 8.84e-02 | -0.174000 | 2.59e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 6.87e-02 | 0.173000 | 2.22e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 71 | 1.19e-02 | -0.173000 | 6.20e-02 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 1.82e-01 | 0.173000 | 4.14e-01 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 3.46e-01 | 0.172000 | 5.87e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 24 | 1.45e-01 | -0.172000 | 3.62e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 92 | 4.43e-03 | -0.172000 | 2.84e-02 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 1.55e-01 | -0.172000 | 3.77e-01 |
ION TRANSPORT BY P TYPE ATPASES | 48 | 4.00e-02 | 0.171000 | 1.53e-01 |
RHOU GTPASE CYCLE | 33 | 8.87e-02 | 0.171000 | 2.59e-01 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.55e-01 | -0.171000 | 3.77e-01 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 8.46e-02 | 0.171000 | 2.53e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 16 | 2.37e-01 | -0.171000 | 4.84e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 1.65e-01 | -0.171000 | 3.87e-01 |
SIGNAL AMPLIFICATION | 30 | 1.06e-01 | -0.171000 | 2.90e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 2.34e-02 | -0.171000 | 1.03e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 4.77e-02 | -0.171000 | 1.71e-01 |
DISEASES OF GLYCOSYLATION | 126 | 9.75e-04 | 0.170000 | 8.04e-03 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 1.26e-01 | 0.170000 | 3.28e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 1.60e-01 | 0.169000 | 3.83e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 11 | 3.31e-01 | -0.169000 | 5.72e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 2.14e-01 | -0.169000 | 4.52e-01 |
GLUTATHIONE CONJUGATION | 29 | 1.15e-01 | -0.169000 | 3.10e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 598 | 3.12e-12 | -0.167000 | 1.83e-10 |
NEUTROPHIL DEGRANULATION | 384 | 2.31e-08 | -0.166000 | 8.19e-07 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 1.58e-01 | -0.166000 | 3.81e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 3.02e-01 | -0.166000 | 5.39e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 107 | 3.18e-03 | 0.165000 | 2.17e-02 |
SIGNALING BY PDGF | 57 | 3.11e-02 | 0.165000 | 1.27e-01 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 15 | 2.68e-01 | 0.165000 | 5.11e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 2.14e-01 | 0.165000 | 4.52e-01 |
GABA RECEPTOR ACTIVATION | 53 | 3.84e-02 | -0.164000 | 1.50e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 2.55e-01 | -0.164000 | 4.96e-01 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 1.73e-01 | 0.164000 | 4.03e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 77 | 1.29e-02 | 0.164000 | 6.49e-02 |
MISMATCH REPAIR | 14 | 2.91e-01 | -0.163000 | 5.28e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 6.91e-02 | 0.162000 | 2.22e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 30 | 1.25e-01 | -0.162000 | 3.28e-01 |
CA DEPENDENT EVENTS | 36 | 9.41e-02 | 0.161000 | 2.69e-01 |
INTERLEUKIN 1 SIGNALING | 96 | 6.35e-03 | -0.161000 | 3.66e-02 |
RHOH GTPASE CYCLE | 37 | 8.97e-02 | -0.161000 | 2.61e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 120 | 2.32e-03 | 0.161000 | 1.66e-02 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 1.84e-01 | 0.160000 | 4.18e-01 |
THE PHOTOTRANSDUCTION CASCADE | 21 | 2.05e-01 | -0.160000 | 4.42e-01 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 3.19e-01 | 0.160000 | 5.60e-01 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 54 | 4.32e-02 | -0.159000 | 1.61e-01 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 3.61e-01 | -0.159000 | 6.06e-01 |
FRS MEDIATED FGFR2 SIGNALING | 18 | 2.43e-01 | -0.159000 | 4.88e-01 |
GAB1 SIGNALOSOME | 13 | 3.21e-01 | 0.159000 | 5.62e-01 |
PROTEIN FOLDING | 89 | 9.73e-03 | -0.159000 | 5.20e-02 |
COHESIN LOADING ONTO CHROMATIN | 10 | 3.86e-01 | -0.158000 | 6.32e-01 |
NUCLEAR ENVELOPE BREAKDOWN | 49 | 5.54e-02 | 0.158000 | 1.90e-01 |
INSULIN PROCESSING | 24 | 1.81e-01 | -0.158000 | 4.14e-01 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 3.44e-01 | -0.158000 | 5.86e-01 |
KINESINS | 48 | 5.87e-02 | 0.158000 | 1.99e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 56 | 4.14e-02 | 0.158000 | 1.57e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 2.39e-01 | -0.156000 | 4.84e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 2.85e-01 | -0.154000 | 5.24e-01 |
RND2 GTPASE CYCLE | 38 | 1.00e-01 | 0.154000 | 2.80e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 2.45e-01 | -0.154000 | 4.88e-01 |
SIGNALING BY EGFR IN CANCER | 21 | 2.22e-01 | -0.154000 | 4.62e-01 |
INFLAMMASOMES | 19 | 2.49e-01 | -0.153000 | 4.90e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 34 | 1.24e-01 | -0.153000 | 3.24e-01 |
RHOV GTPASE CYCLE | 32 | 1.35e-01 | 0.153000 | 3.44e-01 |
PCP CE PATHWAY | 91 | 1.21e-02 | -0.152000 | 6.23e-02 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 83 | 1.66e-02 | 0.152000 | 7.92e-02 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 2.07e-01 | -0.152000 | 4.45e-01 |
METALLOPROTEASE DUBS | 26 | 1.80e-01 | -0.152000 | 4.14e-01 |
CHROMOSOME MAINTENANCE | 101 | 8.69e-03 | -0.151000 | 4.72e-02 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 1.63e-01 | -0.150000 | 3.83e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 11 | 3.91e-01 | -0.149000 | 6.37e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 1.88e-01 | -0.149000 | 4.23e-01 |
BIOLOGICAL OXIDATIONS | 122 | 4.56e-03 | -0.149000 | 2.90e-02 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 2.62e-01 | -0.149000 | 5.03e-01 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 2.89e-01 | 0.149000 | 5.28e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 2.39e-01 | 0.149000 | 4.84e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 3.94e-01 | -0.149000 | 6.38e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 7.57e-02 | 0.148000 | 2.36e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 33 | 1.42e-01 | -0.148000 | 3.57e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 1.20e-01 | -0.148000 | 3.19e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 1.55e-01 | 0.148000 | 3.77e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 6.58e-02 | -0.148000 | 2.17e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 2.11e-01 | -0.147000 | 4.51e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 3.97e-01 | -0.147000 | 6.41e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 2.25e-01 | -0.146000 | 4.68e-01 |
CARDIAC CONDUCTION | 108 | 8.74e-03 | 0.146000 | 4.72e-02 |
TNF SIGNALING | 43 | 9.83e-02 | 0.146000 | 2.77e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 1.30e-01 | -0.146000 | 3.37e-01 |
INTERLEUKIN 10 SIGNALING | 20 | 2.60e-01 | -0.146000 | 5.02e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 2.37e-01 | 0.146000 | 4.84e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 1.49e-01 | 0.145000 | 3.66e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 4.26e-01 | -0.145000 | 6.62e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 3.31e-01 | 0.145000 | 5.72e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 3.02e-01 | -0.145000 | 5.39e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 32 | 1.60e-01 | 0.143000 | 3.83e-01 |
LYSOSOME VESICLE BIOGENESIS | 32 | 1.62e-01 | -0.143000 | 3.83e-01 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 1.91e-01 | 0.143000 | 4.26e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 2.58e-01 | -0.143000 | 5.00e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 1.63e-01 | 0.143000 | 3.83e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 80 | 2.81e-02 | -0.142000 | 1.19e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 20 | 2.72e-01 | 0.142000 | 5.13e-01 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 2.85e-01 | -0.142000 | 5.24e-01 |
G PROTEIN MEDIATED EVENTS | 52 | 7.70e-02 | 0.142000 | 2.39e-01 |
SYNTHESIS OF PA | 29 | 1.87e-01 | 0.141000 | 4.23e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 27 | 2.04e-01 | -0.141000 | 4.41e-01 |
HATS ACETYLATE HISTONES | 92 | 1.93e-02 | 0.141000 | 8.80e-02 |
SIGNALING BY WNT IN CANCER | 30 | 1.82e-01 | 0.141000 | 4.14e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 65 | 4.98e-02 | -0.141000 | 1.76e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 1.03e-01 | -0.141000 | 2.85e-01 |
SHC MEDIATED CASCADE FGFR1 | 14 | 3.63e-01 | -0.140000 | 6.07e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 4.21e-01 | 0.140000 | 6.57e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 107 | 1.25e-02 | 0.140000 | 6.37e-02 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 3.33e-01 | 0.140000 | 5.74e-01 |
SIGNALLING TO RAS | 18 | 3.08e-01 | 0.139000 | 5.48e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 4.06e-01 | 0.139000 | 6.45e-01 |
TRANS GOLGI NETWORK VESICLE BUDDING | 69 | 4.67e-02 | -0.139000 | 1.68e-01 |
INTERLEUKIN 7 SIGNALING | 20 | 2.84e-01 | 0.138000 | 5.24e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 47 | 1.02e-01 | -0.138000 | 2.83e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 30 | 1.92e-01 | -0.138000 | 4.26e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 2.73e-04 | -0.137000 | 2.60e-03 |
PURINE SALVAGE | 12 | 4.10e-01 | -0.137000 | 6.49e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 2.01e-01 | 0.137000 | 4.38e-01 |
SHC MEDIATED CASCADE FGFR3 | 13 | 3.92e-01 | -0.137000 | 6.38e-01 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 3.95e-01 | 0.136000 | 6.38e-01 |
RND3 GTPASE CYCLE | 38 | 1.46e-01 | 0.136000 | 3.64e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 32 | 1.83e-01 | 0.136000 | 4.15e-01 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 4.57e-01 | 0.136000 | 6.87e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 9.10e-02 | -0.136000 | 2.63e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 57 | 7.77e-02 | 0.135000 | 2.40e-01 |
COMPLEMENT CASCADE | 24 | 2.52e-01 | -0.135000 | 4.94e-01 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 188 | 1.43e-03 | 0.135000 | 1.12e-02 |
SARS COV 1 INFECTION | 48 | 1.07e-01 | -0.135000 | 2.93e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 8.73e-02 | 0.135000 | 2.59e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 2.77e-01 | 0.134000 | 5.18e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 4.06e-01 | 0.133000 | 6.45e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 40 | 1.45e-01 | 0.133000 | 3.62e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 2.42e-01 | 0.133000 | 4.88e-01 |
ION CHANNEL TRANSPORT | 139 | 7.64e-03 | 0.131000 | 4.28e-02 |
INFECTIOUS DISEASE | 723 | 2.52e-09 | -0.131000 | 1.23e-07 |
RHO GTPASE CYCLE | 422 | 4.40e-06 | 0.131000 | 7.26e-05 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 23 | 2.78e-01 | -0.131000 | 5.19e-01 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 49 | 1.14e-01 | 0.131000 | 3.08e-01 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 2.70e-01 | 0.130000 | 5.12e-01 |
NOD1 2 SIGNALING PATHWAY | 34 | 1.90e-01 | 0.130000 | 4.25e-01 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 4.38e-01 | 0.129000 | 6.71e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 4.02e-01 | 0.129000 | 6.44e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 101 | 2.48e-02 | -0.129000 | 1.08e-01 |
ACYL CHAIN REMODELLING OF PS | 14 | 4.03e-01 | 0.129000 | 6.44e-01 |
SENSORY PROCESSING OF SOUND | 60 | 8.58e-02 | 0.128000 | 2.55e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 4.42e-01 | 0.128000 | 6.76e-01 |
TP53 REGULATES METABOLIC GENES | 85 | 4.29e-02 | -0.127000 | 1.61e-01 |
CIRCADIAN CLOCK | 68 | 7.06e-02 | 0.127000 | 2.26e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 21 | 3.15e-01 | 0.127000 | 5.57e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 71 | 6.52e-02 | 0.127000 | 2.15e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 9.03e-02 | 0.126000 | 2.62e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 2.47e-01 | -0.126000 | 4.89e-01 |
MITOTIC G2 G2 M PHASES | 186 | 3.21e-03 | -0.125000 | 2.17e-02 |
PROLACTIN RECEPTOR SIGNALING | 11 | 4.72e-01 | 0.125000 | 6.96e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 12 | 4.53e-01 | -0.125000 | 6.85e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 53 | 1.16e-01 | 0.125000 | 3.10e-01 |
PI 3K CASCADE FGFR4 | 11 | 4.73e-01 | -0.125000 | 6.96e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 27 | 2.64e-01 | -0.124000 | 5.05e-01 |
TBC RABGAPS | 43 | 1.62e-01 | 0.123000 | 3.83e-01 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 2.96e-01 | -0.123000 | 5.34e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 2.14e-01 | 0.123000 | 4.52e-01 |
PI 3K CASCADE FGFR2 | 16 | 3.94e-01 | -0.123000 | 6.38e-01 |
THE NLRP3 INFLAMMASOME | 15 | 4.09e-01 | -0.123000 | 6.49e-01 |
ELASTIC FIBRE FORMATION | 36 | 2.02e-01 | 0.123000 | 4.39e-01 |
ERK MAPK TARGETS | 22 | 3.20e-01 | 0.123000 | 5.61e-01 |
PEROXISOMAL PROTEIN IMPORT | 57 | 1.10e-01 | -0.122000 | 3.00e-01 |
LDL CLEARANCE | 16 | 3.97e-01 | -0.122000 | 6.41e-01 |
ION HOMEOSTASIS | 49 | 1.40e-01 | 0.122000 | 3.55e-01 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 35 | 2.13e-01 | -0.122000 | 4.52e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 5.07e-01 | 0.121000 | 7.20e-01 |
INTEGRATION OF ENERGY METABOLISM | 98 | 3.88e-02 | 0.121000 | 1.50e-01 |
METABOLISM OF NUCLEOTIDES | 92 | 4.56e-02 | -0.121000 | 1.66e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 19 | 3.65e-01 | 0.120000 | 6.08e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 2.08e-01 | 0.120000 | 4.46e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 15 | 4.24e-01 | -0.119000 | 6.62e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 62 | 1.05e-01 | -0.119000 | 2.89e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 1.82e-01 | 0.119000 | 4.14e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 4.26e-01 | -0.119000 | 6.62e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 2.61e-01 | -0.118000 | 5.03e-01 |
HS GAG BIOSYNTHESIS | 30 | 2.62e-01 | 0.118000 | 5.03e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 2.79e-01 | -0.118000 | 5.19e-01 |
HCMV EARLY EVENTS | 80 | 6.82e-02 | 0.118000 | 2.21e-01 |
DNA STRAND ELONGATION | 32 | 2.49e-01 | -0.118000 | 4.90e-01 |
MUCOPOLYSACCHARIDOSES | 11 | 4.99e-01 | 0.118000 | 7.12e-01 |
M PHASE | 339 | 2.05e-04 | -0.118000 | 2.05e-03 |
RA BIOSYNTHESIS PATHWAY | 14 | 4.46e-01 | -0.118000 | 6.80e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 29 | 2.73e-01 | -0.118000 | 5.16e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 139 | 1.76e-02 | -0.117000 | 8.24e-02 |
PLASMA LIPOPROTEIN REMODELING | 15 | 4.34e-01 | -0.117000 | 6.68e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 1.78e-01 | 0.116000 | 4.12e-01 |
HEME BIOSYNTHESIS | 13 | 4.69e-01 | 0.116000 | 6.96e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 2.35e-01 | 0.116000 | 4.81e-01 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 3.28e-01 | 0.115000 | 5.68e-01 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 5.29e-01 | -0.115000 | 7.32e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 46 | 1.77e-01 | 0.115000 | 4.12e-01 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 1.92e-01 | -0.115000 | 4.26e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 1.85e-01 | -0.114000 | 4.20e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 115 | 3.47e-02 | 0.114000 | 1.39e-01 |
ARACHIDONIC ACID METABOLISM | 39 | 2.18e-01 | -0.114000 | 4.57e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 3.79e-01 | 0.114000 | 6.26e-01 |
ANTIMICROBIAL PEPTIDES | 13 | 4.78e-01 | -0.114000 | 7.00e-01 |
HS GAG DEGRADATION | 21 | 3.67e-01 | 0.114000 | 6.12e-01 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 35 | 2.47e-01 | 0.113000 | 4.89e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 102 | 4.86e-02 | -0.113000 | 1.73e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 3.94e-01 | 0.113000 | 6.38e-01 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 3.49e-01 | -0.113000 | 5.91e-01 |
INNATE IMMUNE SYSTEM | 773 | 1.10e-07 | -0.113000 | 3.06e-06 |
AQUAPORIN MEDIATED TRANSPORT | 40 | 2.17e-01 | -0.113000 | 4.57e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 5.18e-01 | 0.113000 | 7.32e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 2.13e-01 | 0.112000 | 4.52e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 144 | 2.02e-02 | -0.112000 | 9.10e-02 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 4.38e-01 | 0.112000 | 6.71e-01 |
HEDGEHOG ON STATE | 83 | 7.91e-02 | -0.112000 | 2.43e-01 |
SEMAPHORIN INTERACTIONS | 64 | 1.23e-01 | 0.111000 | 3.24e-01 |
MET PROMOTES CELL MOTILITY | 39 | 2.30e-01 | 0.111000 | 4.76e-01 |
SULFUR AMINO ACID METABOLISM | 22 | 3.68e-01 | -0.111000 | 6.12e-01 |
NUCLEOBASE CATABOLISM | 31 | 2.90e-01 | -0.110000 | 5.28e-01 |
NEDDYLATION | 218 | 5.36e-03 | -0.110000 | 3.22e-02 |
MYOGENESIS | 25 | 3.44e-01 | 0.109000 | 5.86e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 24 | 3.54e-01 | -0.109000 | 5.97e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 5.33e-01 | 0.109000 | 7.34e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 3.89e-01 | -0.109000 | 6.36e-01 |
SARS COV 2 INFECTION | 65 | 1.31e-01 | -0.108000 | 3.39e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 3.59e-01 | 0.108000 | 6.04e-01 |
PEXOPHAGY | 11 | 5.35e-01 | 0.108000 | 7.35e-01 |
ONCOGENIC MAPK SIGNALING | 77 | 1.02e-01 | 0.108000 | 2.83e-01 |
FRS MEDIATED FGFR1 SIGNALING | 16 | 4.59e-01 | -0.107000 | 6.89e-01 |
PI3K AKT SIGNALING IN CANCER | 87 | 8.48e-02 | 0.107000 | 2.53e-01 |
PLATELET CALCIUM HOMEOSTASIS | 27 | 3.39e-01 | 0.106000 | 5.82e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 1.90e-01 | 0.106000 | 4.25e-01 |
STRIATED MUSCLE CONTRACTION | 28 | 3.33e-01 | -0.106000 | 5.74e-01 |
PYRIMIDINE CATABOLISM | 10 | 5.64e-01 | -0.105000 | 7.50e-01 |
CELL CYCLE MITOTIC | 474 | 9.36e-05 | -0.105000 | 1.01e-03 |
REGULATION OF TNFR1 SIGNALING | 34 | 2.93e-01 | 0.104000 | 5.30e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 11 | 5.50e-01 | -0.104000 | 7.41e-01 |
KERATAN SULFATE DEGRADATION | 11 | 5.53e-01 | -0.103000 | 7.42e-01 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 5.22e-01 | -0.103000 | 7.32e-01 |
HEME SIGNALING | 44 | 2.40e-01 | 0.102000 | 4.85e-01 |
NEURONAL SYSTEM | 366 | 8.05e-04 | 0.102000 | 6.94e-03 |
MEIOSIS | 63 | 1.61e-01 | -0.102000 | 3.83e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 4.53e-01 | 0.102000 | 6.85e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 94 | 8.79e-02 | -0.102000 | 2.59e-01 |
FRS MEDIATED FGFR3 SIGNALING | 15 | 4.95e-01 | -0.102000 | 7.10e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 4.31e-01 | -0.102000 | 6.64e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 343 | 1.28e-03 | -0.101000 | 1.02e-02 |
SIGNALING BY RETINOIC ACID | 34 | 3.06e-01 | -0.101000 | 5.46e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 2.62e-01 | 0.101000 | 5.03e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 3.55e-01 | -0.101000 | 5.97e-01 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 13 | 5.29e-01 | -0.101000 | 7.32e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 122 | 5.49e-02 | -0.101000 | 1.89e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 5.30e-01 | 0.101000 | 7.32e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 3.41e-01 | 0.100000 | 5.85e-01 |
L1CAM INTERACTIONS | 107 | 7.31e-02 | 0.100000 | 2.31e-01 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 3.42e-01 | 0.100000 | 5.86e-01 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 5.50e-01 | -0.099800 | 7.41e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 4.66e-01 | 0.099300 | 6.95e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 4.00e-01 | 0.099200 | 6.42e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 4.79e-01 | 0.099200 | 7.00e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 5.37e-01 | 0.098800 | 7.37e-01 |
INTERLEUKIN 27 SIGNALING | 10 | 5.88e-01 | 0.098800 | 7.68e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 5.22e-01 | 0.098800 | 7.32e-01 |
NICOTINATE METABOLISM | 24 | 4.02e-01 | 0.098800 | 6.44e-01 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 5.22e-01 | -0.098700 | 7.32e-01 |
CELL CYCLE | 591 | 4.92e-05 | -0.098100 | 5.88e-04 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 5.26e-01 | 0.097800 | 7.32e-01 |
PEROXISOMAL LIPID METABOLISM | 26 | 3.88e-01 | -0.097700 | 6.36e-01 |
SIGNALING BY EGFR | 46 | 2.53e-01 | 0.097500 | 4.94e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 25 | 3.99e-01 | -0.097400 | 6.42e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 5.45e-01 | 0.097100 | 7.41e-01 |
TELOMERE MAINTENANCE | 78 | 1.39e-01 | -0.097000 | 3.53e-01 |
REPRODUCTION | 75 | 1.48e-01 | -0.096800 | 3.64e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 4.54e-01 | -0.096700 | 6.85e-01 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 5.04e-01 | -0.096500 | 7.17e-01 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 1.80e-01 | -0.096200 | 4.14e-01 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 21 | 4.47e-01 | -0.095900 | 6.80e-01 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 3.14e-01 | -0.095700 | 5.57e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 5.22e-01 | -0.095400 | 7.32e-01 |
RND1 GTPASE CYCLE | 37 | 3.16e-01 | 0.095300 | 5.58e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 6.02e-01 | 0.095300 | 7.78e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 4.54e-01 | 0.094400 | 6.85e-01 |
INITIAL TRIGGERING OF COMPLEMENT | 11 | 5.88e-01 | 0.094200 | 7.68e-01 |
HDACS DEACETYLATE HISTONES | 46 | 2.70e-01 | 0.094100 | 5.12e-01 |
SIGNALING BY INSULIN RECEPTOR | 61 | 2.04e-01 | -0.094000 | 4.42e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 58 | 2.22e-01 | -0.092800 | 4.62e-01 |
CELL CELL COMMUNICATION | 106 | 9.95e-02 | 0.092700 | 2.79e-01 |
RETROGRADE NEUROTROPHIN SIGNALLING | 13 | 5.64e-01 | 0.092500 | 7.50e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 85 | 1.41e-01 | 0.092500 | 3.55e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 5.65e-01 | -0.092200 | 7.50e-01 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 25 | 4.27e-01 | -0.091800 | 6.62e-01 |
INTERLEUKIN 17 SIGNALING | 66 | 1.98e-01 | 0.091600 | 4.34e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 3.63e-01 | -0.091600 | 6.07e-01 |
BILE ACID AND BILE SALT METABOLISM | 25 | 4.28e-01 | 0.091500 | 6.62e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 78 | 1.62e-01 | 0.091500 | 3.83e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 5.53e-01 | 0.091500 | 7.42e-01 |
SIGNALING BY INTERLEUKINS | 347 | 3.50e-03 | -0.091400 | 2.33e-02 |
ERBB2 REGULATES CELL MOTILITY | 13 | 5.69e-01 | 0.091200 | 7.53e-01 |
DUAL INCISION IN TC NER | 64 | 2.07e-01 | -0.091200 | 4.46e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 19 | 4.92e-01 | -0.091100 | 7.08e-01 |
DAP12 SIGNALING | 24 | 4.41e-01 | -0.090800 | 6.76e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 4.51e-01 | -0.090700 | 6.84e-01 |
SIGNALING BY GPCR | 459 | 9.35e-04 | 0.090400 | 7.88e-03 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 5.45e-01 | -0.090400 | 7.41e-01 |
REGULATION OF IFNA SIGNALING | 12 | 5.88e-01 | 0.090300 | 7.68e-01 |
DISEASES OF METABOLISM | 201 | 2.87e-02 | 0.089600 | 1.20e-01 |
G ALPHA S SIGNALLING EVENTS | 98 | 1.26e-01 | 0.089500 | 3.28e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 4.90e-01 | 0.089200 | 7.08e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 83 | 1.62e-01 | -0.088900 | 3.83e-01 |
HYALURONAN METABOLISM | 15 | 5.53e-01 | 0.088600 | 7.42e-01 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 2.12e-01 | -0.088300 | 4.52e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 107 | 1.16e-01 | -0.088100 | 3.10e-01 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 10 | 6.30e-01 | -0.088100 | 7.97e-01 |
GLUCONEOGENESIS | 27 | 4.29e-01 | -0.088000 | 6.62e-01 |
SELECTIVE AUTOPHAGY | 71 | 2.00e-01 | -0.088000 | 4.37e-01 |
SIGNALING BY FLT3 FUSION PROTEINS | 18 | 5.21e-01 | -0.087400 | 7.32e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 19 | 5.12e-01 | -0.086900 | 7.24e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 19 | 5.12e-01 | -0.086900 | 7.24e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 61 | 2.41e-01 | 0.086900 | 4.87e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 4.19e-01 | 0.086700 | 6.56e-01 |
ZINC TRANSPORTERS | 16 | 5.49e-01 | -0.086500 | 7.41e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 3.72e-01 | 0.086100 | 6.17e-01 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 5.64e-01 | -0.086000 | 7.50e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 2.34e-01 | -0.085500 | 4.80e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 4.27e-01 | -0.085300 | 6.62e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 29 | 4.27e-01 | 0.085300 | 6.62e-01 |
KERATINIZATION | 29 | 4.27e-01 | 0.085300 | 6.62e-01 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 6.10e-01 | -0.085100 | 7.83e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 54 | 2.80e-01 | -0.085000 | 5.20e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 6.25e-01 | 0.085000 | 7.95e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 5.12e-01 | -0.084800 | 7.24e-01 |
FGFR2 ALTERNATIVE SPLICING | 25 | 4.63e-01 | -0.084800 | 6.94e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 4.15e-01 | -0.084600 | 6.54e-01 |
JOSEPHIN DOMAIN DUBS | 11 | 6.27e-01 | -0.084500 | 7.96e-01 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 2.91e-01 | -0.083900 | 5.28e-01 |
DEADENYLATION OF MRNA | 25 | 4.68e-01 | -0.083800 | 6.96e-01 |
HIV LIFE CYCLE | 142 | 8.53e-02 | -0.083700 | 2.54e-01 |
RHOQ GTPASE CYCLE | 57 | 2.76e-01 | 0.083500 | 5.17e-01 |
FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 4.17e-01 | 0.082900 | 6.55e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 18 | 5.43e-01 | -0.082800 | 7.41e-01 |
SIGNALING BY FGFR1 | 42 | 3.55e-01 | -0.082600 | 5.97e-01 |
FOXO MEDIATED TRANSCRIPTION | 57 | 2.83e-01 | -0.082300 | 5.24e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 4.90e-01 | 0.081400 | 7.08e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 5.75e-01 | 0.080900 | 7.60e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 3.25e-01 | -0.079800 | 5.64e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 6.06e-01 | -0.079600 | 7.81e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 66 | 2.64e-01 | 0.079500 | 5.05e-01 |
UB SPECIFIC PROCESSING PROTEASES | 169 | 7.49e-02 | -0.079500 | 2.35e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 622 | 7.60e-04 | 0.079400 | 6.64e-03 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 43 | 3.68e-01 | -0.079300 | 6.12e-01 |
CD209 DC SIGN SIGNALING | 18 | 5.62e-01 | -0.079000 | 7.50e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 31 | 4.49e-01 | 0.078600 | 6.81e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 3.75e-01 | 0.078200 | 6.21e-01 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 22 | 5.27e-01 | -0.078000 | 7.32e-01 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 6.55e-01 | 0.077900 | 8.12e-01 |
RHO GTPASES ACTIVATE FORMINS | 118 | 1.47e-01 | -0.077300 | 3.64e-01 |
DUAL INCISION IN GG NER | 40 | 3.99e-01 | -0.077100 | 6.42e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 5.94e-01 | -0.077000 | 7.71e-01 |
REGULATION OF KIT SIGNALING | 16 | 5.94e-01 | 0.077000 | 7.71e-01 |
BASE EXCISION REPAIR AP SITE FORMATION | 29 | 4.73e-01 | -0.077000 | 6.96e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 177 | 7.76e-02 | -0.077000 | 2.40e-01 |
RAB REGULATION OF TRAFFICKING | 119 | 1.47e-01 | 0.077000 | 3.64e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 5.23e-01 | -0.076900 | 7.32e-01 |
PRC2 METHYLATES HISTONES AND DNA | 29 | 4.74e-01 | -0.076900 | 6.96e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 4.74e-01 | 0.076900 | 6.96e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 4.13e-01 | -0.076700 | 6.53e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 6.46e-01 | 0.076600 | 8.09e-01 |
N GLYCAN ANTENNAE ELONGATION | 15 | 6.07e-01 | 0.076600 | 7.82e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 6.33e-01 | -0.076600 | 7.98e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 4.18e-01 | -0.076000 | 6.55e-01 |
SIGNALING BY FGFR2 | 62 | 3.02e-01 | -0.075900 | 5.39e-01 |
EGFR DOWNREGULATION | 27 | 4.97e-01 | 0.075600 | 7.10e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 5.79e-01 | -0.075500 | 7.63e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 3.01e-01 | -0.075400 | 5.39e-01 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 6.65e-01 | 0.075300 | 8.18e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 6.52e-01 | 0.075200 | 8.12e-01 |
ADAPTIVE IMMUNE SYSTEM | 596 | 1.84e-03 | -0.075000 | 1.36e-02 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 77 | 2.57e-01 | -0.074800 | 4.99e-01 |
GLUCOSE METABOLISM | 81 | 2.45e-01 | 0.074800 | 4.88e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 6.68e-01 | 0.074700 | 8.19e-01 |
NUCLEAR SIGNALING BY ERBB4 | 30 | 4.80e-01 | 0.074600 | 7.00e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 82 | 2.44e-01 | 0.074500 | 4.88e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 6.17e-01 | 0.074500 | 7.92e-01 |
AUTOPHAGY | 138 | 1.32e-01 | -0.074400 | 3.39e-01 |
DAP12 INTERACTIONS | 29 | 4.89e-01 | -0.074300 | 7.07e-01 |
SIGNALING BY BMP | 24 | 5.30e-01 | -0.074100 | 7.32e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 5.98e-01 | 0.074000 | 7.75e-01 |
SIGNALING BY ACTIVIN | 12 | 6.58e-01 | 0.073900 | 8.13e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 31 | 4.78e-01 | 0.073700 | 7.00e-01 |
ATTENUATION PHASE | 23 | 5.44e-01 | -0.073200 | 7.41e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 63 | 3.17e-01 | -0.072900 | 5.58e-01 |
REGULATION OF FZD BY UBIQUITINATION | 19 | 5.83e-01 | -0.072800 | 7.66e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 12 | 6.63e-01 | -0.072700 | 8.18e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 2.21e-01 | 0.072400 | 4.61e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 545 | 4.00e-03 | -0.072400 | 2.61e-02 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 6.52e-01 | -0.072300 | 8.12e-01 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 6.94e-01 | -0.071900 | 8.37e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 4.62e-01 | 0.071900 | 6.92e-01 |
MRNA CAPPING | 29 | 5.03e-01 | -0.071800 | 7.17e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 87 | 2.54e-01 | -0.070800 | 4.95e-01 |
GLYCOLYSIS | 67 | 3.17e-01 | 0.070700 | 5.58e-01 |
INTERFERON GAMMA SIGNALING | 75 | 2.90e-01 | -0.070700 | 5.28e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 5.68e-01 | -0.070300 | 7.53e-01 |
G ALPHA Z SIGNALLING EVENTS | 45 | 4.16e-01 | -0.070100 | 6.54e-01 |
PTEN REGULATION | 134 | 1.62e-01 | -0.070000 | 3.83e-01 |
GENE SILENCING BY RNA | 82 | 2.74e-01 | 0.069900 | 5.16e-01 |
CARGO CONCENTRATION IN THE ER | 30 | 5.09e-01 | 0.069700 | 7.22e-01 |
G0 AND EARLY G1 | 25 | 5.47e-01 | -0.069600 | 7.41e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 286 | 4.38e-02 | -0.069400 | 1.61e-01 |
ERKS ARE INACTIVATED | 13 | 6.67e-01 | 0.068800 | 8.19e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 47 | 4.16e-01 | -0.068700 | 6.54e-01 |
PECAM1 INTERACTIONS | 12 | 6.81e-01 | 0.068600 | 8.30e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 14 | 6.57e-01 | 0.068600 | 8.13e-01 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 4.32e-01 | -0.068500 | 6.65e-01 |
FERTILIZATION | 12 | 6.85e-01 | -0.067700 | 8.32e-01 |
AGGREPHAGY | 34 | 4.97e-01 | -0.067300 | 7.10e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 43 | 4.46e-01 | -0.067200 | 6.80e-01 |
COSTIMULATION BY THE CD28 FAMILY | 49 | 4.16e-01 | -0.067200 | 6.54e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 37 | 4.79e-01 | -0.067200 | 7.00e-01 |
BASE EXCISION REPAIR | 56 | 3.85e-01 | -0.067100 | 6.32e-01 |
CD28 CO STIMULATION | 30 | 5.27e-01 | -0.066800 | 7.32e-01 |
GABA B RECEPTOR ACTIVATION | 39 | 4.72e-01 | -0.066600 | 6.96e-01 |
SIGNALING BY ERBB4 | 56 | 3.91e-01 | -0.066400 | 6.37e-01 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 6.46e-01 | -0.066300 | 8.09e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 58 | 3.82e-01 | 0.066300 | 6.30e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 23 | 5.83e-01 | -0.066100 | 7.66e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 5.46e-01 | -0.066000 | 7.41e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 4.45e-01 | 0.065800 | 6.79e-01 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 168 | 1.42e-01 | 0.065800 | 3.57e-01 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 7.20e-01 | 0.065500 | 8.51e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 5.98e-01 | 0.064900 | 7.75e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 6.25e-01 | -0.064700 | 7.95e-01 |
RHOG GTPASE CYCLE | 73 | 3.39e-01 | 0.064700 | 5.82e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 90 | 2.89e-01 | -0.064700 | 5.28e-01 |
P75NTR SIGNALS VIA NF KB | 16 | 6.54e-01 | 0.064700 | 8.12e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 139 | 1.89e-01 | 0.064500 | 4.25e-01 |
SIGNALING BY WNT | 268 | 7.20e-02 | -0.064000 | 2.29e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 20 | 6.21e-01 | 0.063900 | 7.93e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 14 | 6.83e-01 | 0.063100 | 8.32e-01 |
TRNA AMINOACYLATION | 42 | 4.80e-01 | -0.063000 | 7.00e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 7.30e-01 | -0.063000 | 8.55e-01 |
SIGNALING BY MET | 75 | 3.46e-01 | 0.063000 | 5.87e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 6.26e-01 | -0.062900 | 7.95e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 44 | 4.73e-01 | -0.062500 | 6.96e-01 |
SARS COV INFECTIONS | 140 | 2.02e-01 | -0.062500 | 4.40e-01 |
POTASSIUM CHANNELS | 90 | 3.07e-01 | 0.062400 | 5.46e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 102 | 2.78e-01 | 0.062200 | 5.19e-01 |
HEDGEHOG OFF STATE | 107 | 2.68e-01 | -0.062000 | 5.11e-01 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 6.72e-01 | -0.061100 | 8.23e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 6.95e-01 | 0.060600 | 8.38e-01 |
FANCONI ANEMIA PATHWAY | 36 | 5.31e-01 | 0.060400 | 7.32e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 64 | 4.04e-01 | -0.060300 | 6.44e-01 |
SIGNALING BY VEGF | 101 | 3.01e-01 | 0.059600 | 5.39e-01 |
PREGNENOLONE BIOSYNTHESIS | 12 | 7.21e-01 | -0.059500 | 8.51e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 4.71e-01 | -0.059500 | 6.96e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 3.45e-01 | 0.059300 | 5.87e-01 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 7.11e-01 | -0.059300 | 8.46e-01 |
MUSCLE CONTRACTION | 163 | 1.93e-01 | 0.059200 | 4.26e-01 |
SIGNALING BY FGFR | 72 | 3.90e-01 | -0.058600 | 6.37e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 7.25e-01 | -0.058600 | 8.52e-01 |
PI 3K CASCADE FGFR1 | 14 | 7.05e-01 | -0.058500 | 8.44e-01 |
MTOR SIGNALLING | 40 | 5.23e-01 | -0.058400 | 7.32e-01 |
SIGNALING BY NODAL | 16 | 6.87e-01 | 0.058200 | 8.33e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 6.88e-01 | -0.058000 | 8.33e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 14 | 7.08e-01 | -0.057900 | 8.45e-01 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 6.40e-01 | -0.057600 | 8.04e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 6.84e-01 | -0.057100 | 8.32e-01 |
PARASITE INFECTION | 55 | 4.64e-01 | 0.057100 | 6.94e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 3.81e-01 | 0.057100 | 6.28e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 32 | 5.77e-01 | 0.057000 | 7.61e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 90 | 3.52e-01 | 0.056700 | 5.95e-01 |
EXTENSION OF TELOMERES | 49 | 4.93e-01 | -0.056700 | 7.08e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 7.46e-01 | -0.056500 | 8.63e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 6.78e-01 | 0.056400 | 8.28e-01 |
SIGNALING BY NTRKS | 129 | 2.71e-01 | 0.056100 | 5.13e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 4.05e-01 | -0.056000 | 6.45e-01 |
CELLULAR SENESCENCE | 141 | 2.52e-01 | 0.055900 | 4.94e-01 |
REGULATION OF TP53 ACTIVITY | 151 | 2.44e-01 | 0.055000 | 4.88e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 5.53e-01 | 0.054900 | 7.42e-01 |
SIGNALING BY SCF KIT | 41 | 5.46e-01 | 0.054500 | 7.41e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 6.33e-01 | -0.054000 | 7.98e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 4.85e-01 | 0.054000 | 7.05e-01 |
SIGNALING BY HIPPO | 20 | 6.78e-01 | -0.053600 | 8.28e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 6.19e-01 | -0.053400 | 7.93e-01 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 3.80e-01 | 0.053300 | 6.28e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 459 | 5.14e-02 | 0.053200 | 1.79e-01 |
SYNTHESIS OF PC | 25 | 6.45e-01 | 0.053200 | 8.09e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 4.95e-01 | 0.052700 | 7.10e-01 |
RECYCLING PATHWAY OF L1 | 40 | 5.65e-01 | 0.052600 | 7.50e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 6.51e-01 | -0.052400 | 8.12e-01 |
NUCLEOBASE BIOSYNTHESIS | 15 | 7.27e-01 | -0.052200 | 8.52e-01 |
BASIGIN INTERACTIONS | 23 | 6.65e-01 | -0.052100 | 8.18e-01 |
SIGNALING BY PTK6 | 50 | 5.25e-01 | 0.052000 | 7.32e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 5.65e-01 | -0.051900 | 7.50e-01 |
NUCLEOTIDE EXCISION REPAIR | 109 | 3.50e-01 | -0.051800 | 5.92e-01 |
RNA POLYMERASE I TRANSCRIPTION | 67 | 4.65e-01 | -0.051600 | 6.95e-01 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 16 | 7.25e-01 | 0.050900 | 8.52e-01 |
MITOTIC PROMETAPHASE | 176 | 2.46e-01 | -0.050800 | 4.88e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 5.66e-01 | 0.050600 | 7.50e-01 |
SLC TRANSPORTER DISORDERS | 75 | 4.49e-01 | 0.050600 | 6.81e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 14 | 7.44e-01 | 0.050500 | 8.62e-01 |
PLATELET SENSITIZATION BY LDL | 15 | 7.37e-01 | -0.050200 | 8.60e-01 |
SIGNALING BY FGFR4 | 32 | 6.26e-01 | -0.049800 | 7.95e-01 |
NUCLEOTIDE SALVAGE | 21 | 6.97e-01 | -0.049100 | 8.39e-01 |
PI 3K CASCADE FGFR3 | 13 | 7.60e-01 | -0.048900 | 8.74e-01 |
SIALIC ACID METABOLISM | 32 | 6.33e-01 | -0.048800 | 7.98e-01 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 7.70e-01 | 0.048700 | 8.82e-01 |
ESR MEDIATED SIGNALING | 163 | 2.84e-01 | -0.048700 | 5.24e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 7.21e-01 | -0.048600 | 8.51e-01 |
INTERFERON ALPHA BETA SIGNALING | 53 | 5.47e-01 | -0.047800 | 7.41e-01 |
PLATELET HOMEOSTASIS | 78 | 4.67e-01 | -0.047600 | 6.96e-01 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 5.21e-01 | -0.047200 | 7.32e-01 |
NICOTINAMIDE SALVAGING | 15 | 7.52e-01 | -0.047100 | 8.69e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 7.38e-01 | 0.047000 | 8.60e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 7.70e-01 | 0.046900 | 8.82e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 4.81e-01 | -0.046800 | 7.01e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 63 | 5.25e-01 | -0.046300 | 7.32e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 60 | 5.36e-01 | 0.046200 | 7.35e-01 |
RESOLUTION OF D LOOP STRUCTURES | 30 | 6.62e-01 | 0.046200 | 8.17e-01 |
INTERFERON SIGNALING | 163 | 3.15e-01 | -0.045700 | 5.57e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 7.38e-01 | -0.045600 | 8.60e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 6.05e-01 | 0.045600 | 7.80e-01 |
COPII MEDIATED VESICLE TRANSPORT | 64 | 5.30e-01 | 0.045400 | 7.32e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 238 | 2.30e-01 | 0.045200 | 4.76e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 75 | 5.00e-01 | -0.045100 | 7.13e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 7.79e-01 | -0.044900 | 8.90e-01 |
RAC3 GTPASE CYCLE | 88 | 4.71e-01 | 0.044400 | 6.96e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 5.48e-01 | 0.044400 | 7.41e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 50 | 5.89e-01 | -0.044200 | 7.68e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 5.72e-01 | -0.044100 | 7.55e-01 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 8.10e-01 | 0.044000 | 9.02e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 8.10e-01 | 0.044000 | 9.02e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 4.85e-01 | 0.043600 | 7.05e-01 |
ENDOGENOUS STEROLS | 20 | 7.38e-01 | -0.043200 | 8.60e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 6.78e-01 | 0.043000 | 8.28e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 221 | 2.72e-01 | -0.043000 | 5.13e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 6.28e-01 | -0.042700 | 7.96e-01 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 7.99e-01 | -0.042500 | 8.99e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 6.36e-01 | -0.042300 | 7.99e-01 |
FLT3 SIGNALING IN DISEASE | 27 | 7.05e-01 | -0.042000 | 8.44e-01 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 92 | 4.87e-01 | 0.041900 | 7.07e-01 |
METABOLISM OF CARBOHYDRATES | 259 | 2.47e-01 | 0.041900 | 4.89e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 6.03e-01 | 0.041700 | 7.79e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 7.54e-01 | -0.041500 | 8.70e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 7.09e-01 | -0.041500 | 8.45e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 44 | 6.35e-01 | 0.041400 | 7.99e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 7.58e-01 | 0.040900 | 8.72e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 15 | 7.87e-01 | 0.040300 | 8.94e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 41 | 6.56e-01 | 0.040300 | 8.12e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 7.88e-01 | -0.040200 | 8.94e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 7.13e-01 | -0.039500 | 8.46e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1085 | 2.96e-02 | -0.039400 | 1.24e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 85 | 5.34e-01 | -0.039100 | 7.34e-01 |
MET RECEPTOR RECYCLING | 10 | 8.31e-01 | -0.039000 | 9.13e-01 |
SIGNALING BY FGFR IN DISEASE | 55 | 6.19e-01 | -0.038700 | 7.93e-01 |
DEUBIQUITINATION | 243 | 3.02e-01 | -0.038500 | 5.39e-01 |
CILIUM ASSEMBLY | 190 | 3.62e-01 | 0.038400 | 6.06e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 6.86e-01 | -0.037900 | 8.33e-01 |
METABOLISM OF STEROIDS | 113 | 4.88e-01 | -0.037800 | 7.07e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 7.71e-01 | -0.037600 | 8.82e-01 |
PROLONGED ERK ACTIVATION EVENTS | 13 | 8.15e-01 | -0.037500 | 9.04e-01 |
NEGATIVE REGULATION OF FLT3 | 15 | 8.02e-01 | 0.037400 | 8.99e-01 |
REGULATION OF INSULIN SECRETION | 71 | 5.87e-01 | 0.037300 | 7.68e-01 |
ACYL CHAIN REMODELLING OF PC | 17 | 7.91e-01 | 0.037100 | 8.97e-01 |
RAC2 GTPASE CYCLE | 86 | 5.61e-01 | 0.036300 | 7.50e-01 |
HSF1 DEPENDENT TRANSACTIVATION | 33 | 7.18e-01 | 0.036300 | 8.50e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 92 | 5.50e-01 | 0.036100 | 7.41e-01 |
SIGNALLING TO ERKS | 32 | 7.25e-01 | 0.036000 | 8.52e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 179 | 4.07e-01 | 0.036000 | 6.45e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 7.42e-01 | 0.036000 | 8.62e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 8.30e-01 | -0.035900 | 9.13e-01 |
RAF ACTIVATION | 34 | 7.17e-01 | -0.035900 | 8.50e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 7.45e-01 | 0.035500 | 8.63e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 6.97e-01 | -0.035100 | 8.39e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 20 | 7.87e-01 | 0.034900 | 8.94e-01 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 8.09e-01 | 0.034800 | 9.02e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 8.04e-01 | -0.034800 | 8.99e-01 |
HCMV INFECTION | 103 | 5.43e-01 | 0.034700 | 7.41e-01 |
EPHRIN SIGNALING | 19 | 7.94e-01 | 0.034700 | 8.98e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 8.43e-01 | 0.034600 | 9.20e-01 |
TELOMERE EXTENSION BY TELOMERASE | 22 | 7.80e-01 | 0.034400 | 8.90e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 8.51e-01 | -0.034300 | 9.23e-01 |
HOMOLOGY DIRECTED REPAIR | 107 | 5.40e-01 | -0.034300 | 7.39e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 280 | 3.24e-01 | 0.034300 | 5.64e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 7.01e-01 | -0.034200 | 8.42e-01 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 20 | 7.92e-01 | -0.034100 | 8.97e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 41 | 7.07e-01 | 0.033900 | 8.45e-01 |
RHO GTPASES ACTIVATE IQGAPS | 23 | 7.81e-01 | -0.033500 | 8.90e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 7.37e-01 | -0.033300 | 8.60e-01 |
CELL CELL JUNCTION ORGANIZATION | 50 | 6.87e-01 | -0.032900 | 8.33e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 8.14e-01 | -0.032900 | 9.04e-01 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 88 | 5.94e-01 | -0.032900 | 7.71e-01 |
MAPK FAMILY SIGNALING CASCADES | 286 | 3.43e-01 | 0.032600 | 5.86e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 7.00e-01 | 0.032500 | 8.41e-01 |
RHO GTPASE EFFECTORS | 245 | 3.85e-01 | -0.032300 | 6.32e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 6.24e-01 | 0.032100 | 7.95e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 7.40e-01 | -0.031900 | 8.61e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 69 | 6.49e-01 | -0.031700 | 8.11e-01 |
SPHINGOLIPID METABOLISM | 80 | 6.26e-01 | -0.031600 | 7.95e-01 |
SUMOYLATION | 161 | 4.92e-01 | 0.031400 | 7.08e-01 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 8.65e-01 | -0.031000 | 9.30e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 6.55e-01 | 0.030700 | 8.12e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 130 | 5.51e-01 | 0.030300 | 7.41e-01 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 8.15e-01 | 0.030200 | 9.04e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 364 | 3.23e-01 | 0.030200 | 5.64e-01 |
RHOD GTPASE CYCLE | 50 | 7.12e-01 | 0.030200 | 8.46e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 8.63e-01 | -0.030000 | 9.30e-01 |
SIGNALING BY ERBB2 | 47 | 7.26e-01 | -0.029600 | 8.52e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 8.39e-01 | -0.029300 | 9.18e-01 |
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 8.73e-01 | -0.029200 | 9.33e-01 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 8.01e-01 | 0.029100 | 8.99e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 8.56e-01 | 0.029100 | 9.25e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 93 | 6.31e-01 | 0.028900 | 7.98e-01 |
SYNDECAN INTERACTIONS | 26 | 8.02e-01 | -0.028500 | 8.99e-01 |
NGF STIMULATED TRANSCRIPTION | 37 | 7.67e-01 | -0.028200 | 8.80e-01 |
SIGNALING BY ERBB2 IN CANCER | 24 | 8.11e-01 | -0.028100 | 9.03e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 7.09e-01 | 0.028100 | 8.45e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 8.30e-01 | -0.027800 | 9.13e-01 |
GLYCOSPHINGOLIPID METABOLISM | 39 | 7.65e-01 | -0.027700 | 8.78e-01 |
METABOLISM OF PORPHYRINS | 19 | 8.36e-01 | 0.027400 | 9.18e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 8.20e-01 | 0.027300 | 9.07e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 94 | 6.48e-01 | -0.027200 | 8.11e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 27 | 8.07e-01 | 0.027200 | 9.02e-01 |
TIGHT JUNCTION INTERACTIONS | 19 | 8.38e-01 | 0.027000 | 9.18e-01 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 8.67e-01 | 0.026900 | 9.31e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 223 | 4.91e-01 | -0.026800 | 7.08e-01 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 88 | 6.64e-01 | 0.026800 | 8.18e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 52 | 7.39e-01 | -0.026700 | 8.60e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 7.81e-01 | -0.026400 | 8.90e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 8.55e-01 | 0.026300 | 9.25e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 102 | 6.55e-01 | -0.025600 | 8.12e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 151 | 6.00e-01 | 0.024800 | 7.76e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 35 | 8.00e-01 | 0.024800 | 8.99e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 7.49e-01 | -0.024600 | 8.65e-01 |
G1 S SPECIFIC TRANSCRIPTION | 26 | 8.29e-01 | 0.024500 | 9.13e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 8.91e-01 | -0.024000 | 9.40e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 22 | 8.46e-01 | -0.023900 | 9.21e-01 |
CELL JUNCTION ORGANIZATION | 74 | 7.23e-01 | 0.023800 | 8.52e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 8.13e-01 | -0.023800 | 9.04e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 8.58e-01 | 0.023700 | 9.27e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 8.74e-01 | -0.023600 | 9.33e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 342 | 4.56e-01 | -0.023500 | 6.87e-01 |
SIGNALING BY NOTCH | 189 | 5.83e-01 | 0.023200 | 7.66e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 47 | 7.83e-01 | 0.023200 | 8.91e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 16 | 8.72e-01 | 0.023200 | 9.33e-01 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 8.48e-01 | -0.023000 | 9.21e-01 |
P38MAPK EVENTS | 12 | 8.92e-01 | 0.022600 | 9.40e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 7.11e-01 | -0.022300 | 8.46e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 42 | 8.03e-01 | 0.022200 | 8.99e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 8.32e-01 | 0.022000 | 9.14e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 8.84e-01 | -0.021700 | 9.40e-01 |
NERVOUS SYSTEM DEVELOPMENT | 547 | 3.99e-01 | -0.021200 | 6.42e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 8.44e-01 | -0.021100 | 9.21e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 9.09e-01 | -0.020800 | 9.50e-01 |
DEVELOPMENTAL BIOLOGY | 814 | 3.18e-01 | 0.020700 | 5.60e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 8.45e-01 | -0.020300 | 9.21e-01 |
INTERLEUKIN 35 SIGNALLING | 10 | 9.13e-01 | 0.020100 | 9.50e-01 |
EPH EPHRIN SIGNALING | 92 | 7.43e-01 | 0.019800 | 8.62e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1213 | 2.52e-01 | -0.019700 | 4.94e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 7.65e-01 | -0.019700 | 8.78e-01 |
TOLL LIKE RECEPTOR CASCADES | 137 | 6.92e-01 | -0.019600 | 8.36e-01 |
AMYLOID FIBER FORMATION | 57 | 7.98e-01 | -0.019600 | 8.99e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 21 | 8.77e-01 | -0.019500 | 9.36e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 9.11e-01 | 0.019400 | 9.50e-01 |
MEMBRANE TRAFFICKING | 576 | 4.29e-01 | 0.019300 | 6.62e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 9.05e-01 | 0.019200 | 9.48e-01 |
PLASMA LIPOPROTEIN CLEARANCE | 27 | 8.65e-01 | -0.019000 | 9.30e-01 |
HCMV LATE EVENTS | 65 | 7.94e-01 | 0.018700 | 8.98e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 282 | 5.91e-01 | 0.018700 | 7.69e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 8.67e-01 | 0.018600 | 9.31e-01 |
RHOF GTPASE CYCLE | 40 | 8.39e-01 | 0.018600 | 9.18e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 8.89e-01 | 0.018600 | 9.40e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 6.67e-01 | 0.018400 | 8.19e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 96 | 7.56e-01 | -0.018400 | 8.71e-01 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 9.02e-01 | 0.018400 | 9.46e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 8.88e-01 | 0.017800 | 9.40e-01 |
CA2 PATHWAY | 56 | 8.19e-01 | -0.017600 | 9.07e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 7.95e-01 | 0.017600 | 8.98e-01 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 8.47e-01 | 0.017400 | 9.21e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 7.97e-01 | -0.017300 | 8.99e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 9.12e-01 | -0.017000 | 9.50e-01 |
SIGNALING BY NTRK2 TRKB | 24 | 8.86e-01 | 0.016900 | 9.40e-01 |
SPRY REGULATION OF FGF SIGNALING | 16 | 9.08e-01 | 0.016600 | 9.50e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 8.19e-01 | -0.016600 | 9.07e-01 |
DNA METHYLATION | 20 | 8.98e-01 | -0.016600 | 9.43e-01 |
SIGNALING BY FGFR1 IN DISEASE | 32 | 8.72e-01 | -0.016400 | 9.33e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 8.82e-01 | -0.016200 | 9.38e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 8.30e-01 | 0.016200 | 9.13e-01 |
G ALPHA I SIGNALLING EVENTS | 189 | 7.03e-01 | -0.016100 | 8.43e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 29 | 8.81e-01 | -0.016000 | 9.38e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 9.16e-01 | -0.015800 | 9.51e-01 |
SIGNALING BY FGFR3 | 35 | 8.72e-01 | -0.015700 | 9.33e-01 |
ACYL CHAIN REMODELLING OF PE | 16 | 9.15e-01 | -0.015400 | 9.51e-01 |
DISEASES OF DNA REPAIR | 11 | 9.30e-01 | -0.015300 | 9.60e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 90 | 8.04e-01 | -0.015200 | 8.99e-01 |
METABOLISM OF LIPIDS | 610 | 5.26e-01 | 0.015100 | 7.32e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 9.35e-01 | 0.014900 | 9.63e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 62 | 8.42e-01 | -0.014700 | 9.20e-01 |
LEISHMANIA INFECTION | 190 | 7.29e-01 | 0.014600 | 8.54e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 8.97e-01 | 0.014600 | 9.43e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 8.91e-01 | 0.014000 | 9.40e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 57 | 8.55e-01 | -0.014000 | 9.25e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 9.28e-01 | 0.013900 | 9.60e-01 |
HEMOSTASIS | 474 | 6.08e-01 | 0.013800 | 7.82e-01 |
FLT3 SIGNALING | 37 | 8.87e-01 | -0.013500 | 9.40e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 282 | 6.99e-01 | -0.013400 | 8.40e-01 |
METAL ION SLC TRANSPORTERS | 25 | 9.08e-01 | 0.013400 | 9.50e-01 |
SURFACTANT METABOLISM | 17 | 9.24e-01 | 0.013300 | 9.58e-01 |
VESICLE MEDIATED TRANSPORT | 604 | 5.89e-01 | 0.012900 | 7.68e-01 |
MEIOTIC SYNAPSIS | 39 | 8.91e-01 | -0.012700 | 9.40e-01 |
RHOJ GTPASE CYCLE | 54 | 8.74e-01 | -0.012500 | 9.33e-01 |
OPIOID SIGNALLING | 86 | 8.48e-01 | -0.012000 | 9.21e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 8.61e-01 | -0.011900 | 9.30e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 8.97e-01 | -0.011300 | 9.43e-01 |
FCERI MEDIATED CA 2 MOBILIZATION | 26 | 9.21e-01 | -0.011300 | 9.55e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 103 | 8.46e-01 | 0.011100 | 9.21e-01 |
LYSINE CATABOLISM | 11 | 9.50e-01 | 0.010900 | 9.70e-01 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 13 | 9.46e-01 | 0.010900 | 9.69e-01 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 9.48e-01 | 0.010400 | 9.69e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 164 | 8.27e-01 | -0.009890 | 9.13e-01 |
TRANSPORT OF SMALL MOLECULES | 574 | 6.88e-01 | 0.009830 | 8.33e-01 |
REDUCTION OF CYTOSOLIC CA LEVELS | 12 | 9.56e-01 | 0.009290 | 9.75e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 9.19e-01 | -0.009050 | 9.54e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 18 | 9.47e-01 | 0.009010 | 9.69e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 9.40e-01 | 0.008900 | 9.67e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 9.28e-01 | -0.008650 | 9.60e-01 |
SIGNALING BY HEDGEHOG | 142 | 8.62e-01 | -0.008450 | 9.30e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 9.32e-01 | -0.008410 | 9.62e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 110 | 8.81e-01 | 0.008260 | 9.38e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 9.49e-01 | -0.008110 | 9.69e-01 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 26 | 9.45e-01 | 0.007790 | 9.69e-01 |
UNWINDING OF DNA | 12 | 9.63e-01 | 0.007770 | 9.80e-01 |
OTHER INTERLEUKIN SIGNALING | 19 | 9.57e-01 | 0.007070 | 9.76e-01 |
IRS MEDIATED SIGNALLING | 37 | 9.42e-01 | -0.006850 | 9.68e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 9.35e-01 | -0.006800 | 9.63e-01 |
SENSORY PERCEPTION | 148 | 8.87e-01 | 0.006790 | 9.40e-01 |
MITOTIC PROPHASE | 94 | 9.10e-01 | -0.006720 | 9.50e-01 |
SNRNP ASSEMBLY | 51 | 9.41e-01 | -0.006010 | 9.67e-01 |
PYRIMIDINE SALVAGE | 10 | 9.74e-01 | 0.005970 | 9.86e-01 |
CGMP EFFECTS | 15 | 9.69e-01 | -0.005780 | 9.83e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 136 | 9.10e-01 | -0.005630 | 9.50e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 9.30e-01 | -0.005510 | 9.60e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 9.79e-01 | 0.004880 | 9.88e-01 |
GPCR LIGAND BINDING | 244 | 8.96e-01 | -0.004850 | 9.43e-01 |
RAP1 SIGNALLING | 15 | 9.75e-01 | -0.004610 | 9.86e-01 |
DISEASES OF IMMUNE SYSTEM | 23 | 9.70e-01 | 0.004490 | 9.84e-01 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 32 | 9.69e-01 | 0.004030 | 9.83e-01 |
VISUAL PHOTOTRANSDUCTION | 60 | 9.58e-01 | 0.003920 | 9.76e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 9.83e-01 | 0.003780 | 9.90e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 179 | 9.48e-01 | -0.002860 | 9.69e-01 |
INTRAFLAGELLAR TRANSPORT | 50 | 9.72e-01 | -0.002840 | 9.85e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 9.84e-01 | -0.002430 | 9.90e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 9.89e-01 | -0.002170 | 9.94e-01 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 9.84e-01 | -0.002080 | 9.90e-01 |
GOLGI TO ER RETROGRADE TRANSPORT | 119 | 9.76e-01 | 0.001580 | 9.86e-01 |
DNA REPAIR | 292 | 9.66e-01 | -0.001430 | 9.82e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 9.92e-01 | -0.001330 | 9.95e-01 |
CS DS DEGRADATION | 14 | 9.93e-01 | 0.001320 | 9.95e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 25 | 9.92e-01 | 0.001220 | 9.95e-01 |
TRNA PROCESSING | 105 | 9.84e-01 | 0.001160 | 9.90e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 9.96e-01 | 0.000709 | 9.97e-01 |
G ALPHA Q SIGNALLING EVENTS | 146 | 9.90e-01 | 0.000586 | 9.95e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 9.97e-01 | 0.000473 | 9.97e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1
1049 | |
---|---|
set | SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 |
setSize | 12 |
pANOVA | 8.74e-05 |
s.dist | -0.654 |
p.adjustANOVA | 0.000959 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Spcs2 | -8284 |
Dpp4 | -7834 |
Spcs3 | -7739 |
Spcs1 | -6626 |
Pcsk1 | -6429 |
Sec11a | -6393 |
Sec11c | -5203 |
Grp | -4619 |
Tcf7l2 | -3842 |
Pax6 | -3357 |
Ctnnb1 | -2569 |
Gng13 | -2173 |
GeneID | Gene Rank |
---|---|
Spcs2 | -8284 |
Dpp4 | -7834 |
Spcs3 | -7739 |
Spcs1 | -6626 |
Pcsk1 | -6429 |
Sec11a | -6393 |
Sec11c | -5203 |
Grp | -4619 |
Tcf7l2 | -3842 |
Pax6 | -3357 |
Ctnnb1 | -2569 |
Gng13 | -2173 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION
438 | |
---|---|
set | INCRETIN SYNTHESIS SECRETION AND INACTIVATION |
setSize | 13 |
pANOVA | 5.27e-05 |
s.dist | -0.648 |
p.adjustANOVA | 0.000623 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Spcs2 | -8284 |
Dpp4 | -7834 |
Spcs3 | -7739 |
Spcs1 | -6626 |
Pcsk1 | -6429 |
Sec11a | -6393 |
Sec11c | -5203 |
Isl1 | -4715 |
Grp | -4619 |
Tcf7l2 | -3842 |
Pax6 | -3357 |
Ctnnb1 | -2569 |
Gng13 | -2173 |
GeneID | Gene Rank |
---|---|
Spcs2 | -8284 |
Dpp4 | -7834 |
Spcs3 | -7739 |
Spcs1 | -6626 |
Pcsk1 | -6429 |
Sec11a | -6393 |
Sec11c | -5203 |
Isl1 | -4715 |
Grp | -4619 |
Tcf7l2 | -3842 |
Pax6 | -3357 |
Ctnnb1 | -2569 |
Gng13 | -2173 |
EUKARYOTIC TRANSLATION ELONGATION
303 | |
---|---|
set | EUKARYOTIC TRANSLATION ELONGATION |
setSize | 87 |
pANOVA | 1.86e-20 |
s.dist | -0.575 |
p.adjustANOVA | 4.36e-18 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Rpl22l1 | -8141 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Rpl27a | -7806 |
Rps2 | -7768 |
Eef1g | -7647 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Rps3a1 | -7247 |
Rpl15 | -7145 |
Rps4x | -7101 |
Rpl6 | -6987 |
Eef1b2 | -6800 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Rpl22l1 | -8141 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Rpl27a | -7806 |
Rps2 | -7768 |
Eef1g | -7647 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Rps3a1 | -7247 |
Rpl15 | -7145 |
Rps4x | -7101 |
Rpl6 | -6987 |
Eef1b2 | -6800 |
Rps6 | -6778 |
Rpl9 | -6764 |
Rpl24 | -6731 |
Rps3 | -6619 |
Rpl7 | -6613 |
Rps8 | -6582 |
Rpl13a | -6546 |
Rpl17 | -6544 |
Rps23 | -6540 |
Rps27a | -6495 |
Rpl11 | -6314 |
Rpl14 | -6262 |
Rpl4 | -6223 |
Rpl22 | -6168 |
Rps14 | -6141 |
Rps13 | -6050 |
Rps27l | -5975 |
Eef1a1 | -5772 |
Rps25 | -5718 |
Rpl23a | -5554 |
Rpl18a | -5540 |
Rpl23 | -5442 |
Rps9 | -5358 |
Rpl31 | -5187 |
Rps16 | -5184 |
Rps20 | -5080 |
Rpl21 | -5011 |
Rpl27 | -4994 |
Rpl36al | -4919 |
Rpl10a | -4803 |
Rps19 | -4737 |
Rpsa | -4551 |
Rps11 | -4519 |
Rpl7a | -4362 |
Rps10 | -4314 |
Uba52 | -3960 |
Rpl28 | -3949 |
Rps26 | -3865 |
Rps17 | -3848 |
Rpl19 | -3712 |
Rpl32 | -3656 |
Rps27 | -3639 |
Rps15a | -3370 |
Fau | -3267 |
Rpl37a | -3095 |
Rps5 | -3041 |
Rpl34 | -3010 |
Rpl18 | -2938 |
Rpl39 | -2737 |
Rplp1 | -2691 |
Rpl8 | -2622 |
Rps15 | -2201 |
Rpl13 | -1947 |
Rpl35 | -1857 |
Rps12 | -1815 |
Eef1d | -1550 |
Rps21 | -1427 |
Eef1a2 | -1005 |
Eef2 | -752 |
Rplp2 | -429 |
Rpl36 | -165 |
Rpl37 | 145 |
Rpl10 | 514 |
Rpl12 | 951 |
Rpl38 | 1302 |
Rps28 | 2422 |
Rps29 | 4006 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION
371 | |
---|---|
set | GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION |
setSize | 31 |
pANOVA | 8.89e-08 |
s.dist | -0.555 |
p.adjustANOVA | 2.57e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tcp1 | -8258 |
Cdc42 | -8238 |
Rplp0 | -8066 |
Hnrnpdl | -7924 |
Rap1b | -7871 |
Ppia | -7845 |
Hspa9 | -7462 |
Rala | -7435 |
Hnrnpa2b1 | -7378 |
Pdcd4 | -6988 |
Mtap | -6818 |
Psme2 | -6584 |
Lcp1 | -5846 |
Capza1 | -5795 |
Gsto1 | -5545 |
Snrpa1 | -5224 |
Cnn2 | -5021 |
Pak2 | -4999 |
Hnrnpf | -4672 |
Taldo1 | -3813 |
GeneID | Gene Rank |
---|---|
Tcp1 | -8258 |
Cdc42 | -8238 |
Rplp0 | -8066 |
Hnrnpdl | -7924 |
Rap1b | -7871 |
Ppia | -7845 |
Hspa9 | -7462 |
Rala | -7435 |
Hnrnpa2b1 | -7378 |
Pdcd4 | -6988 |
Mtap | -6818 |
Psme2 | -6584 |
Lcp1 | -5846 |
Capza1 | -5795 |
Gsto1 | -5545 |
Snrpa1 | -5224 |
Cnn2 | -5021 |
Pak2 | -4999 |
Hnrnpf | -4672 |
Taldo1 | -3813 |
Sod2 | -3755 |
Sod1 | -3215 |
Cfl1 | -3018 |
Aip | -2618 |
Pitpna | -1698 |
Msn | -1261 |
Arf1 | -564 |
Bola2 | -8 |
Anxa2 | 509 |
Lmnb1 | 1473 |
Mif | 4007 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
28 | |
---|---|
set | ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S |
setSize | 59 |
pANOVA | 1.92e-13 |
s.dist | -0.553 |
p.adjustANOVA | 1.25e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Eif2s2 | -8324 |
Eif4a2 | -8274 |
Eif3j2 | -8206 |
Eif3e | -8202 |
Eif4e | -8156 |
Eif2s1 | -8079 |
Eif3m | -8002 |
Rps2 | -7768 |
Rps24 | -7591 |
Pabpc1 | -7327 |
Rps3a1 | -7247 |
Eif3h | -7126 |
Rps4x | -7101 |
Rps6 | -6778 |
Eif1ax | -6714 |
Eif2s3x | -6648 |
Rps3 | -6619 |
Rps8 | -6582 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Eif2s2 | -8324 |
Eif4a2 | -8274 |
Eif3j2 | -8206 |
Eif3e | -8202 |
Eif4e | -8156 |
Eif2s1 | -8079 |
Eif3m | -8002 |
Rps2 | -7768 |
Rps24 | -7591 |
Pabpc1 | -7327 |
Rps3a1 | -7247 |
Eif3h | -7126 |
Rps4x | -7101 |
Rps6 | -6778 |
Eif1ax | -6714 |
Eif2s3x | -6648 |
Rps3 | -6619 |
Rps8 | -6582 |
Rps23 | -6540 |
Rps27a | -6495 |
Rps14 | -6141 |
Rps13 | -6050 |
Eif3a | -6011 |
Rps27l | -5975 |
Eif4b | -5755 |
Rps25 | -5718 |
Rps9 | -5358 |
Eif3g | -5313 |
Rps16 | -5184 |
Rps20 | -5080 |
Rps19 | -4737 |
Rpsa | -4551 |
Rps11 | -4519 |
Rps10 | -4314 |
Eif4a1 | -4206 |
Eif3j1 | -4145 |
Rps26 | -3865 |
Rps17 | -3848 |
Rps27 | -3639 |
Rps15a | -3370 |
Eif4ebp1 | -3362 |
Fau | -3267 |
Rps5 | -3041 |
Eif3c | -2718 |
Eif3k | -2431 |
Eif3d | -2344 |
Rps15 | -2201 |
Rps12 | -1815 |
Eif3f | -1745 |
Rps21 | -1427 |
Eif3i | 284 |
Eif4h | 1596 |
Eif3l | 2389 |
Rps28 | 2422 |
Eif3b | 3053 |
Eif4g1 | 3969 |
Rps29 | 4006 |
EUKARYOTIC TRANSLATION INITIATION
304 | |
---|---|
set | EUKARYOTIC TRANSLATION INITIATION |
setSize | 114 |
pANOVA | 3.62e-24 |
s.dist | -0.549 |
p.adjustANOVA | 2.12e-21 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Eif2s2 | -8324 |
Eif5b | -8297 |
Rpl30 | -8293 |
Eif4a2 | -8274 |
Eif5 | -8213 |
Eif3j2 | -8206 |
Eif3e | -8202 |
Eif4e | -8156 |
Rpl22l1 | -8141 |
Eif2s1 | -8079 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Eif3m | -8002 |
Rpl27a | -7806 |
Rps2 | -7768 |
Rpl36a | -7624 |
Rps24 | -7591 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Eif2s2 | -8324 |
Eif5b | -8297 |
Rpl30 | -8293 |
Eif4a2 | -8274 |
Eif5 | -8213 |
Eif3j2 | -8206 |
Eif3e | -8202 |
Eif4e | -8156 |
Rpl22l1 | -8141 |
Eif2s1 | -8079 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Eif3m | -8002 |
Rpl27a | -7806 |
Rps2 | -7768 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Pabpc1 | -7327 |
Rps3a1 | -7247 |
Rpl15 | -7145 |
Eif3h | -7126 |
Rps4x | -7101 |
Rpl6 | -6987 |
Eif2b3 | -6845 |
Rps6 | -6778 |
Rpl9 | -6764 |
Rpl24 | -6731 |
Eif1ax | -6714 |
Eif2s3x | -6648 |
Rps3 | -6619 |
Rpl7 | -6613 |
Rps8 | -6582 |
Rpl13a | -6546 |
Rpl17 | -6544 |
Rps23 | -6540 |
Rps27a | -6495 |
Rpl11 | -6314 |
Rpl14 | -6262 |
Rpl4 | -6223 |
Rpl22 | -6168 |
Rps14 | -6141 |
Rps13 | -6050 |
Eif3a | -6011 |
Rps27l | -5975 |
Eif4b | -5755 |
Rps25 | -5718 |
Rpl23a | -5554 |
Rpl18a | -5540 |
Rpl23 | -5442 |
Rps9 | -5358 |
Eif3g | -5313 |
Rpl31 | -5187 |
Rps16 | -5184 |
Rps20 | -5080 |
Rpl21 | -5011 |
Rpl27 | -4994 |
Rpl36al | -4919 |
Rpl10a | -4803 |
Rps19 | -4737 |
Rpsa | -4551 |
Rps11 | -4519 |
Rpl7a | -4362 |
Rps10 | -4314 |
Eif4a1 | -4206 |
Eif3j1 | -4145 |
Uba52 | -3960 |
Rpl28 | -3949 |
Rps26 | -3865 |
Rps17 | -3848 |
Rpl19 | -3712 |
Rpl32 | -3656 |
Rps27 | -3639 |
Rps15a | -3370 |
Eif4ebp1 | -3362 |
Fau | -3267 |
Rpl37a | -3095 |
Rps5 | -3041 |
Rpl34 | -3010 |
Rpl18 | -2938 |
Rpl39 | -2737 |
Eif3c | -2718 |
Rplp1 | -2691 |
Rpl8 | -2622 |
Eif2b5 | -2578 |
Eif3k | -2431 |
Eif3d | -2344 |
Rps15 | -2201 |
Rpl13 | -1947 |
Rpl35 | -1857 |
Rps12 | -1815 |
Eif3f | -1745 |
Rps21 | -1427 |
Rplp2 | -429 |
Rpl36 | -165 |
Rpl37 | 145 |
Eif3i | 284 |
Rpl10 | 514 |
Rpl12 | 951 |
Rpl38 | 1302 |
Eif4h | 1596 |
Eif2b4 | 2120 |
Eif3l | 2389 |
Rps28 | 2422 |
Eif2b1 | 2549 |
Eif3b | 3053 |
Eif4g1 | 3969 |
Rps29 | 4006 |
Eif2b2 | 6854 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
1007 | |
---|---|
set | SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE |
setSize | 106 |
pANOVA | 4.81e-22 |
s.dist | -0.542 |
p.adjustANOVA | 1.45e-19 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Spcs2 | -8284 |
Rpl22l1 | -8141 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Srp54a | -7879 |
Rpl27a | -7806 |
Rps2 | -7768 |
Spcs3 | -7739 |
Rpl36a | -7624 |
Srp19 | -7606 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Ssr3 | -7313 |
Rps3a1 | -7247 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Spcs2 | -8284 |
Rpl22l1 | -8141 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Srp54a | -7879 |
Rpl27a | -7806 |
Rps2 | -7768 |
Spcs3 | -7739 |
Rpl36a | -7624 |
Srp19 | -7606 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Ssr3 | -7313 |
Rps3a1 | -7247 |
Ssr1 | -7167 |
Rpl15 | -7145 |
Rps4x | -7101 |
Rpl6 | -6987 |
Rps6 | -6778 |
Rpl9 | -6764 |
Sec61g | -6747 |
Rpl24 | -6731 |
Srp14 | -6719 |
Spcs1 | -6626 |
Rps3 | -6619 |
Rpl7 | -6613 |
Rps8 | -6582 |
Rpl13a | -6546 |
Rpl17 | -6544 |
Rps23 | -6540 |
Rps27a | -6495 |
Sec11a | -6393 |
Rpl11 | -6314 |
Rpl14 | -6262 |
Rpl4 | -6223 |
Rpl22 | -6168 |
Rps14 | -6141 |
Srp9 | -6063 |
Rps13 | -6050 |
Rps27l | -5975 |
Rps25 | -5718 |
Rpl23a | -5554 |
Rpl18a | -5540 |
Rpl23 | -5442 |
Rps9 | -5358 |
Sec11c | -5203 |
Rpl31 | -5187 |
Rps16 | -5184 |
Rps20 | -5080 |
Rpl21 | -5011 |
Rpl27 | -4994 |
Rpl36al | -4919 |
Rpl10a | -4803 |
Rps19 | -4737 |
Rpsa | -4551 |
Rps11 | -4519 |
Rpl7a | -4362 |
Rps10 | -4314 |
Rpn1 | -4191 |
Uba52 | -3960 |
Rpl28 | -3949 |
Rps26 | -3865 |
Rps17 | -3848 |
Rpl19 | -3712 |
Rpl32 | -3656 |
Rps27 | -3639 |
Rps15a | -3370 |
Fau | -3267 |
Tram1 | -3222 |
Rpl37a | -3095 |
Rps5 | -3041 |
Rpl34 | -3010 |
Rpl18 | -2938 |
Sec61b | -2933 |
Rpl39 | -2737 |
Srp72 | -2721 |
Ssr4 | -2693 |
Rplp1 | -2691 |
Rpl8 | -2622 |
Ssr2 | -2440 |
Rps15 | -2201 |
Rpl13 | -1947 |
Rpl35 | -1857 |
Rps12 | -1815 |
Rps21 | -1427 |
Rplp2 | -429 |
Rpn2 | -246 |
Rpl36 | -165 |
Srprb | 131 |
Rpl37 | 145 |
Ddost | 192 |
Rpl10 | 514 |
Rpl12 | 951 |
Rpl38 | 1302 |
Sec61a2 | 1781 |
Rps28 | 2422 |
Srpr | 2709 |
Rps29 | 4006 |
Srp68 | 6072 |
Sec61a1 | 7338 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
837 | |
---|---|
set | RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY |
setSize | 94 |
pANOVA | 2.31e-19 |
s.dist | -0.537 |
p.adjustANOVA | 3.86e-17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Eif2s2 | -8324 |
Rpl30 | -8293 |
Rpl22l1 | -8141 |
Eif2s1 | -8079 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Rpl27a | -7806 |
Cebpg | -7782 |
Rps2 | -7768 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Rps3a1 | -7247 |
Rpl15 | -7145 |
Rps4x | -7101 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Eif2s2 | -8324 |
Rpl30 | -8293 |
Rpl22l1 | -8141 |
Eif2s1 | -8079 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Rpl27a | -7806 |
Cebpg | -7782 |
Rps2 | -7768 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Rps3a1 | -7247 |
Rpl15 | -7145 |
Rps4x | -7101 |
Rpl6 | -6987 |
Rps6 | -6778 |
Rpl9 | -6764 |
Rpl24 | -6731 |
Eif2s3x | -6648 |
Rps3 | -6619 |
Rpl7 | -6613 |
Rps8 | -6582 |
Rpl13a | -6546 |
Rpl17 | -6544 |
Rps23 | -6540 |
Rps27a | -6495 |
Asns | -6350 |
Rpl11 | -6314 |
Impact | -6270 |
Rpl14 | -6262 |
Rpl4 | -6223 |
Rpl22 | -6168 |
Rps14 | -6141 |
Rps13 | -6050 |
Rps27l | -5975 |
Rps25 | -5718 |
Rpl23a | -5554 |
Rpl18a | -5540 |
Rpl23 | -5442 |
Atf2 | -5437 |
Rps9 | -5358 |
Rpl31 | -5187 |
Rps16 | -5184 |
Rps20 | -5080 |
Rpl21 | -5011 |
Rpl27 | -4994 |
Rpl36al | -4919 |
Rpl10a | -4803 |
Rps19 | -4737 |
Rpsa | -4551 |
Rps11 | -4519 |
Rpl7a | -4362 |
Rps10 | -4314 |
Uba52 | -3960 |
Rpl28 | -3949 |
Rps26 | -3865 |
Rps17 | -3848 |
Rpl19 | -3712 |
Rpl32 | -3656 |
Rps27 | -3639 |
Rps15a | -3370 |
Fau | -3267 |
Rpl37a | -3095 |
Rps5 | -3041 |
Rpl34 | -3010 |
Rpl18 | -2938 |
Rpl39 | -2737 |
Rplp1 | -2691 |
Rpl8 | -2622 |
Rps15 | -2201 |
Rpl13 | -1947 |
Rpl35 | -1857 |
Rps12 | -1815 |
Rps21 | -1427 |
Atf3 | -1057 |
Rplp2 | -429 |
Atf4 | -352 |
Rpl36 | -165 |
Rpl37 | 145 |
Ddit3 | 207 |
Rpl10 | 514 |
Rpl12 | 951 |
Rpl38 | 1302 |
Rps28 | 2422 |
Rps29 | 4006 |
Cebpb | 6857 |
Eif2ak4 | 8309 |
Gcn1 | 8499 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN
1048 | |
---|---|
set | SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN |
setSize | 12 |
pANOVA | 0.00155 |
s.dist | -0.528 |
p.adjustANOVA | 0.0119 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Spcs2 | -8284 |
Pla2g7 | -8192 |
Spcs3 | -7739 |
Spcs1 | -6626 |
Pcsk1 | -6429 |
Sec11a | -6393 |
Bche | -5750 |
Sec11c | -5203 |
Igf1 | -3521 |
Klf4 | -2316 |
Crhr2 | 3746 |
Ache | 4463 |
GeneID | Gene Rank |
---|---|
Spcs2 | -8284 |
Pla2g7 | -8192 |
Spcs3 | -7739 |
Spcs1 | -6626 |
Pcsk1 | -6429 |
Sec11a | -6393 |
Bche | -5750 |
Sec11c | -5203 |
Igf1 | -3521 |
Klf4 | -2316 |
Crhr2 | 3746 |
Ache | 4463 |
ADENYLATE CYCLASE ACTIVATING PATHWAY
35 | |
---|---|
set | ADENYLATE CYCLASE ACTIVATING PATHWAY |
setSize | 10 |
pANOVA | 0.00491 |
s.dist | 0.514 |
p.adjustANOVA | 0.0302 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy6 | 8343 |
Adcy1 | 7876 |
Adcy4 | 7558 |
Adcy3 | 6270 |
Adcy5 | 6103 |
Adcy9 | 6004 |
Adcy7 | 5768 |
Gnal | 1960 |
Adcy2 | -1367 |
Adcy8 | -3914 |
GeneID | Gene Rank |
---|---|
Adcy6 | 8343 |
Adcy1 | 7876 |
Adcy4 | 7558 |
Adcy3 | 6270 |
Adcy5 | 6103 |
Adcy9 | 6004 |
Adcy7 | 5768 |
Gnal | 1960 |
Adcy2 | -1367 |
Adcy8 | -3914 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
1030 | |
---|---|
set | SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES |
setSize | 29 |
pANOVA | 3.4e-06 |
s.dist | -0.498 |
p.adjustANOVA | 5.85e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ube2b | -8167 |
Ube2d2a | -8123 |
Ube2l3 | -8107 |
Ube2d1 | -8100 |
Ube2e1 | -8074 |
Ube2k | -7794 |
Ube2a | -7638 |
Ube2w | -7489 |
Ube2e3 | -7471 |
Ube2r2 | -7384 |
Ube2t | -7149 |
Ube2g1 | -7107 |
Ube2q2 | -6665 |
Rps27a | -6495 |
Uchl3 | -6205 |
Uba52 | -3960 |
Otulin | -3806 |
Ube2s | -3359 |
Uba6 | -2871 |
Usp9x | -2098 |
GeneID | Gene Rank |
---|---|
Ube2b | -8167 |
Ube2d2a | -8123 |
Ube2l3 | -8107 |
Ube2d1 | -8100 |
Ube2e1 | -8074 |
Ube2k | -7794 |
Ube2a | -7638 |
Ube2w | -7489 |
Ube2e3 | -7471 |
Ube2r2 | -7384 |
Ube2t | -7149 |
Ube2g1 | -7107 |
Ube2q2 | -6665 |
Rps27a | -6495 |
Uchl3 | -6205 |
Uba52 | -3960 |
Otulin | -3806 |
Ube2s | -3359 |
Uba6 | -2871 |
Usp9x | -2098 |
Ubb | -1705 |
Cdc34 | -1533 |
Usp7 | -413 |
Ubc | 176 |
Ube2z | 993 |
Ube2h | 1794 |
Usp5 | 1843 |
Uba1 | 2293 |
Ube2g2 | 5693 |
COMPLEX I BIOGENESIS
171 | |
---|---|
set | COMPLEX I BIOGENESIS |
setSize | 56 |
pANOVA | 1.5e-10 |
s.dist | -0.495 |
p.adjustANOVA | 8.35e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ndufv2 | -8225 |
mt-Nd3 | -8217 |
Ndufc2 | -8184 |
Ndufaf2 | -8036 |
Ndufaf4 | -7811 |
Ndufs4 | -7781 |
mt-Nd1 | -7775 |
mt-Nd2 | -7691 |
Ndufa10 | -7690 |
Ndufb4 | -7616 |
Ndufaf1 | -7515 |
mt-Nd4 | -7348 |
Ndufaf5 | -7171 |
Ndufb5 | -7049 |
mt-Nd6 | -7046 |
Ndufb6 | -6773 |
mt-Nd5 | -6712 |
Ndufc1 | -6489 |
Nubpl | -6400 |
Ndufa8 | -6288 |
GeneID | Gene Rank |
---|---|
Ndufv2 | -8225 |
mt-Nd3 | -8217 |
Ndufc2 | -8184 |
Ndufaf2 | -8036 |
Ndufaf4 | -7811 |
Ndufs4 | -7781 |
mt-Nd1 | -7775 |
mt-Nd2 | -7691 |
Ndufa10 | -7690 |
Ndufb4 | -7616 |
Ndufaf1 | -7515 |
mt-Nd4 | -7348 |
Ndufaf5 | -7171 |
Ndufb5 | -7049 |
mt-Nd6 | -7046 |
Ndufb6 | -6773 |
mt-Nd5 | -6712 |
Ndufc1 | -6489 |
Nubpl | -6400 |
Ndufa8 | -6288 |
Ndufa9 | -6258 |
Ndufs2 | -6093 |
Ndufb3 | -6047 |
Ndufb9 | -5882 |
Ndufa12 | -5878 |
Ndufa5 | -5746 |
Ndufs5 | -5271 |
Ndufb2 | -5052 |
Ndufs6 | -5003 |
Ndufs1 | -4858 |
Ndufb11 | -4703 |
Ndufb8 | -4574 |
Tmem126b | -4549 |
Ndufaf6 | -4409 |
Ndufa6 | -3969 |
Ndufs8 | -3711 |
Ndufs3 | -3557 |
Ndufaf7 | -2652 |
Ndufv1 | -2446 |
Ndufa1 | -2342 |
Ndufb1 | -1848 |
Timmdc1 | -1652 |
Ndufab1 | -1622 |
Ndufaf3 | -1006 |
Ndufa7 | -922 |
Ndufb7 | -677 |
Ndufa13 | -112 |
Ndufb10 | 93 |
Ndufa2 | 115 |
Ndufa11 | 761 |
Ndufv3 | 1316 |
Acad9 | 1432 |
Ndufs7 | 2959 |
Ndufa3 | 3432 |
Ecsit | 5455 |
Tmem186 | 5506 |
CD28 DEPENDENT VAV1 PATHWAY
125 | |
---|---|
set | CD28 DEPENDENT VAV1 PATHWAY |
setSize | 11 |
pANOVA | 0.00494 |
s.dist | -0.489 |
p.adjustANOVA | 0.0303 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cdc42 | -8238 |
Pak1 | -8116 |
Pak3 | -6854 |
Rac1 | -5803 |
Cd86 | -5012 |
Pak2 | -4999 |
Cd80 | -2882 |
Grb2 | -2784 |
Lck | -1794 |
Fyn | 1001 |
Vav1 | 1149 |
GeneID | Gene Rank |
---|---|
Cdc42 | -8238 |
Pak1 | -8116 |
Pak3 | -6854 |
Rac1 | -5803 |
Cd86 | -5012 |
Pak2 | -4999 |
Cd80 | -2882 |
Grb2 | -2784 |
Lck | -1794 |
Fyn | 1001 |
Vav1 | 1149 |
TERMINATION OF O GLYCAN BIOSYNTHESIS
1058 | |
---|---|
set | TERMINATION OF O GLYCAN BIOSYNTHESIS |
setSize | 10 |
pANOVA | 0.00748 |
s.dist | 0.488 |
p.adjustANOVA | 0.0421 |
Top enriched genes
GeneID | Gene Rank |
---|---|
St3gal3 | 7969 |
St6galnac2 | 7809 |
St3gal1 | 7172 |
St3gal2 | 5158 |
Muc3a | 5143 |
St6galnac4 | 5022 |
St6galnac3 | 3407 |
Muc6 | 2068 |
St3gal4 | -442 |
St6gal1 | -847 |
GeneID | Gene Rank |
---|---|
St3gal3 | 7969 |
St6galnac2 | 7809 |
St3gal1 | 7172 |
St3gal2 | 5158 |
Muc3a | 5143 |
St6galnac4 | 5022 |
St6galnac3 | 3407 |
Muc6 | 2068 |
St3gal4 | -442 |
St6gal1 | -847 |
CRMPS IN SEMA3A SIGNALING
189 | |
---|---|
set | CRMPS IN SEMA3A SIGNALING |
setSize | 16 |
pANOVA | 0.000719 |
s.dist | 0.488 |
p.adjustANOVA | 0.00633 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dpysl5 | 8431 |
Plxna1 | 8242 |
Plxna3 | 7928 |
Dpysl4 | 7605 |
Fes | 7245 |
Plxna2 | 6985 |
Plxna4 | 6955 |
Crmp1 | 6150 |
Nrp1 | 6030 |
Dpysl2 | 2869 |
Cdk5 | 2570 |
Fyn | 1001 |
Gsk3b | -138 |
Cdk5r1 | -305 |
Dpysl3 | -1629 |
Sema3a | -2039 |
GeneID | Gene Rank |
---|---|
Dpysl5 | 8431 |
Plxna1 | 8242 |
Plxna3 | 7928 |
Dpysl4 | 7605 |
Fes | 7245 |
Plxna2 | 6985 |
Plxna4 | 6955 |
Crmp1 | 6150 |
Nrp1 | 6030 |
Dpysl2 | 2869 |
Cdk5 | 2570 |
Fyn | 1001 |
Gsk3b | -138 |
Cdk5r1 | -305 |
Dpysl3 | -1629 |
Sema3a | -2039 |
SELENOAMINO ACID METABOLISM
909 | |
---|---|
set | SELENOAMINO ACID METABOLISM |
setSize | 109 |
pANOVA | 2.85e-18 |
s.dist | -0.483 |
p.adjustANOVA | 3.71e-16 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Eef1e1 | -8345 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Rpl22l1 | -8141 |
Hnmt | -8090 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Rpl27a | -7806 |
Rps2 | -7768 |
Rars | -7667 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Ahcy | -7587 |
Aimp1 | -7569 |
Rpl26 | -7528 |
Dars | -7464 |
Rpl3 | -7423 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Eef1e1 | -8345 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Rpl22l1 | -8141 |
Hnmt | -8090 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Rpl27a | -7806 |
Rps2 | -7768 |
Rars | -7667 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Ahcy | -7587 |
Aimp1 | -7569 |
Rpl26 | -7528 |
Dars | -7464 |
Rpl3 | -7423 |
Rps3a1 | -7247 |
Sars | -7189 |
Rpl15 | -7145 |
Rps4x | -7101 |
Rpl6 | -6987 |
Rps6 | -6778 |
Rpl9 | -6764 |
Rpl24 | -6731 |
Rps3 | -6619 |
Rpl7 | -6613 |
Rps8 | -6582 |
Rpl13a | -6546 |
Rpl17 | -6544 |
Rps23 | -6540 |
Rps27a | -6495 |
Rpl11 | -6314 |
Rpl14 | -6262 |
Rpl4 | -6223 |
Rpl22 | -6168 |
Rps14 | -6141 |
Rps13 | -6050 |
Rps27l | -5975 |
Rps25 | -5718 |
Pstk | -5613 |
Rpl23a | -5554 |
Rpl18a | -5540 |
Rpl23 | -5442 |
Rps9 | -5358 |
Rpl31 | -5187 |
Rps16 | -5184 |
Rps20 | -5080 |
Eprs | -5045 |
Rpl21 | -5011 |
Rpl27 | -4994 |
Rpl36al | -4919 |
Rpl10a | -4803 |
Papss2 | -4778 |
Rps19 | -4737 |
Sephs2 | -4674 |
Rpsa | -4551 |
Rps11 | -4519 |
Rpl7a | -4362 |
Rps10 | -4314 |
Uba52 | -3960 |
Rpl28 | -3949 |
Rps26 | -3865 |
Rps17 | -3848 |
Rpl19 | -3712 |
Rpl32 | -3656 |
Rps27 | -3639 |
Kars | -3398 |
Rps15a | -3370 |
Fau | -3267 |
Rpl37a | -3095 |
Rps5 | -3041 |
Rpl34 | -3010 |
Rpl18 | -2938 |
Papss1 | -2803 |
Rpl39 | -2737 |
Rplp1 | -2691 |
Gsr | -2684 |
Rpl8 | -2622 |
Cbs | -2611 |
Rps15 | -2201 |
Rpl13 | -1947 |
Rpl35 | -1857 |
Rps12 | -1815 |
Rps21 | -1427 |
Lars | -1221 |
Aimp2 | -461 |
Inmt | -456 |
Rplp2 | -429 |
Rpl36 | -165 |
Rpl37 | 145 |
Rpl10 | 514 |
Rpl12 | 951 |
Eefsec | 1273 |
Rpl38 | 1302 |
Scly | 1988 |
Sepsecs | 2320 |
Rps28 | 2422 |
Cth | 2453 |
Txnrd1 | 3664 |
Rps29 | 4006 |
Iars | 5545 |
Gnmt | 6059 |
Qars | 6325 |
Mars1 | 6721 |
Secisbp2 | 8325 |
APOPTOSIS INDUCED DNA FRAGMENTATION
66 | |
---|---|
set | APOPTOSIS INDUCED DNA FRAGMENTATION |
setSize | 10 |
pANOVA | 0.00903 |
s.dist | -0.477 |
p.adjustANOVA | 0.0485 |
Top enriched genes
GeneID | Gene Rank |
---|---|
H1f2 | -8340 |
Casp3 | -8259 |
Hmgb1 | -8226 |
H1f0 | -8175 |
Hmgb2 | -7878 |
H1f4 | -5807 |
Kpna1 | -5448 |
Kpnb1 | 1223 |
Dffb | 5687 |
Dffa | 5989 |
GeneID | Gene Rank |
---|---|
H1f2 | -8340 |
Casp3 | -8259 |
Hmgb1 | -8226 |
H1f0 | -8175 |
Hmgb2 | -7878 |
H1f4 | -5807 |
Kpna1 | -5448 |
Kpnb1 | 1223 |
Dffb | 5687 |
Dffa | 5989 |
PROTEIN METHYLATION
751 | |
---|---|
set | PROTEIN METHYLATION |
setSize | 17 |
pANOVA | 0.000785 |
s.dist | -0.47 |
p.adjustANOVA | 0.00681 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Calm1 | -8268 |
Hspa8 | -7919 |
Rps2 | -7768 |
Eef1akmt2 | -7275 |
Kin | -7228 |
Vcpkmt | -7225 |
Vcp | -6370 |
Eef1a1 | -5772 |
Etfb | -5388 |
Etfbkmt | -5260 |
Eef1akmt1 | -4743 |
Camkmt | -2777 |
Mettl21a | -1900 |
Eef2 | -752 |
Eef2kmt | 2336 |
Prmt3 | 5164 |
Mettl22 | 5398 |
GeneID | Gene Rank |
---|---|
Calm1 | -8268 |
Hspa8 | -7919 |
Rps2 | -7768 |
Eef1akmt2 | -7275 |
Kin | -7228 |
Vcpkmt | -7225 |
Vcp | -6370 |
Eef1a1 | -5772 |
Etfb | -5388 |
Etfbkmt | -5260 |
Eef1akmt1 | -4743 |
Camkmt | -2777 |
Mettl21a | -1900 |
Eef2 | -752 |
Eef2kmt | 2336 |
Prmt3 | 5164 |
Mettl22 | 5398 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
1099 | |
---|---|
set | TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR |
setSize | 11 |
pANOVA | 0.00839 |
s.dist | -0.459 |
p.adjustANOVA | 0.0461 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hsp90b1 | -8325 |
Tlr3 | -8233 |
Ctsl | -7964 |
Ctss | -7943 |
Ctsb | -6536 |
Lgmn | -5798 |
Tlr7 | -1935 |
Ctsk | -1464 |
Cnpy3 | 1852 |
Tlr9 | 2356 |
Unc93b1 | 2491 |
GeneID | Gene Rank |
---|---|
Hsp90b1 | -8325 |
Tlr3 | -8233 |
Ctsl | -7964 |
Ctss | -7943 |
Ctsb | -6536 |
Lgmn | -5798 |
Tlr7 | -1935 |
Ctsk | -1464 |
Cnpy3 | 1852 |
Tlr9 | 2356 |
Unc93b1 | 2491 |
RESPIRATORY ELECTRON TRANSPORT
834 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT |
setSize | 102 |
pANOVA | 1.34e-15 |
s.dist | -0.458 |
p.adjustANOVA | 1.21e-13 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cycs | -8327 |
Ndufv2 | -8225 |
mt-Nd3 | -8217 |
Ndufc2 | -8184 |
mt-Co1 | -8117 |
Ndufaf2 | -8036 |
Uqcrc2 | -7974 |
Ndufaf4 | -7811 |
Ndufs4 | -7781 |
mt-Nd1 | -7775 |
mt-Nd2 | -7691 |
Ndufa10 | -7690 |
Cox20 | -7655 |
Ndufb4 | -7616 |
Ndufaf1 | -7515 |
Cox7a2l | -7370 |
Etfa | -7356 |
mt-Nd4 | -7348 |
mt-Co2 | -7285 |
mt-Cytb | -7188 |
GeneID | Gene Rank |
---|---|
Cycs | -8327 |
Ndufv2 | -8225 |
mt-Nd3 | -8217 |
Ndufc2 | -8184 |
mt-Co1 | -8117 |
Ndufaf2 | -8036 |
Uqcrc2 | -7974 |
Ndufaf4 | -7811 |
Ndufs4 | -7781 |
mt-Nd1 | -7775 |
mt-Nd2 | -7691 |
Ndufa10 | -7690 |
Cox20 | -7655 |
Ndufb4 | -7616 |
Ndufaf1 | -7515 |
Cox7a2l | -7370 |
Etfa | -7356 |
mt-Nd4 | -7348 |
mt-Co2 | -7285 |
mt-Cytb | -7188 |
Ndufaf5 | -7171 |
Sco1 | -7112 |
Ndufb5 | -7049 |
mt-Nd6 | -7046 |
mt-Co3 | -7028 |
Cox7b | -6990 |
Ndufb6 | -6773 |
Ndufa4 | -6744 |
Coq10b | -6737 |
mt-Nd5 | -6712 |
Ndufc1 | -6489 |
Nubpl | -6400 |
Ndufa8 | -6288 |
Ndufa9 | -6258 |
Cox16 | -6207 |
Uqcrb | -6105 |
Ndufs2 | -6093 |
Ndufb3 | -6047 |
Sdhc | -5905 |
Ndufb9 | -5882 |
Ndufa12 | -5878 |
Ndufa5 | -5746 |
Cox6c | -5703 |
Etfb | -5388 |
Ndufs5 | -5271 |
Ndufb2 | -5052 |
Ndufs6 | -5003 |
Sdhd | -4864 |
Ndufs1 | -4858 |
Etfdh | -4829 |
Ndufb11 | -4703 |
Ndufb8 | -4574 |
Surf1 | -4552 |
Tmem126b | -4549 |
Uqcrh | -4432 |
Ndufaf6 | -4409 |
Cox5a | -4305 |
Cox7c | -4253 |
Sdha | -4022 |
Cox4i1 | -3971 |
Ndufa6 | -3969 |
Ndufs8 | -3711 |
Ndufs3 | -3557 |
Sdhb | -3435 |
Sco2 | -3311 |
Uqcrq | -2949 |
Ndufaf7 | -2652 |
Ndufv1 | -2446 |
Cox14 | -2445 |
Ndufa1 | -2342 |
Ndufb1 | -1848 |
Cox19 | -1734 |
Timmdc1 | -1652 |
Ndufab1 | -1622 |
Cox6b1 | -1294 |
Lrpprc | -1274 |
Cox6a1 | -1024 |
Ndufaf3 | -1006 |
Ndufa7 | -922 |
Uqcrfs1 | -898 |
Ndufb7 | -677 |
Uqcr10 | -620 |
Ndufa13 | -112 |
Ndufb10 | 93 |
Ndufa2 | 115 |
Cox5b | 523 |
Coq10a | 573 |
Cox8a | 688 |
Ndufa11 | 761 |
Cyc1 | 765 |
Uqcr11 | 1036 |
Cox11 | 1132 |
Ndufv3 | 1316 |
Acad9 | 1432 |
Uqcrc1 | 1965 |
Ndufs7 | 2959 |
Ndufa3 | 3432 |
Ecsit | 5455 |
Tmem186 | 5506 |
Cox18 | 6026 |
Taco1 | 6075 |
Trap1 | 6575 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
40 | |
---|---|
set | ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 |
setSize | 19 |
pANOVA | 0.000594 |
s.dist | -0.455 |
p.adjustANOVA | 0.00531 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gng11 | -8252 |
P2ry12 | -7451 |
Gng10 | -7220 |
Gnai3 | -7219 |
Gng12 | -7193 |
Gnai1 | -6304 |
Gnb4 | -5408 |
Gngt2 | -5362 |
Gnb1 | -5114 |
Gng5 | -4383 |
Gng2 | -4118 |
Gng3 | -4032 |
Gng4 | -2468 |
Gng13 | -2173 |
Gnb5 | -453 |
Gnai2 | 477 |
Gng8 | 917 |
Gnb2 | 2170 |
Gng7 | 2566 |
GeneID | Gene Rank |
---|---|
Gng11 | -8252 |
P2ry12 | -7451 |
Gng10 | -7220 |
Gnai3 | -7219 |
Gng12 | -7193 |
Gnai1 | -6304 |
Gnb4 | -5408 |
Gngt2 | -5362 |
Gnb1 | -5114 |
Gng5 | -4383 |
Gng2 | -4118 |
Gng3 | -4032 |
Gng4 | -2468 |
Gng13 | -2173 |
Gnb5 | -453 |
Gnai2 | 477 |
Gng8 | 917 |
Gnb2 | 2170 |
Gng7 | 2566 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO
790 | |
---|---|
set | REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO |
setSize | 10 |
pANOVA | 0.0138 |
s.dist | 0.45 |
p.adjustANOVA | 0.0684 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slit1 | 8421 |
Src | 8036 |
Slit3 | 7063 |
Nell2 | 5337 |
Robo1 | 4327 |
Robo3 | 3267 |
Ntn1 | 3114 |
Dcc | 2128 |
Robo2 | 1898 |
Slit2 | -4402 |
GeneID | Gene Rank |
---|---|
Slit1 | 8421 |
Src | 8036 |
Slit3 | 7063 |
Nell2 | 5337 |
Robo1 | 4327 |
Robo3 | 3267 |
Ntn1 | 3114 |
Dcc | 2128 |
Robo2 | 1898 |
Slit2 | -4402 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION
911 | |
---|---|
set | SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION |
setSize | 14 |
pANOVA | 0.00379 |
s.dist | 0.447 |
p.adjustANOVA | 0.0249 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Plxna1 | 8242 |
Plxna3 | 7928 |
Tln1 | 7271 |
Fes | 7245 |
Plxna2 | 6985 |
Plxna4 | 6955 |
Pip5k1c | 6851 |
Nrp1 | 6030 |
Farp2 | 4925 |
Rras | 1710 |
Fyn | 1001 |
Sema3a | -2039 |
Rnd1 | -2788 |
Rac1 | -5803 |
GeneID | Gene Rank |
---|---|
Plxna1 | 8242 |
Plxna3 | 7928 |
Tln1 | 7271 |
Fes | 7245 |
Plxna2 | 6985 |
Plxna4 | 6955 |
Pip5k1c | 6851 |
Nrp1 | 6030 |
Farp2 | 4925 |
Rras | 1710 |
Fyn | 1001 |
Sema3a | -2039 |
Rnd1 | -2788 |
Rac1 | -5803 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY
815 | |
---|---|
set | REGULATION OF RUNX1 EXPRESSION AND ACTIVITY |
setSize | 17 |
pANOVA | 0.00143 |
s.dist | 0.447 |
p.adjustANOVA | 0.0112 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mov10 | 8303 |
Src | 8036 |
Tnrc6c | 7552 |
Ago2 | 7472 |
Pml | 7138 |
Ago3 | 7117 |
Ago1 | 7076 |
Ptpn11 | 6108 |
Cdk6 | 6065 |
Tnrc6a | 5731 |
Tnrc6b | 5465 |
Ccnd3 | 3485 |
Ccnd2 | 2989 |
Runx1 | -2910 |
Ago4 | -3818 |
Cbfb | -4532 |
Ccnd1 | -5131 |
GeneID | Gene Rank |
---|---|
Mov10 | 8303 |
Src | 8036 |
Tnrc6c | 7552 |
Ago2 | 7472 |
Pml | 7138 |
Ago3 | 7117 |
Ago1 | 7076 |
Ptpn11 | 6108 |
Cdk6 | 6065 |
Tnrc6a | 5731 |
Tnrc6b | 5465 |
Ccnd3 | 3485 |
Ccnd2 | 2989 |
Runx1 | -2910 |
Ago4 | -3818 |
Cbfb | -4532 |
Ccnd1 | -5131 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
190 | |
---|---|
set | CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES |
setSize | 47 |
pANOVA | 1.2e-07 |
s.dist | -0.446 |
p.adjustANOVA | 3.28e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmc1 | -8281 |
Psmd12 | -8214 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
Psmd7 | -6678 |
Psme2 | -6584 |
Psmd8 | -6421 |
GeneID | Gene Rank |
---|---|
Psmc1 | -8281 |
Psmd12 | -8214 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
Psmd7 | -6678 |
Psme2 | -6584 |
Psmd8 | -6421 |
Mrc1 | -5916 |
Psma7 | -5400 |
Psmc5 | -4628 |
Psmb4 | -4130 |
Fcgr1 | -3874 |
Psme3 | -3372 |
Sem1 | -3270 |
Psmd5 | -3241 |
Psme1 | -3149 |
Psmc3 | -3144 |
Psmb9 | -3039 |
Psmb10 | -2592 |
Psmb6 | -1711 |
Psmd13 | -1434 |
Psmb3 | -868 |
Psmd2 | -105 |
Psmd9 | 182 |
Psmf1 | 393 |
Mrc2 | 451 |
Psmd11 | 661 |
Psmb2 | 1247 |
Psmd4 | 1519 |
Psmc4 | 2323 |
Psmb11 | 2711 |
Psme4 | 3582 |
Psmb5 | 4171 |
Psmd3 | 7171 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING
610 | |
---|---|
set | NEGATIVE REGULATION OF NOTCH4 SIGNALING |
setSize | 54 |
pANOVA | 1.46e-08 |
s.dist | -0.446 |
p.adjustANOVA | 5.5e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Skp1 | -8308 |
Psmc1 | -8281 |
Fbxw7 | -8219 |
Psmd12 | -8214 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Rbx1 | -6792 |
Psma1 | -6696 |
GeneID | Gene Rank |
---|---|
Skp1 | -8308 |
Psmc1 | -8281 |
Fbxw7 | -8219 |
Psmd12 | -8214 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Rbx1 | -6792 |
Psma1 | -6696 |
Psmd7 | -6678 |
Psme2 | -6584 |
Rps27a | -6495 |
Psmd8 | -6421 |
Ywhaz | -6204 |
Psma7 | -5400 |
Psmc5 | -4628 |
Psmb4 | -4130 |
Uba52 | -3960 |
Psme3 | -3372 |
Sem1 | -3270 |
Psmd5 | -3241 |
Psme1 | -3149 |
Psmc3 | -3144 |
Psmb9 | -3039 |
Cul1 | -2786 |
Psmb10 | -2592 |
Psmb6 | -1711 |
Ubb | -1705 |
Psmd13 | -1434 |
Psmb3 | -868 |
Psmd2 | -105 |
Ubc | 176 |
Psmd9 | 182 |
Psmf1 | 393 |
Psmd11 | 661 |
Psmb2 | 1247 |
Psmd4 | 1519 |
Psmc4 | 2323 |
Tacc3 | 2328 |
Psmb5 | 4171 |
Akt1 | 5806 |
Psmd3 | 7171 |
Notch4 | 7821 |
NONSENSE MEDIATED DECAY NMD
632 | |
---|---|
set | NONSENSE MEDIATED DECAY NMD |
setSize | 109 |
pANOVA | 9.02e-16 |
s.dist | -0.446 |
p.adjustANOVA | 9.49e-14 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Rpl22l1 | -8141 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Rbm8a | -7969 |
Ppp2r2a | -7843 |
Rpl27a | -7806 |
Rps2 | -7768 |
Ncbp2 | -7698 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Pabpc1 | -7327 |
Etf1 | -7308 |
Rps3a1 | -7247 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Rpl22l1 | -8141 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Rbm8a | -7969 |
Ppp2r2a | -7843 |
Rpl27a | -7806 |
Rps2 | -7768 |
Ncbp2 | -7698 |
Rpl36a | -7624 |
Rps24 | -7591 |
Rpl29 | -7590 |
Rpl26 | -7528 |
Rpl3 | -7423 |
Pabpc1 | -7327 |
Etf1 | -7308 |
Rps3a1 | -7247 |
Ppp2ca | -7194 |
Rpl15 | -7145 |
Rps4x | -7101 |
Pnrc2 | -7015 |
Rpl6 | -6987 |
Rps6 | -6778 |
Rpl9 | -6764 |
Rpl24 | -6731 |
Magoh | -6642 |
Rps3 | -6619 |
Upf3b | -6617 |
Rpl7 | -6613 |
Rps8 | -6582 |
Rpl13a | -6546 |
Rpl17 | -6544 |
Rps23 | -6540 |
Rps27a | -6495 |
Rpl11 | -6314 |
Rpl14 | -6262 |
Rpl4 | -6223 |
Rpl22 | -6168 |
Rps14 | -6141 |
Rps13 | -6050 |
Rps27l | -5975 |
Rps25 | -5718 |
Rpl23a | -5554 |
Rpl18a | -5540 |
Rpl23 | -5442 |
Rps9 | -5358 |
Rpl31 | -5187 |
Rps16 | -5184 |
Rps20 | -5080 |
Rpl21 | -5011 |
Rpl27 | -4994 |
Rpl36al | -4919 |
Rpl10a | -4803 |
Rps19 | -4737 |
Rpsa | -4551 |
Rps11 | -4519 |
Rpl7a | -4362 |
Rps10 | -4314 |
Upf2 | -4067 |
Magohb | -4000 |
Uba52 | -3960 |
Rpl28 | -3949 |
Rps26 | -3865 |
Rps17 | -3848 |
Rpl19 | -3712 |
Rpl32 | -3656 |
Rps27 | -3639 |
Rps15a | -3370 |
Fau | -3267 |
Rpl37a | -3095 |
Rps5 | -3041 |
Rpl34 | -3010 |
Rpl18 | -2938 |
Rpl39 | -2737 |
Rplp1 | -2691 |
Rpl8 | -2622 |
Upf3a | -2326 |
Rps15 | -2201 |
Rpl13 | -1947 |
Rpl35 | -1857 |
Rps12 | -1815 |
Eif4a3 | -1511 |
Rps21 | -1427 |
Rplp2 | -429 |
Rpl36 | -165 |
Rpl37 | 145 |
Gspt2 | 283 |
Rpl10 | 514 |
Ppp2r1a | 824 |
Rnps1 | 916 |
Rpl12 | 951 |
Rpl38 | 1302 |
Gspt1 | 2174 |
Rps28 | 2422 |
Ncbp1 | 3139 |
Eif4g1 | 3969 |
Rps29 | 4006 |
Smg8 | 4278 |
Smg7 | 5010 |
Smg6 | 5352 |
Dcp1a | 5376 |
Smg9 | 6453 |
Casc3 | 7238 |
Smg1 | 7531 |
Upf1 | 7910 |
Smg5 | 8469 |
TRIGLYCERIDE CATABOLISM
1140 | |
---|---|
set | TRIGLYCERIDE CATABOLISM |
setSize | 14 |
pANOVA | 0.00425 |
s.dist | -0.441 |
p.adjustANOVA | 0.0275 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fabp7 | -8292 |
Prkacb | -7640 |
Fabp5 | -7221 |
Ppp1cb | -7098 |
Abhd5 | -6324 |
Gpd2 | -5443 |
Ppp1ca | -4020 |
Ppp1cc | -3616 |
Fabp3 | -3553 |
Cav1 | -3345 |
Plin3 | -3306 |
Mgll | 751 |
Lipe | 2686 |
Prkaca | 5710 |
GeneID | Gene Rank |
---|---|
Fabp7 | -8292 |
Prkacb | -7640 |
Fabp5 | -7221 |
Ppp1cb | -7098 |
Abhd5 | -6324 |
Gpd2 | -5443 |
Ppp1ca | -4020 |
Ppp1cc | -3616 |
Fabp3 | -3553 |
Cav1 | -3345 |
Plin3 | -3306 |
Mgll | 751 |
Lipe | 2686 |
Prkaca | 5710 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS
791 | |
---|---|
set | REGULATION OF EXPRESSION OF SLITS AND ROBOS |
setSize | 161 |
pANOVA | 4.97e-22 |
s.dist | -0.441 |
p.adjustANOVA | 1.45e-19 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Psmc1 | -8281 |
Psmd12 | -8214 |
Rpl22l1 | -8141 |
Psma6 | -8083 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Psma3 | -8008 |
Rbm8a | -7969 |
Psmc6 | -7952 |
Eloc | -7935 |
Rpl27a | -7806 |
Rps2 | -7768 |
Ncbp2 | -7698 |
Rpl36a | -7624 |
Psmb1 | -7592 |
Rps24 | -7591 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Rps7 | -8344 |
Rpl35a | -8326 |
Rpl30 | -8293 |
Psmc1 | -8281 |
Psmd12 | -8214 |
Rpl22l1 | -8141 |
Psma6 | -8083 |
Rplp0 | -8066 |
Rpl5 | -8040 |
Psma3 | -8008 |
Rbm8a | -7969 |
Psmc6 | -7952 |
Eloc | -7935 |
Rpl27a | -7806 |
Rps2 | -7768 |
Ncbp2 | -7698 |
Rpl36a | -7624 |
Psmb1 | -7592 |
Rps24 | -7591 |
Rpl29 | -7590 |
Psmd14 | -7555 |
Rpl26 | -7528 |
Psmd6 | -7433 |
Rpl3 | -7423 |
Psma2 | -7377 |
Psmb7 | -7343 |
Pabpc1 | -7327 |
Etf1 | -7308 |
Rps3a1 | -7247 |
Psmd10 | -7234 |
Psma4 | -7157 |
Rpl15 | -7145 |
Psma5 | -7119 |
Rps4x | -7101 |
Psmd1 | -7050 |
Rpl6 | -6987 |
Cul2 | -6925 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Rbx1 | -6792 |
Rps6 | -6778 |
Rpl9 | -6764 |
Rpl24 | -6731 |
Psma1 | -6696 |
Psmd7 | -6678 |
Magoh | -6642 |
Rps3 | -6619 |
Upf3b | -6617 |
Rpl7 | -6613 |
Psme2 | -6584 |
Rps8 | -6582 |
Rpl13a | -6546 |
Rpl17 | -6544 |
Rps23 | -6540 |
Rps27a | -6495 |
Psmd8 | -6421 |
Rpl11 | -6314 |
Rpl14 | -6262 |
Rpl4 | -6223 |
Rpl22 | -6168 |
Rps14 | -6141 |
Rps13 | -6050 |
Rps27l | -5975 |
Rps25 | -5718 |
Rpl23a | -5554 |
Rpl18a | -5540 |
Rpl23 | -5442 |
Psma7 | -5400 |
Rps9 | -5358 |
Rpl31 | -5187 |
Rps16 | -5184 |
Rps20 | -5080 |
Rpl21 | -5011 |
Rpl27 | -4994 |
Rpl36al | -4919 |
Rpl10a | -4803 |
Rps19 | -4737 |
Isl1 | -4715 |
Psmc5 | -4628 |
Rpsa | -4551 |
Rps11 | -4519 |
Slit2 | -4402 |
Rpl7a | -4362 |
Rps10 | -4314 |
Psmb4 | -4130 |
Upf2 | -4067 |
Magohb | -4000 |
Uba52 | -3960 |
Rpl28 | -3949 |
Rps26 | -3865 |
Rps17 | -3848 |
Rpl19 | -3712 |
Rpl32 | -3656 |
Rps27 | -3639 |
Psme3 | -3372 |
Rps15a | -3370 |
Sem1 | -3270 |
Fau | -3267 |
Psmd5 | -3241 |
Psme1 | -3149 |
Psmc3 | -3144 |
Rpl37a | -3095 |
Elob | -3074 |
Usp33 | -3067 |
Rps5 | -3041 |
Psmb9 | -3039 |
Rpl34 | -3010 |
Rpl18 | -2938 |
Rpl39 | -2737 |
Rplp1 | -2691 |
Rpl8 | -2622 |
Psmb10 | -2592 |
Upf3a | -2326 |
Rps15 | -2201 |
Rpl13 | -1947 |
Rpl35 | -1857 |
Rps12 | -1815 |
Psmb6 | -1711 |
Ubb | -1705 |
Eif4a3 | -1511 |
Psmd13 | -1434 |
Rps21 | -1427 |
Psmb3 | -868 |
Rplp2 | -429 |
Rpl36 | -165 |
Psmd2 | -105 |
Rpl37 | 145 |
Ubc | 176 |
Psmd9 | 182 |
Gspt2 | 283 |
Psmf1 | 393 |
Rpl10 | 514 |
Psmd11 | 661 |
Rnps1 | 916 |
Rpl12 | 951 |
Psmb2 | 1247 |
Lhx9 | 1292 |
Rpl38 | 1302 |
Psmd4 | 1519 |
Robo2 | 1898 |
Dag1 | 1968 |
Gspt1 | 2174 |
Psmc4 | 2323 |
Rps28 | 2422 |
Lhx2 | 2616 |
Psmb11 | 2711 |
Ncbp1 | 3139 |
Robo3 | 3267 |
Psme4 | 3582 |
Eif4g1 | 3969 |
Rps29 | 4006 |
Psmb5 | 4171 |
Robo1 | 4327 |
Col4a5 | 5231 |
Msi1 | 5486 |
Ldb1 | 6869 |
Psmd3 | 7171 |
Casc3 | 7238 |
Zswim8 | 8269 |
Slit1 | 8421 |
CRISTAE FORMATION
188 | |
---|---|
set | CRISTAE FORMATION |
setSize | 31 |
pANOVA | 2.3e-05 |
s.dist | -0.439 |
p.adjustANOVA | 0.000306 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Apoo | -8251 |
Atp5pb | -7848 |
Mtx2 | -7791 |
Atp5c1 | -7618 |
Hspa9 | -7462 |
Dmac2l | -7416 |
mt-Atp6 | -7410 |
Atp5h | -7400 |
Micos10 | -7239 |
Atp5b | -6701 |
Atp5a1 | -6246 |
Atp5j | -6240 |
Atp5l | -5922 |
Atp5g3 | -5787 |
Immt | -5462 |
Apool | -5075 |
Atp5o | -4857 |
Chchd3 | -4146 |
Atp5j2 | -3789 |
Tmem11 | -3632 |
GeneID | Gene Rank |
---|---|
Apoo | -8251 |
Atp5pb | -7848 |
Mtx2 | -7791 |
Atp5c1 | -7618 |
Hspa9 | -7462 |
Dmac2l | -7416 |
mt-Atp6 | -7410 |
Atp5h | -7400 |
Micos10 | -7239 |
Atp5b | -6701 |
Atp5a1 | -6246 |
Atp5j | -6240 |
Atp5l | -5922 |
Atp5g3 | -5787 |
Immt | -5462 |
Apool | -5075 |
Atp5o | -4857 |
Chchd3 | -4146 |
Atp5j2 | -3789 |
Tmem11 | -3632 |
Atp5e | -3319 |
Samm50 | -2911 |
Chchd6 | -2414 |
Micos13 | -2255 |
mt-Atp8 | -20 |
Atp5d | 1601 |
Mtx1 | 3627 |
Dnajc11 | 3699 |
Atp5g1 | 4677 |
Atp5k | 5443 |
Atp5g2 | 6507 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
835 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS |
setSize | 125 |
pANOVA | 2.82e-17 |
s.dist | -0.438 |
p.adjustANOVA | 3.3e-15 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cycs | -8327 |
Ndufv2 | -8225 |
mt-Nd3 | -8217 |
Ndufc2 | -8184 |
mt-Co1 | -8117 |
Ndufaf2 | -8036 |
Uqcrc2 | -7974 |
Atp5pb | -7848 |
Ndufaf4 | -7811 |
Ndufs4 | -7781 |
mt-Nd1 | -7775 |
mt-Nd2 | -7691 |
Ndufa10 | -7690 |
Ucp3 | -7686 |
Cox20 | -7655 |
Atp5c1 | -7618 |
Ndufb4 | -7616 |
Ndufaf1 | -7515 |
Dmac2l | -7416 |
mt-Atp6 | -7410 |
GeneID | Gene Rank |
---|---|
Cycs | -8327 |
Ndufv2 | -8225 |
mt-Nd3 | -8217 |
Ndufc2 | -8184 |
mt-Co1 | -8117 |
Ndufaf2 | -8036 |
Uqcrc2 | -7974 |
Atp5pb | -7848 |
Ndufaf4 | -7811 |
Ndufs4 | -7781 |
mt-Nd1 | -7775 |
mt-Nd2 | -7691 |
Ndufa10 | -7690 |
Ucp3 | -7686 |
Cox20 | -7655 |
Atp5c1 | -7618 |
Ndufb4 | -7616 |
Ndufaf1 | -7515 |
Dmac2l | -7416 |
mt-Atp6 | -7410 |
Atp5h | -7400 |
Cox7a2l | -7370 |
Etfa | -7356 |
mt-Nd4 | -7348 |
mt-Co2 | -7285 |
mt-Cytb | -7188 |
Ndufaf5 | -7171 |
Sco1 | -7112 |
Ndufb5 | -7049 |
mt-Nd6 | -7046 |
mt-Co3 | -7028 |
Slc25a14 | -7019 |
Cox7b | -6990 |
Ndufb6 | -6773 |
Ndufa4 | -6744 |
Coq10b | -6737 |
mt-Nd5 | -6712 |
Atp5b | -6701 |
Ndufc1 | -6489 |
Nubpl | -6400 |
Ndufa8 | -6288 |
Ndufa9 | -6258 |
Atp5a1 | -6246 |
Atp5j | -6240 |
Cox16 | -6207 |
Uqcrb | -6105 |
Ndufs2 | -6093 |
Ndufb3 | -6047 |
Atp5l | -5922 |
Sdhc | -5905 |
Ndufb9 | -5882 |
Ndufa12 | -5878 |
Atp5g3 | -5787 |
Ndufa5 | -5746 |
Cox6c | -5703 |
Etfb | -5388 |
Ndufs5 | -5271 |
Ndufb2 | -5052 |
Ndufs6 | -5003 |
Sdhd | -4864 |
Ndufs1 | -4858 |
Atp5o | -4857 |
Etfdh | -4829 |
Ndufb11 | -4703 |
Ndufb8 | -4574 |
Surf1 | -4552 |
Tmem126b | -4549 |
Uqcrh | -4432 |
Ndufaf6 | -4409 |
Cox5a | -4305 |
Cox7c | -4253 |
Sdha | -4022 |
Cox4i1 | -3971 |
Ndufa6 | -3969 |
Atp5j2 | -3789 |
Ndufs8 | -3711 |
Ndufs3 | -3557 |
Sdhb | -3435 |
Atp5e | -3319 |
Sco2 | -3311 |
Uqcrq | -2949 |
Ndufaf7 | -2652 |
Ndufv1 | -2446 |
Cox14 | -2445 |
Ndufa1 | -2342 |
Pm20d1 | -1959 |
Ndufb1 | -1848 |
Cox19 | -1734 |
Timmdc1 | -1652 |
Ndufab1 | -1622 |
Cox6b1 | -1294 |
Lrpprc | -1274 |
Cox6a1 | -1024 |
Ndufaf3 | -1006 |
Ndufa7 | -922 |
Uqcrfs1 | -898 |
Ndufb7 | -677 |
Uqcr10 | -620 |
Ndufa13 | -112 |
mt-Atp8 | -20 |
Ndufb10 | 93 |
Ndufa2 | 115 |
Cox5b | 523 |
Coq10a | 573 |
Cox8a | 688 |
Ndufa11 | 761 |
Cyc1 | 765 |
Uqcr11 | 1036 |
Cox11 | 1132 |
Ndufv3 | 1316 |
Acad9 | 1432 |
Atp5d | 1601 |
Uqcrc1 | 1965 |
Ndufs7 | 2959 |
Ndufa3 | 3432 |
Atp5g1 | 4677 |
Atp5k | 5443 |
Ecsit | 5455 |
Tmem186 | 5506 |
Cox18 | 6026 |
Taco1 | 6075 |
Atp5g2 | 6507 |
Trap1 | 6575 |
Slc25a27 | 7257 |
Ucp2 | 7420 |
NRAGE SIGNALS DEATH THROUGH JNK
644 | |
---|---|
set | NRAGE SIGNALS DEATH THROUGH JNK |
setSize | 55 |
pANOVA | 2.09e-08 |
s.dist | 0.437 |
p.adjustANOVA | 7.63e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Obscn | 8445 |
Vav2 | 8423 |
Arhgef10 | 8316 |
Mcf2l | 8253 |
Plekhg2 | 8207 |
Arhgef5 | 8173 |
Plekhg5 | 8020 |
Akap13 | 7920 |
Arhgef4 | 7919 |
Arhgef18 | 7879 |
Kalrn | 7815 |
Arhgef7 | 7761 |
Arhgef17 | 7754 |
Arhgef2 | 7731 |
Arhgef1 | 7709 |
Trio | 7554 |
Arhgef11 | 7503 |
Abr | 7479 |
Rasgrf2 | 7289 |
Prex1 | 6987 |
GeneID | Gene Rank |
---|---|
Obscn | 8445 |
Vav2 | 8423 |
Arhgef10 | 8316 |
Mcf2l | 8253 |
Plekhg2 | 8207 |
Arhgef5 | 8173 |
Plekhg5 | 8020 |
Akap13 | 7920 |
Arhgef4 | 7919 |
Arhgef18 | 7879 |
Kalrn | 7815 |
Arhgef7 | 7761 |
Arhgef17 | 7754 |
Arhgef2 | 7731 |
Arhgef1 | 7709 |
Trio | 7554 |
Arhgef11 | 7503 |
Abr | 7479 |
Rasgrf2 | 7289 |
Prex1 | 6987 |
Arhgef40 | 6957 |
Arhgef19 | 6752 |
Fgd1 | 6592 |
Arhgef10l | 6441 |
Itsn1 | 6345 |
Arhgef12 | 6278 |
Arhgef6 | 6116 |
Arhgef33 | 5616 |
Fgd2 | 5476 |
Tiam1 | 5244 |
Arhgef37 | 4214 |
Tiam2 | 3403 |
Maged1 | 2776 |
Arhgef16 | 2421 |
Arhgef26 | 1975 |
Fgd3 | 1899 |
Ngf | 1659 |
Arhgef3 | 1641 |
Vav1 | 1149 |
Aatf | 1000 |
Gna13 | 947 |
Arhgef9 | 447 |
Net1 | 121 |
Sos1 | -264 |
Fgd4 | -322 |
Bad | -378 |
Bcl2l11 | -1041 |
Vav3 | -1069 |
Ngef | -1236 |
Sos2 | -1968 |
Arhgef15 | -3897 |
Ngfr | -5353 |
Mapk8 | -5712 |
Rac1 | -5803 |
Mcf2 | -6586 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21
906 | |
---|---|
set | SCF SKP2 MEDIATED DEGRADATION OF P27 P21 |
setSize | 59 |
pANOVA | 6.58e-09 |
s.dist | -0.437 |
p.adjustANOVA | 2.85e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Skp1 | -8308 |
Psmc1 | -8281 |
Psmd12 | -8214 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Ccne2 | -7699 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
Psmd7 | -6678 |
GeneID | Gene Rank |
---|---|
Skp1 | -8308 |
Psmc1 | -8281 |
Psmd12 | -8214 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Ccne2 | -7699 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
Psmd7 | -6678 |
Psme2 | -6584 |
Rps27a | -6495 |
Psmd8 | -6421 |
Ccna2 | -5415 |
Psma7 | -5400 |
Ccnd1 | -5131 |
Psmc5 | -4628 |
Psmb4 | -4130 |
Uba52 | -3960 |
Cdkn1a | -3492 |
Psme3 | -3372 |
Cks1b | -3320 |
Sem1 | -3270 |
Psmd5 | -3241 |
Psme1 | -3149 |
Psmc3 | -3144 |
Psmb9 | -3039 |
Cdkn1b | -2999 |
Cdk4 | -2980 |
Cul1 | -2786 |
Psmb10 | -2592 |
Psmb6 | -1711 |
Ubb | -1705 |
Psmd13 | -1434 |
Psmb3 | -868 |
Ccne1 | -728 |
Psmd2 | -105 |
Ubc | 176 |
Psmd9 | 182 |
Psmf1 | 393 |
Psmd11 | 661 |
Psmb2 | 1247 |
Psmd4 | 1519 |
Psmc4 | 2323 |
Skp2 | 4008 |
Ccna1 | 4014 |
Psmb5 | 4171 |
Cdk2 | 4827 |
Psmd3 | 7171 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS
217 | |
---|---|
set | DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS |
setSize | 59 |
pANOVA | 8e-09 |
s.dist | -0.434 |
p.adjustANOVA | 3.23e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmc1 | -8281 |
Psmd12 | -8214 |
Erlec1 | -8118 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Derl2 | -7847 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
Psmd7 | -6678 |
GeneID | Gene Rank |
---|---|
Psmc1 | -8281 |
Psmd12 | -8214 |
Erlec1 | -8118 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Derl2 | -7847 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
Psmd7 | -6678 |
Psme2 | -6584 |
Rps27a | -6495 |
Rnf5 | -6487 |
Psmd8 | -6421 |
Vcp | -6370 |
Psma7 | -5400 |
Psmc5 | -4628 |
Derl1 | -4452 |
Psmb4 | -4130 |
Uba52 | -3960 |
Psme3 | -3372 |
Sem1 | -3270 |
Psmd5 | -3241 |
Psme1 | -3149 |
Psmc3 | -3144 |
Psmb9 | -3039 |
Psmb10 | -2592 |
Erlin1 | -2579 |
Rnf185 | -1770 |
Os9 | -1766 |
Psmb6 | -1711 |
Ubb | -1705 |
Psmd13 | -1434 |
Derl3 | -1361 |
Psmb3 | -868 |
Psmd2 | -105 |
Ubc | 176 |
Psmd9 | 182 |
Psmf1 | 393 |
Psmd11 | 661 |
Psmb2 | 1247 |
Psmd4 | 1519 |
Psmc4 | 2323 |
Sel1l | 2625 |
Psmb11 | 2711 |
Erlin2 | 3055 |
Psme4 | 3582 |
Psmb5 | 4171 |
Psmd3 | 7171 |
SIGNALING BY LEPTIN
963 | |
---|---|
set | SIGNALING BY LEPTIN |
setSize | 10 |
pANOVA | 0.0178 |
s.dist | 0.433 |
p.adjustANOVA | 0.0824 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sh2b1 | 8211 |
Stat3 | 6485 |
Ptpn11 | 6108 |
Stat5b | 4875 |
Irs1 | 4502 |
Jak2 | 4364 |
Irs2 | 3402 |
Stat5a | 2969 |
Socs3 | -685 |
Lepr | -2482 |
GeneID | Gene Rank |
---|---|
Sh2b1 | 8211 |
Stat3 | 6485 |
Ptpn11 | 6108 |
Stat5b | 4875 |
Irs1 | 4502 |
Jak2 | 4364 |
Irs2 | 3402 |
Stat5a | 2969 |
Socs3 | -685 |
Lepr | -2482 |
INTERLEUKIN 12 SIGNALING
469 | |
---|---|
set | INTERLEUKIN 12 SIGNALING |
setSize | 37 |
pANOVA | 5.34e-06 |
s.dist | -0.432 |
p.adjustANOVA | 8.61e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tcp1 | -8258 |
Cdc42 | -8238 |
Rplp0 | -8066 |
Hnrnpdl | -7924 |
Rap1b | -7871 |
Ppia | -7845 |
Hspa9 | -7462 |
Rala | -7435 |
Hnrnpa2b1 | -7378 |
Pdcd4 | -6988 |
Mtap | -6818 |
Psme2 | -6584 |
Lcp1 | -5846 |
Capza1 | -5795 |
Gsto1 | -5545 |
Snrpa1 | -5224 |
Cnn2 | -5021 |
Pak2 | -4999 |
Hnrnpf | -4672 |
P4hb | -4375 |
GeneID | Gene Rank |
---|---|
Tcp1 | -8258 |
Cdc42 | -8238 |
Rplp0 | -8066 |
Hnrnpdl | -7924 |
Rap1b | -7871 |
Ppia | -7845 |
Hspa9 | -7462 |
Rala | -7435 |
Hnrnpa2b1 | -7378 |
Pdcd4 | -6988 |
Mtap | -6818 |
Psme2 | -6584 |
Lcp1 | -5846 |
Capza1 | -5795 |
Gsto1 | -5545 |
Snrpa1 | -5224 |
Cnn2 | -5021 |
Pak2 | -4999 |
Hnrnpf | -4672 |
P4hb | -4375 |
Taldo1 | -3813 |
Sod2 | -3755 |
Sod1 | -3215 |
Cfl1 | -3018 |
Aip | -2618 |
Jak1 | -2019 |
Pitpna | -1698 |
Msn | -1261 |
Arf1 | -564 |
Il12a | -358 |
Bola2 | -8 |
Anxa2 | 509 |
Lmnb1 | 1473 |
Mif | 4007 |
Jak2 | 4364 |
Il12rb1 | 5221 |
Tyk2 | 8074 |
PROCESSING OF SMDT1
742 | |
---|---|
set | PROCESSING OF SMDT1 |
setSize | 16 |
pANOVA | 0.00291 |
s.dist | -0.43 |
p.adjustANOVA | 0.0202 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Maip1 | -7981 |
Pmpcb | -7895 |
Micu2 | -7860 |
Micu3 | -7016 |
Yme1l1 | -7007 |
Phb | -6580 |
Mcub | -6561 |
Parl | -6114 |
Smdt1 | -4004 |
Stoml2 | -3740 |
Micu1 | -1008 |
Phb2 | -100 |
Pmpca | 348 |
Spg7 | 1923 |
Mcu | 2786 |
Afg3l2 | 4406 |
GeneID | Gene Rank |
---|---|
Maip1 | -7981 |
Pmpcb | -7895 |
Micu2 | -7860 |
Micu3 | -7016 |
Yme1l1 | -7007 |
Phb | -6580 |
Mcub | -6561 |
Parl | -6114 |
Smdt1 | -4004 |
Stoml2 | -3740 |
Micu1 | -1008 |
Phb2 | -100 |
Pmpca | 348 |
Spg7 | 1923 |
Mcu | 2786 |
Afg3l2 | 4406 |
GLYCOGEN SYNTHESIS
388 | |
---|---|
set | GLYCOGEN SYNTHESIS |
setSize | 14 |
pANOVA | 0.0056 |
s.dist | -0.428 |
p.adjustANOVA | 0.0333 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ugp2 | -8317 |
Ppp1r3c | -8314 |
Gyg | -6830 |
Rps27a | -6495 |
Pgm2l1 | -6098 |
Pgm2 | -5623 |
Uba52 | -3960 |
Epm2a | -3490 |
Gbe1 | -3313 |
Pgm1 | -2590 |
Ubb | -1705 |
Nhlrc1 | 143 |
Ubc | 176 |
Gys1 | 7324 |
GeneID | Gene Rank |
---|---|
Ugp2 | -8317 |
Ppp1r3c | -8314 |
Gyg | -6830 |
Rps27a | -6495 |
Pgm2l1 | -6098 |
Pgm2 | -5623 |
Uba52 | -3960 |
Epm2a | -3490 |
Gbe1 | -3313 |
Pgm1 | -2590 |
Ubb | -1705 |
Nhlrc1 | 143 |
Ubc | 176 |
Gys1 | 7324 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA
85 | |
---|---|
set | AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA |
setSize | 54 |
pANOVA | 7.14e-08 |
s.dist | -0.424 |
p.adjustANOVA | 2.2e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmc1 | -8281 |
Psmd12 | -8214 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Hspa8 | -7919 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Pabpc1 | -7327 |
Hnrnpd | -7317 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
GeneID | Gene Rank |
---|---|
Psmc1 | -8281 |
Psmd12 | -8214 |
Psma6 | -8083 |
Psma3 | -8008 |
Psmc6 | -7952 |
Hspa8 | -7919 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Pabpc1 | -7327 |
Hnrnpd | -7317 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Psmd1 | -7050 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
Psmd7 | -6678 |
Psme2 | -6584 |
Rps27a | -6495 |
Psmd8 | -6421 |
Psma7 | -5400 |
Psmc5 | -4628 |
Psmb4 | -4130 |
Uba52 | -3960 |
Psme3 | -3372 |
Sem1 | -3270 |
Psmd5 | -3241 |
Psme1 | -3149 |
Psmc3 | -3144 |
Psmb9 | -3039 |
Psmb10 | -2592 |
Psmb6 | -1711 |
Ubb | -1705 |
Psmd13 | -1434 |
Psmb3 | -868 |
Psmd2 | -105 |
Ubc | 176 |
Psmd9 | 182 |
Psmf1 | 393 |
Psmd11 | 661 |
Hspa1a | 1010 |
Psmb2 | 1247 |
Psmd4 | 1519 |
Psmc4 | 2323 |
Psmb11 | 2711 |
Psme4 | 3582 |
Eif4g1 | 3969 |
Psmb5 | 4171 |
Hspb1 | 4930 |
Psmd3 | 7171 |
TRANSLATION
1122 | |
---|---|
set | TRANSLATION |
setSize | 286 |
pANOVA | 7.33e-35 |
s.dist | -0.423 |
p.adjustANOVA | 8.59e-32 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Eef1e1 | -8345 |
Rps7 | -8344 |
Rpl35a | -8326 |
Eif2s2 | -8324 |
N6amt1 | -8311 |
Eif5b | -8297 |
Rpl30 | -8293 |
Spcs2 | -8284 |
Eif4a2 | -8274 |
Ppa1 | -8273 |
Eif5 | -8213 |
Eif3j2 | -8206 |
Eif3e | -8202 |
Eif4e | -8156 |
Mrpl50 | -8144 |
Rpl22l1 | -8141 |
Mrps31 | -8106 |
Eif2s1 | -8079 |
Rplp0 | -8066 |
GeneID | Gene Rank |
---|---|
Rps18 | -8356 |
Eef1e1 | -8345 |
Rps7 | -8344 |
Rpl35a | -8326 |
Eif2s2 | -8324 |
N6amt1 | -8311 |
Eif5b | -8297 |
Rpl30 | -8293 |
Spcs2 | -8284 |
Eif4a2 | -8274 |
Ppa1 | -8273 |
Eif5 | -8213 |
Eif3j2 | -8206 |
Eif3e | -8202 |
Eif4e | -8156 |
Mrpl50 | -8144 |
Rpl22l1 | -8141 |
Mrps31 | -8106 |
Eif2s1 | -8079 |
Rplp0 | -8066 |
Mrps22 | -8059 |
Rpl5 | -8040 |
Eif3m | -8002 |
Mrps30 | -7993 |
Nars | -7987 |
Srp54a | -7879 |
Mrpl15 | -7863 |
Mrps18c | -7808 |
Rpl27a | -7806 |
Rps2 | -7768 |
Spcs3 | -7739 |
Rars | -7667 |
Eef1g | -7647 |
Mrpl48 | -7642 |
Rpl36a | -7624 |
Srp19 | -7606 |
Mrpl1 | -7604 |
Rps24 | -7591 |
Rpl29 | -7590 |
Aimp1 | -7569 |
Ptcd3 | -7536 |
Rpl26 | -7528 |
Mrps36 | -7475 |
Dars | -7464 |
Rpl3 | -7423 |
Gars | -7392 |
Mrpl13 | -7390 |
Mrpl33 | -7361 |
Pabpc1 | -7327 |
Mrps23 | -7315 |
Ssr3 | -7313 |
Etf1 | -7308 |
Rps3a1 | -7247 |
Sars | -7189 |
Mrpl19 | -7180 |
Ssr1 | -7167 |
Rpl15 | -7145 |
Eif3h | -7126 |
Mrpl32 | -7120 |
Mrpl16 | -7108 |
Rps4x | -7101 |
Ppa2 | -7040 |
Rpl6 | -6987 |
Chchd1 | -6871 |
Mrpl47 | -6859 |
Eif2b3 | -6845 |
Mrpl34 | -6826 |
Eef1b2 | -6800 |
Rps6 | -6778 |
Rpl9 | -6764 |
Sec61g | -6747 |
Rpl24 | -6731 |
Srp14 | -6719 |
Eif1ax | -6714 |
Mrps25 | -6671 |
Eif2s3x | -6648 |
Spcs1 | -6626 |
Mrps5 | -6624 |
Mrps35 | -6621 |
Rps3 | -6619 |
Rpl7 | -6613 |
Rps8 | -6582 |
Rpl13a | -6546 |
Rpl17 | -6544 |
Rps23 | -6540 |
Rps27a | -6495 |
Mrpl54 | -6411 |
Sec11a | -6393 |
Hars | -6384 |
Mrpl39 | -6377 |
Mrps10 | -6372 |
Mrpl35 | -6327 |
Rpl11 | -6314 |
Rpl14 | -6262 |
Mrpl42 | -6237 |
Rpl4 | -6223 |
Mtif3 | -6198 |
Rpl22 | -6168 |
Mrpl11 | -6165 |
Rps14 | -6141 |
Mrpl30 | -6085 |
Srp9 | -6063 |
Rps13 | -6050 |
Eif3a | -6011 |
Trmt112 | -6003 |
Rps27l | -5975 |
Mrps14 | -5890 |
Eef1a1 | -5772 |
Eif4b | -5755 |
Rps25 | -5718 |
Mrpl18 | -5711 |
Mrps33 | -5649 |
Mrps2 | -5634 |
Rpl23a | -5554 |
Rpl18a | -5540 |
Mrpl40 | -5479 |
Tsfm | -5467 |
Rpl23 | -5442 |
Rps9 | -5358 |
Eif3g | -5313 |
Mrpl17 | -5226 |
Sec11c | -5203 |
Rpl31 | -5187 |
Rps16 | -5184 |
Mrps7 | -5182 |
Mtrf1l | -5086 |
Rps20 | -5080 |
Eprs | -5045 |
Rpl21 | -5011 |
Rpl27 | -4994 |
Rpl36al | -4919 |
Mrpl24 | -4884 |
Mrpl3 | -4810 |
Rpl10a | -4803 |
Mrpl23 | -4772 |
Mrpl10 | -4753 |
Rps19 | -4737 |
Mtif2 | -4710 |
Mrpl43 | -4558 |
Rpsa | -4551 |
Mrps18b | -4540 |
Aurkaip1 | -4521 |
Rps11 | -4519 |
Rpl7a | -4362 |
Mrpl12 | -4341 |
Rps10 | -4314 |
Mrpl44 | -4260 |
Mrps18a | -4231 |
Eif4a1 | -4206 |
Rpn1 | -4191 |
Eif3j1 | -4145 |
Dars2 | -4141 |
Mrps9 | -4127 |
Mrps16 | -4124 |
Mrps28 | -4082 |
Rars2 | -4079 |
Uba52 | -3960 |
Rpl28 | -3949 |
Rps26 | -3865 |
Rps17 | -3848 |
Mrps6 | -3721 |
Rpl19 | -3712 |
Mrpl49 | -3668 |
Rpl32 | -3656 |
Rps27 | -3639 |
Kars | -3398 |
Rps15a | -3370 |
Eif4ebp1 | -3362 |
Mrpl51 | -3295 |
Mrpl9 | -3284 |
Fau | -3267 |
Tram1 | -3222 |
Yars2 | -3212 |
Rpl37a | -3095 |
Mars2 | -3057 |
Yars | -3043 |
Rps5 | -3041 |
Fars2 | -3040 |
Mrps17 | -3013 |
Rpl34 | -3010 |
Mrpl46 | -2970 |
Rpl18 | -2938 |
Sec61b | -2933 |
Mrpl41 | -2811 |
Rpl39 | -2737 |
Srp72 | -2721 |
Eif3c | -2718 |
Ssr4 | -2693 |
Rplp1 | -2691 |
Mrpl27 | -2636 |
Rpl8 | -2622 |
Eif2b5 | -2578 |
Mrps21 | -2509 |
Mrpl22 | -2443 |
Ssr2 | -2440 |
Eif3k | -2431 |
Eif3d | -2344 |
Mrps24 | -2317 |
Mrpl21 | -2283 |
Rps15 | -2201 |
Farsb | -2005 |
Rpl13 | -1947 |
Mrpl52 | -1931 |
Mrpl28 | -1883 |
Rpl35 | -1857 |
Rps12 | -1815 |
Eif3f | -1745 |
Eef1d | -1550 |
Gadd45gip1 | -1433 |
Rps21 | -1427 |
Gfm1 | -1293 |
Mrrf | -1288 |
Lars | -1221 |
Mrpl36 | -1190 |
Eef1a2 | -1005 |
Eef2 | -752 |
Mrps12 | -732 |
Mrps15 | -684 |
Mrpl14 | -672 |
Mrpl55 | -612 |
Aimp2 | -461 |
Rplp2 | -429 |
Mrpl20 | -371 |
Mrps26 | -247 |
Rpn2 | -246 |
Rpl36 | -165 |
Nars2 | 17 |
Srprb | 131 |
Rpl37 | 145 |
Ddost | 192 |
Tars | 251 |
Mrpl53 | 258 |
Gspt2 | 283 |
Eif3i | 284 |
Aars | 355 |
Rpl10 | 514 |
Mrpl2 | 760 |
Mrpl57 | 904 |
Rpl12 | 951 |
Tufm | 1249 |
Rpl38 | 1302 |
Pars2 | 1528 |
Eif4h | 1596 |
Mtfmt | 1692 |
Sec61a2 | 1781 |
Mrps11 | 1827 |
Mrps34 | 1876 |
Ears2 | 1928 |
Mrpl58 | 1955 |
Hars2 | 2071 |
Eif2b4 | 2120 |
Gspt1 | 2174 |
Eif3l | 2389 |
Rps28 | 2422 |
Eif2b1 | 2549 |
Tars2 | 2665 |
Srpr | 2709 |
Eif3b | 3053 |
Mrpl38 | 3067 |
Iars2 | 3149 |
Dap3 | 3316 |
Apeh | 3619 |
Lars2 | 3659 |
Gfm2 | 3691 |
Mrps27 | 3875 |
Eif4g1 | 3969 |
Rps29 | 4006 |
Wars2 | 4219 |
Wars | 4475 |
Iars | 5545 |
Mrpl37 | 5577 |
Cars | 5765 |
Oxa1l | 6029 |
Srp68 | 6072 |
Sars2 | 6259 |
Qars | 6325 |
Farsa | 6334 |
Vars | 6427 |
Mars1 | 6721 |
Eif2b2 | 6854 |
Cars2 | 7047 |
Mrpl4 | 7211 |
Sec61a1 | 7338 |
Eral1 | 7587 |
Vars2 | 7733 |
Aars2 | 7882 |
MITOCHONDRIAL TRANSLATION
570 | |
---|---|
set | MITOCHONDRIAL TRANSLATION |
setSize | 93 |
pANOVA | 1.81e-12 |
s.dist | -0.423 |
p.adjustANOVA | 1.11e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mrpl50 | -8144 |
Mrps31 | -8106 |
Mrps22 | -8059 |
Mrps30 | -7993 |
Mrpl15 | -7863 |
Mrps18c | -7808 |
Mrpl48 | -7642 |
Mrpl1 | -7604 |
Ptcd3 | -7536 |
Mrps36 | -7475 |
Mrpl13 | -7390 |
Mrpl33 | -7361 |
Mrps23 | -7315 |
Mrpl19 | -7180 |
Mrpl32 | -7120 |
Mrpl16 | -7108 |
Chchd1 | -6871 |
Mrpl47 | -6859 |
Mrpl34 | -6826 |
Mrps25 | -6671 |
GeneID | Gene Rank |
---|---|
Mrpl50 | -8144 |
Mrps31 | -8106 |
Mrps22 | -8059 |
Mrps30 | -7993 |
Mrpl15 | -7863 |
Mrps18c | -7808 |
Mrpl48 | -7642 |
Mrpl1 | -7604 |
Ptcd3 | -7536 |
Mrps36 | -7475 |
Mrpl13 | -7390 |
Mrpl33 | -7361 |
Mrps23 | -7315 |
Mrpl19 | -7180 |
Mrpl32 | -7120 |
Mrpl16 | -7108 |
Chchd1 | -6871 |
Mrpl47 | -6859 |
Mrpl34 | -6826 |
Mrps25 | -6671 |
Mrps5 | -6624 |
Mrps35 | -6621 |
Mrpl54 | -6411 |
Mrpl39 | -6377 |
Mrps10 | -6372 |
Mrpl35 | -6327 |
Mrpl42 | -6237 |
Mtif3 | -6198 |
Mrpl11 | -6165 |
Mrpl30 | -6085 |
Mrps14 | -5890 |
Mrpl18 | -5711 |
Mrps33 | -5649 |
Mrps2 | -5634 |
Mrpl40 | -5479 |
Tsfm | -5467 |
Mrpl17 | -5226 |
Mrps7 | -5182 |
Mtrf1l | -5086 |
Mrpl24 | -4884 |
Mrpl3 | -4810 |
Mrpl23 | -4772 |
Mrpl10 | -4753 |
Mtif2 | -4710 |
Mrpl43 | -4558 |
Mrps18b | -4540 |
Aurkaip1 | -4521 |
Mrpl12 | -4341 |
Mrpl44 | -4260 |
Mrps18a | -4231 |
Mrps9 | -4127 |
Mrps16 | -4124 |
Mrps28 | -4082 |
Mrps6 | -3721 |
Mrpl49 | -3668 |
Mrpl51 | -3295 |
Mrpl9 | -3284 |
Mrps17 | -3013 |
Mrpl46 | -2970 |
Mrpl41 | -2811 |
Mrpl27 | -2636 |
Mrps21 | -2509 |
Mrpl22 | -2443 |
Mrps24 | -2317 |
Mrpl21 | -2283 |
Mrpl52 | -1931 |
Mrpl28 | -1883 |
Gadd45gip1 | -1433 |
Gfm1 | -1293 |
Mrrf | -1288 |
Mrpl36 | -1190 |
Mrps12 | -732 |
Mrps15 | -684 |
Mrpl14 | -672 |
Mrpl55 | -612 |
Mrpl20 | -371 |
Mrps26 | -247 |
Mrpl53 | 258 |
Mrpl2 | 760 |
Mrpl57 | 904 |
Tufm | 1249 |
Mtfmt | 1692 |
Mrps11 | 1827 |
Mrps34 | 1876 |
Mrpl58 | 1955 |
Mrpl38 | 3067 |
Dap3 | 3316 |
Gfm2 | 3691 |
Mrps27 | 3875 |
Mrpl37 | 5577 |
Oxa1l | 6029 |
Mrpl4 | 7211 |
Eral1 | 7587 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
327 | |
---|---|
set | FORMATION OF ATP BY CHEMIOSMOTIC COUPLING |
setSize | 18 |
pANOVA | 0.00191 |
s.dist | -0.423 |
p.adjustANOVA | 0.014 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp5pb | -7848 |
Atp5c1 | -7618 |
Dmac2l | -7416 |
mt-Atp6 | -7410 |
Atp5h | -7400 |
Atp5b | -6701 |
Atp5a1 | -6246 |
Atp5j | -6240 |
Atp5l | -5922 |
Atp5g3 | -5787 |
Atp5o | -4857 |
Atp5j2 | -3789 |
Atp5e | -3319 |
mt-Atp8 | -20 |
Atp5d | 1601 |
Atp5g1 | 4677 |
Atp5k | 5443 |
Atp5g2 | 6507 |
GeneID | Gene Rank |
---|---|
Atp5pb | -7848 |
Atp5c1 | -7618 |
Dmac2l | -7416 |
mt-Atp6 | -7410 |
Atp5h | -7400 |
Atp5b | -6701 |
Atp5a1 | -6246 |
Atp5j | -6240 |
Atp5l | -5922 |
Atp5g3 | -5787 |
Atp5o | -4857 |
Atp5j2 | -3789 |
Atp5e | -3319 |
mt-Atp8 | -20 |
Atp5d | 1601 |
Atp5g1 | 4677 |
Atp5k | 5443 |
Atp5g2 | 6507 |
METABOLISM OF POLYAMINES
551 | |
---|---|
set | METABOLISM OF POLYAMINES |
setSize | 58 |
pANOVA | 3.07e-08 |
s.dist | -0.42 |
p.adjustANOVA | 1.06e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psmc1 | -8281 |
Psmd12 | -8214 |
Amd1 | -8099 |
Psma6 | -8083 |
Sat1 | -8037 |
Psma3 | -8008 |
Psmc6 | -7952 |
Sms | -7780 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Oaz3 | -7086 |
Psmd1 | -7050 |
Oaz2 | -6911 |
Psmc2 | -6811 |
GeneID | Gene Rank |
---|---|
Psmc1 | -8281 |
Psmd12 | -8214 |
Amd1 | -8099 |
Psma6 | -8083 |
Sat1 | -8037 |
Psma3 | -8008 |
Psmc6 | -7952 |
Sms | -7780 |
Psmb1 | -7592 |
Psmd14 | -7555 |
Psmd6 | -7433 |
Psma2 | -7377 |
Psmb7 | -7343 |
Psmd10 | -7234 |
Psma4 | -7157 |
Psma5 | -7119 |
Oaz3 | -7086 |
Psmd1 | -7050 |
Oaz2 | -6911 |
Psmc2 | -6811 |
Psmb8 | -6795 |
Psma1 | -6696 |
Psmd7 | -6678 |
Psme2 | -6584 |
Psmd8 | -6421 |
Nqo1 | -5963 |
Psma7 | -5400 |
Psmc5 | -4628 |
Azin1 | -4611 |
Psmb4 | -4130 |
Oaz1 | -4001 |
Odc1 | -3909 |
Paox | -3581 |
Psme3 | -3372 |
Sem1 | -3270 |
Psmd5 | -3241 |
Psme1 | -3149 |
Psmc3 | -3144 |
Psmb9 | -3039 |
Psmb10 | -2592 |
Psmb6 | -1711 |
Psmd13 | -1434 |
Psmb3 | -868 |
Psmd2 | -105 |
Psmd9 | 182 |
Psmf1 | 393 |
Psmd11 | 661 |
Psmb2 | 1247 |
Psmd4 | 1519 |
Agmat | 1990 |
Psmc4 | 2323 |
Psmb11 | 2711 |
Psme4 | 3582 |
Psmb5 | 4171 |
Azin2 | 5123 |
Psmd3 | 7171 |
Srm | 7557 |
Smox | 8548 |
SYNAPTIC ADHESION LIKE MOLECULES
1028 | |
---|---|
set | SYNAPTIC ADHESION LIKE MOLECULES |
setSize | 21 |
pANOVA | 0.000884 |
s.dist | 0.419 |
p.adjustANOVA | 0.0075 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptprs | 8535 |
Grin2c | 8250 |
Grin1 | 8150 |
Ptprf | 7633 |
Lrfn2 | 7441 |
Grin2d | 7182 |
Grin2a | 7145 |
Grin2b | 6025 |
Lrfn1 | 5728 |
Gria1 | 5625 |
Lrfn4 | 5582 |
Dlg4 | 4881 |
Flot2 | 4865 |
Lrfn3 | 4373 |
Dlg3 | 2731 |
Flot1 | 2121 |
Ptprd | 795 |
Gria3 | -1082 |
Dlg1 | -6018 |
Gria4 | -6217 |
GeneID | Gene Rank |
---|---|
Ptprs | 8535 |
Grin2c | 8250 |
Grin1 | 8150 |
Ptprf | 7633 |
Lrfn2 | 7441 |
Grin2d | 7182 |
Grin2a | 7145 |
Grin2b | 6025 |
Lrfn1 | 5728 |
Gria1 | 5625 |
Lrfn4 | 5582 |
Dlg4 | 4881 |
Flot2 | 4865 |
Lrfn3 | 4373 |
Dlg3 | 2731 |
Flot1 | 2121 |
Ptprd | 795 |
Gria3 | -1082 |
Dlg1 | -6018 |
Gria4 | -6217 |
Rtn3 | -6949 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
180 | |
---|---|
set | COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING |
setSize | 26 |
pANOVA | 0.000251 |
s.dist | -0.415 |
p.adjustANOVA | 0.00244 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cct6a | -8302 |
Tcp1 | -8258 |
Vbp1 | -8131 |
Cct2 | -8114 |
Pfdn4 | -8042 |
Cct4 | -7975 |
Cct8 | -7759 |
Pfdn1 | -6376 |
Cct3 | -6259 |
Cct7 | -5893 |
Pfdn2 | -5607 |
Pfdn5 | -4226 |
Cct5 | -4077 |
Pfdn6 | -3885 |
Tuba4a | -3429 |
Tuba1b | -3400 |
Tuba1a | -3146 |
Tuba8 | -1901 |
Tubb6 | -1519 |
Actb | -1167 |
GeneID | Gene Rank |
---|---|
Cct6a | -8302 |
Tcp1 | -8258 |
Vbp1 | -8131 |
Cct2 | -8114 |
Pfdn4 | -8042 |
Cct4 | -7975 |
Cct8 | -7759 |
Pfdn1 | -6376 |
Cct3 | -6259 |
Cct7 | -5893 |
Pfdn2 | -5607 |
Pfdn5 | -4226 |
Cct5 | -4077 |
Pfdn6 | -3885 |
Tuba4a | -3429 |
Tuba1b | -3400 |
Tuba1a | -3146 |
Tuba8 | -1901 |
Tubb6 | -1519 |
Actb | -1167 |
Tubb4b | -822 |
Tubb3 | 440 |
Tubb2b | 1631 |
Tubb2a | 4725 |
Tubb4a | 4793 |
Tuba1c | 8404 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
146 | |
---|---|
set | CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX |
setSize | 10 |
pANOVA | 0.0237 |
s.dist | -0.413 |
p.adjustANOVA | 0.104 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ywhaq | -8300 |
Ywhab | -8049 |
Ywhae | -7948 |
Ywhah | -6972 |
Ywhaz | -6204 |
Chek2 | -5935 |
Chek1 | -3066 |
Wee1 | 952 |
Ywhag | 4934 |
Sfn | 6755 |
GeneID | Gene Rank |
---|---|
Ywhaq | -8300 |
Ywhab | -8049 |
Ywhae | -7948 |
Ywhah | -6972 |
Ywhaz | -6204 |
Chek2 | -5935 |
Chek1 | -3066 |
Wee1 | 952 |
Ywhag | 4934 |
Sfn | 6755 |
G BETA GAMMA SIGNALLING THROUGH CDC42
351 | |
---|---|
set | G BETA GAMMA SIGNALLING THROUGH CDC42 |
setSize | 18 |
pANOVA | 0.00246 |
s.dist | -0.412 |
p.adjustANOVA | 0.0175 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gng11 | -8252 |
Cdc42 | -8238 |
Pak1 | -8116 |
Gng10 | -7220 |
Gng12 | -7193 |
Gnb4 | -5408 |
Gngt2 | -5362 |
Gnb1 | -5114 |
Gng5 | -4383 |
Gng2 | -4118 |
Gng3 | -4032 |
Gng4 | -2468 |
Gng13 | -2173 |
Gnb5 | -453 |
Gng8 | 917 |
Gnb2 | 2170 |
Gng7 | 2566 |
Arhgef6 | 6116 |
GeneID | Gene Rank |
---|---|
Gng11 | -8252 |
Cdc42 | -8238 |
Pak1 | -8116 |
Gng10 | -7220 |
Gng12 | -7193 |
Gnb4 | -5408 |
Gngt2 | -5362 |
Gnb1 | -5114 |
Gng5 | -4383 |
Gng2 | -4118 |
Gng3 | -4032 |
Gng4 | -2468 |
Gng13 | -2173 |
Gnb5 | -453 |
Gng8 | 917 |
Gnb2 | 2170 |
Gng7 | 2566 |
Arhgef6 | 6116 |
ACTIVATION OF SMO
26 | |
---|---|
set | ACTIVATION OF SMO |
setSize | 16 |
pANOVA | 0.00472 |
s.dist | 0.408 |
p.adjustANOVA | 0.0296 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Arrb2 | 8039 |
Evc2 | 7665 |
Smo | 7653 |
Boc | 6967 |
Iqce | 6685 |
Cdon | 6010 |
Gas8 | 5833 |
Arrb1 | 5258 |
Evc | 5254 |
Grk2 | 5048 |
Ptch1 | 4944 |
Gas1 | 1456 |
Kif3a | -2304 |
Csnk1a1 | -2327 |
Shh | -3498 |
Efcab7 | -5660 |
GeneID | Gene Rank |
---|---|
Arrb2 | 8039 |
Evc2 | 7665 |
Smo | 7653 |
Boc | 6967 |
Iqce | 6685 |
Cdon | 6010 |
Gas8 | 5833 |
Arrb1 | 5258 |
Evc | 5254 |
Grk2 | 5048 |
Ptch1 | 4944 |
Gas1 | 1456 |
Kif3a | -2304 |
Csnk1a1 | -2327 |
Shh | -3498 |
Efcab7 | -5660 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT
1063 | |
---|---|
set | THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT |
setSize | 172 |
pANOVA | 2.88e-20 |
s.dist | -0.408 |
p.adjustANOVA | 5.63e-18 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cycs | -8327 |
Slc16a1 | -8316 |
Ndufv2 | -8225 |
mt-Nd3 | -8217 |
Ndufc2 | -8184 |
mt-Co1 | -8117 |
Dld | -8103 |
Ndufaf2 | -8036 |
Uqcrc2 | -7974 |
Atp5pb | -7848 |
Ndufaf4 | -7811 |
Ndufs4 | -7781 |
mt-Nd1 | -7775 |
Fh1 | -7716 |
mt-Nd2 | -7691 |
Ndufa10 | -7690 |
Ucp3 | -7686 |
Cox20 | -7655 |
Glo1 | -7630 |
Atp5c1 | -7618 |
GeneID | Gene Rank |
---|---|
Cycs | -8327 |
Slc16a1 | -8316 |
Ndufv2 | -8225 |
mt-Nd3 | -8217 |
Ndufc2 | -8184 |
mt-Co1 | -8117 |
Dld | -8103 |
Ndufaf2 | -8036 |
Uqcrc2 | -7974 |
Atp5pb | -7848 |
Ndufaf4 | -7811 |
Ndufs4 | -7781 |
mt-Nd1 | -7775 |
Fh1 | -7716 |
mt-Nd2 | -7691 |
Ndufa10 | -7690 |
Ucp3 | -7686 |
Cox20 | -7655 |
Glo1 | -7630 |
Atp5c1 | -7618 |
Ndufb4 | -7616 |
Ndufaf1 | -7515 |
Mpc2 | -7458 |
Sucla2 | -7429 |
Dmac2l | -7416 |
mt-Atp6 | -7410 |
Pdha1 | -7404 |
Atp5h | -7400 |
Cox7a2l | -7370 |
Pdhb | -7363 |
Etfa | -7356 |
mt-Nd4 | -7348 |
Vdac1 | -7307 |
mt-Co2 | -7285 |
mt-Cytb | -7188 |
Ndufaf5 | -7171 |
Sco1 | -7112 |
Idh3a | -7067 |
Ndufb5 | -7049 |
Suclg2 | -7048 |
mt-Nd6 | -7046 |
mt-Co3 | -7028 |
Slc25a14 | -7019 |
Me1 | -6992 |
Cox7b | -6990 |
Mpc1 | -6940 |
Pdp1 | -6808 |
Ndufb6 | -6773 |
Ndufa4 | -6744 |
Coq10b | -6737 |
mt-Nd5 | -6712 |
Atp5b | -6701 |
Ndufc1 | -6489 |
Nubpl | -6400 |
Bsg | -6399 |
Ndufa8 | -6288 |
Ndufa9 | -6258 |
Atp5a1 | -6246 |
Atp5j | -6240 |
Fahd1 | -6232 |
Cox16 | -6207 |
Uqcrb | -6105 |
Ndufs2 | -6093 |
Ndufb3 | -6047 |
Atp5l | -5922 |
Sdhc | -5905 |
Ndufb9 | -5882 |
Ndufa12 | -5878 |
Atp5g3 | -5787 |
Ndufa5 | -5746 |
Cox6c | -5703 |
Adhfe1 | -5510 |
Pdhx | -5464 |
Suclg1 | -5405 |
Pdk3 | -5398 |
Etfb | -5388 |
Ldha | -5319 |
Ndufs5 | -5271 |
Ndufb2 | -5052 |
Ndufs6 | -5003 |
Sdhd | -4864 |
Ndufs1 | -4858 |
Atp5o | -4857 |
Etfdh | -4829 |
Ldhb | -4796 |
Ndufb11 | -4703 |
Me2 | -4666 |
Ndufb8 | -4574 |
L2hgdh | -4572 |
Surf1 | -4552 |
Tmem126b | -4549 |
Dlat | -4457 |
Uqcrh | -4432 |
Ndufaf6 | -4409 |
Cox5a | -4305 |
Cox7c | -4253 |
Sdha | -4022 |
Pdp2 | -3998 |
Cox4i1 | -3971 |
Ndufa6 | -3969 |
Atp5j2 | -3789 |
Ndufs8 | -3711 |
Ndufs3 | -3557 |
Sdhb | -3435 |
Atp5e | -3319 |
Sco2 | -3311 |
Uqcrq | -2949 |
Pdk4 | -2902 |
Ndufaf7 | -2652 |
Cs | -2586 |
Ndufv1 | -2446 |
Cox14 | -2445 |
Ndufa1 | -2342 |
Pm20d1 | -1959 |
Gstz1 | -1919 |
Ndufb1 | -1848 |
Cox19 | -1734 |
Timmdc1 | -1652 |
Ndufab1 | -1622 |
Cox6b1 | -1294 |
Lrpprc | -1274 |
Cox6a1 | -1024 |
Ndufaf3 | -1006 |
Ndufa7 | -922 |
Uqcrfs1 | -898 |
Aco2 | -835 |
Slc16a3 | -829 |
Nnt | -698 |
Ndufb7 | -677 |
Uqcr10 | -620 |
Hagh | -385 |
Idh3b | -364 |
Ndufa13 | -112 |
mt-Atp8 | -20 |
Ndufb10 | 93 |
Ndufa2 | 115 |
Mdh2 | 162 |
Cox5b | 523 |
Coq10a | 573 |
Cox8a | 688 |
Ndufa11 | 761 |
Cyc1 | 765 |
Me3 | 941 |
Uqcr11 | 1036 |
Cox11 | 1132 |
Ndufv3 | 1316 |
Acad9 | 1432 |
Atp5d | 1601 |
Uqcrc1 | 1965 |
Pdk2 | 2092 |
Ogdh | 2420 |
Dlst | 2717 |
Ndufs7 | 2959 |
Ndufa3 | 3432 |
Pdk1 | 3939 |
Pdpr | 4069 |
Idh3g | 4362 |
Atp5g1 | 4677 |
Atp5k | 5443 |
Ecsit | 5455 |
Tmem186 | 5506 |
Rxra | 5911 |
Cox18 | 6026 |
Taco1 | 6075 |
D2hgdh | 6188 |
Slc16a8 | 6235 |
Atp5g2 | 6507 |
Trap1 | 6575 |
Idh2 | 6751 |
Slc25a27 | 7257 |
Ucp2 | 7420 |
Ppard | 8045 |
CROSSLINKING OF COLLAGEN FIBRILS
191 | |
---|---|
set | CROSSLINKING OF COLLAGEN FIBRILS |
setSize | 15 |
pANOVA | 0.00647 |
s.dist | 0.406 |
p.adjustANOVA | 0.0368 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pxdn | 8424 |
Col4a3 | 7549 |
Loxl3 | 7501 |
Col4a2 | 6279 |
Col4a1 | 5895 |
Col4a5 | 5231 |
Bmp1 | 4599 |
Col4a4 | 4592 |
Loxl1 | 4222 |
Tll2 | 2651 |
Col1a1 | 1861 |
Pcolce | 67 |
Loxl2 | -1046 |
Tll1 | -1920 |
Col1a2 | -2692 |
GeneID | Gene Rank |
---|---|
Pxdn | 8424 |
Col4a3 | 7549 |
Loxl3 | 7501 |
Col4a2 | 6279 |
Col4a1 | 5895 |
Col4a5 | 5231 |
Bmp1 | 4599 |
Col4a4 | 4592 |
Loxl1 | 4222 |
Tll2 | 2651 |
Col1a1 | 1861 |
Pcolce | 67 |
Loxl2 | -1046 |
Tll1 | -1920 |
Col1a2 | -2692 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.1 (2023-06-16)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.3 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so; LAPACK version 3.10.0
##
## locale:
## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8
## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8
## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C
##
## time zone: /usr/share/zoneinfo/Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] GGally_2.1.2 gtools_3.9.4
## [3] echarts4r_0.4.5 beeswarm_0.4.0
## [5] pkgload_1.3.2.1 vioplot_0.4.0
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.16.0 limma_3.56.2
## [11] eulerr_7.0.0 mitch_1.12.0
## [13] MASS_7.3-60 fgsea_1.26.0
## [15] gplots_3.1.3 DESeq2_1.40.2
## [17] SummarizedExperiment_1.30.2 Biobase_2.60.0
## [19] MatrixGenerics_1.12.3 matrixStats_1.0.0
## [21] GenomicRanges_1.52.0 GenomeInfoDb_1.36.2
## [23] IRanges_2.34.1 S4Vectors_0.38.1
## [25] BiocGenerics_0.46.0 reshape2_1.4.4
## [27] lubridate_1.9.2 forcats_1.0.0
## [29] stringr_1.5.0 dplyr_1.1.2
## [31] purrr_1.0.2 readr_2.1.4
## [33] tidyr_1.3.0 tibble_3.2.1
## [35] ggplot2_3.4.3 tidyverse_2.0.0
## [37] zoo_1.8-12
##
## loaded via a namespace (and not attached):
## [1] bitops_1.0-7 gridExtra_2.3 rlang_1.1.1
## [4] magrittr_2.0.3 compiler_4.3.1 polylabelr_0.2.0
## [7] systemfonts_1.0.4 vctrs_0.6.3 rvest_1.0.3
## [10] pkgconfig_2.0.3 crayon_1.5.2 fastmap_1.1.1
## [13] XVector_0.40.0 ellipsis_0.3.2 labeling_0.4.2
## [16] caTools_1.18.2 utf8_1.2.3 promises_1.2.1
## [19] rmarkdown_2.24 tzdb_0.4.0 xfun_0.40
## [22] zlibbioc_1.46.0 cachem_1.0.8 jsonlite_1.8.7
## [25] highr_0.10 later_1.3.1 DelayedArray_0.26.7
## [28] reshape_0.8.9 BiocParallel_1.34.2 parallel_4.3.1
## [31] R6_2.5.1 bslib_0.5.1 stringi_1.7.12
## [34] RColorBrewer_1.1-3 jquerylib_0.1.4 assertthat_0.2.1
## [37] Rcpp_1.0.11 knitr_1.43 httpuv_1.6.11
## [40] Matrix_1.6-1 timechange_0.2.0 tidyselect_1.2.0
## [43] rstudioapi_0.15.0 abind_1.4-5 yaml_2.3.7
## [46] codetools_0.2-19 lattice_0.21-8 plyr_1.8.8
## [49] shiny_1.7.5 withr_2.5.0 evaluate_0.21
## [52] polyclip_1.10-4 xml2_1.3.5 pillar_1.9.0
## [55] KernSmooth_2.23-22 generics_0.1.3 RCurl_1.98-1.12
## [58] hms_1.1.3 munsell_0.5.0 scales_1.2.1
## [61] xtable_1.8-4 glue_1.6.2 tools_4.3.1
## [64] data.table_1.14.8 webshot_0.5.5 locfit_1.5-9.8
## [67] fastmatch_1.1-4 cowplot_1.1.1 grid_4.3.1
## [70] colorspace_2.1-0 GenomeInfoDbData_1.2.10 cli_3.6.1
## [73] fansi_1.0.4 viridisLite_0.4.2 S4Arrays_1.0.5
## [76] svglite_2.1.1 gtable_0.3.4 sass_0.4.7
## [79] digest_0.6.33 farver_2.1.1 htmlwidgets_1.6.2
## [82] htmltools_0.5.6 lifecycle_1.0.3 httr_1.4.7
## [85] mime_0.12
END of report